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The generation of a functional antigen receptor gene in developing lymphocytes requires that the 
second exon be assembled through a process known as V(D)J recombination, a process that 
necessarily involves the generation and repair of DNA double-strand breaks made by the Rag 
endonuclease.  Double strand breaks incurred during G1 of the cell cycle activate ATM, a PI3-
kinase-like kinase that, in response to genotoxic DNA damage, is known to phosphorylate 
hundreds of proteins with unique and diverse functions.  Notably, deficiencies in ATM lead to 
ataxia-telangiectasia, a syndrome characterized by lymphopenia, genomic instability and a 
predisposition to tumors involving antigen receptor loci suggesting that ATM likely plays a similar 
critical role downstream of Rag-mediated DNA DSBs during V(D)J recombination.  In this body of 
work, I describe three distinct pathways activated by ATM in response to Rag DNA DSBs and 
how defects in these pathways would impair lymphocyte development and contribute to the 
phenotype of ATM-deficient mice and humans.  First, ATM-deficient lymphocytes have a defect in 
the repair of Rag DNA DSBs characterized by an accumulation of unrepaired coding ends and an 
increase in aberrant hybrid joint formation during rearrangement by inversion.  Furthermore, 
these coding ends drift apart and are frequently aberrantly resolved as translocations.  We 
determine that ATM contributes to the repair of Rag DNA DSBs by maintaining the unrepaired 
ends in a stable post-cleavage complex possibly through the phosphorylation of components of 
the MRN complex.  Secondly, in G1-phase lymphocytes, the ATM-dependent phosphorylation of 
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histone H2AX inhibits the robust CtIP-dependent opening and resection of hairpin-sealed coding 
ends thereby preventing their aberrant resolution by alternative repair pathways.  Finally, in 
response to Rag DSBs, through the activation of NF!B and other transcription factors, ATM  
activates a broad genetic program that transcends the canonical DNA damage response and 
includes genes whose known functions are integral to lymphocyte development.  While this work 
has significantly increased our understanding of the cellular response to Rag DNA DSBs, given 
the diversity of the other known substrates of ATM, it seems likely that we have only begun to 
unravel the complexities of the ATM-deficient phenotype. 
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Chapter 1 
 
 
 
 
 
Background 
  
  
! 
2 
The immune system has two component arms, the innate and the adaptive immune 
systems.  The innate immune system is able to rapidly and broadly defend against large numbers 
of potential pathogens based on commonalities amongst them.  Conversely, the adaptive immune 
system, while slow to activate, can recognize and defend against any given pathogen in a specific 
manner based on that pathogen’s unique molecular characteristics.  Importantly, the adaptive 
immune system has memory that enables a more rapid and forceful response on subsequent 
encounters.  The adaptive immune system relies on B and T lymphocytes each of which contains 
a unique receptor (B- and T-cell receptors or BCRs and TCRs, respectively) that enable the cell 
to recognize individual foreign antigens either alone (BCR) or in complex with MHC molecules on 
antigen presenting cells (TCR)(1). 
The BCR is composed of two identical paired immunoglobulin heavy chain (IgH) 
molecules and two identical paired immunoglobulin light chain (IgL) molecules of either the 
lambda or kappa variety (IgL! or IgL", respectively).  The component chains each contain a 
unique variable region that confers the specificity of binding and a constant region that provides 
structure and enables for a cellular signaling cascade in response to antigen binding.  These four 
molecules are covalently linked by multiple disulfide bonds and are arranged such that the 
variable regions of the light and heavy chains are terminally located and together comprise the 
variable region that binds antigen.  Similarly, the TCR consists of molecules with both variable 
and constant regions.  A TCR consists of a single TCR alpha chain (TCR#) and TCR beta chain 
(TCR$) for #$ T cells or a single TCR gamma chain (TCR%) and TCR delta chain (TCR&) for 
TCR%& cells.  The terminus of the assembled TCR also consists of a variable region that binds 
antigen in complex with the MHC molecules(1).   
The genes encoding the individual components of the BCR and TCR are unique in that 
they do not exist in a functional state in the germline configuration.  Rather, the genetic loci 
encoding these receptor components consist of hundreds of different gene segments (grouped as 
V, D and J gene segments) that are joined together somatically to form the functional antigen 
receptor gene during a process known as V(D)J recombination(1-3).   The formation of a 
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functional gene requires a single gene segment from each of these component groups to be 
joined together (V and J gene segments for IgL and TCR# and TCR%, and V, D, and J gene 
segments for IgH, TCR& and TCR$) and attached to a constant region gene segment(1).   
The combination of different component chains and different gene segments for each 
component chain results in the diversity of the resultant BCRs or TCRs that is known as 
combinatorial diversity.  This combined with unique aspects of the V(D)J recombination reaction 
discussed below (generating junctional diversity) generates heterogeneity within the cohort of 
antigen receptors that would be unattainable by any other means.  It is this diversity that enables 
the adaptive immune system to recognize a near unlimited number of possible antigens(1).  The 
development of this powerful arm of the immune system via V(D)J recombination, though, is not 
without risk, as this recombination event requires the generation and repair of DNA double-strand 
breaks (DSBs) generated by the lymphocyte-specific recombination activating gene (RAG) 
endonuclease.  Any form of DNA damage including chemical modifications of nucleotide bases, 
base-pair mismatches, single-stranded DNA nicks or DSBs is inherently dangerous as it poses a 
threat to genomic integrity.  The DNA DSB, however, is the most hazardous(4, 5).  As such, DNA 
DSBs trigger within the cell a collection of pathways known as the DNA damage response that 
serves to limit the repercussions of these DNA lesions(6).  
The focus of this body of work lies in further characterizing the response to and repair of 
the RAG-induced DNA DSB generated in developing lymphocytes undergoing V(D)J 
recombination in an attempt to generate a functional antigen receptor gene.  We begin with a 
brief discussion of the RAG endonuclease and the generation of RAG-mediated DNA DSBs 
(RAG DNA DSBs).  
The RAG Endonuclease 
The RAG endonuclease consists of two protein components, RAG-1 and RAG-2, that are 
expressed exclusively in developing lymphocytes; these components can exist singly or as a 
heterodimeric pair that can form in the absence of DNA(2, 7, 8).  RAG endonuclease activity 
requires both RAG-1 and RAG-2(2, 7, 8).  As RAG-2 is rapidly degraded upon entry into S-phase 
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secondary to its phosphorylation at T490 by a cell cycle dependent kinase, RAG endonuclease 
activity is limited to the G1-phase of the cell cycle(9-11).  The RAG complex, in vitro, also 
consists of the HMG (high mobility group) proteins that bind DNA non-specifically and, in doing 
so, alter the three-dimensional structure of the double-stranded helix bending the DNA strands 
(12, 13).  The contribution of the HMG proteins to V(D)J recombination in vivo is not known(14). 
The RAG-1 and RAG-2 proteins consist of core regions that are necessary and sufficient 
for V(D)J recombination and non-core regions(15, 16). The C-terminal core region of RAG-1 
contains DNA binding domains (nonamer-binding domain and heptamer-binding domain), Rag-2 
binding sites, a zinc finger domain that may facilitate RAG-2 binding, as well as the DDE motif 
that is shared amongst the transposases from which it is evolutionarily derived and affords RAG-1 
its enzymatic activity(17-19).   The N-terminal non-core region of RAG-1 contains a RING domain 
that may have ubiquitylation activity (of histone H3) as well as the second of two zinc finger 
domains(17, 19).  In contrast to RAG-1, the N-terminus of RAG-2 constitutes its core region and 
consists of multiple repeats of a domain that promotes protein-protein binding.  Additionally, RAG-
2 contains a C-terminal acidic region that enhances interaction with histone proteins and a PHD 
domain that binds methylated histone H3 (specifically H3K4me3)(20-22).  RAG-2 has no 
enzymatic activity.  However, various mutations in RAG-2 affect the catalytic activity of RAG-1 in 
vitro suggesting that it may somehow facilitate RAG-1 enzymatic activity, perhaps by contributing 
to the active site of the RAG holocomplex(17, 19, 23).  Interestingly, the non-core regions of both 
RAG-1 and RAG-2 are highly conserved.  Specific functions for these regions are not known this 
time; however, many speculate that these non-core regions may have critical activities in the 
regulation or enhancement of RAG endonuclease activity or the joining of the resultant DNA 
DSBs(17, 19). 
RAG DNA DSB Generation 
The enzymatic activity of RAG-1 activates hydroxyl groups (-OH) to target the 
phosphodiester bond of the sugar-phosphate back of a DNA strand.  The active site of RAG-1 
consists of three negatively charged acidic residues (the DDE motif) that can bind divalent cations 
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(Mg
2+
 in vivo and Mn
2+
 in vitro) that are critical for the activation of the hydroxyl groups as 
nucleophiles(24-26).  When the activated –OH group is from a water molecule, the result is a 
single-stranded DNA nick.  When the activated –OH group, however, is the free 3’ OH at the site 
of a single-stranded DNA nick, the result is intra-molecular trans-esterification reaction that 
results in the formation of a DNA double-strand break with one hairpin-sealed end and a second 
blunt phosphorylated end(27-30).  
Each of the gene segments comprising the antigen receptor loci is flanked by specific 
sequences of DNA recognized by the RAG endonuclease.  These are termed recombination 
signal sequences or RSSs and consist of a highly conserved heptamer (5’-CACAGTG-3’) and 
nonamer (5’-ACAAAAACC-3’) separated by a more variable 12- or 23-base-pair spacer 
sequence. The RSS is oriented such that the heptamer abuts the coding region of the gene 
segment(1).   
Rag-1 and Rag-2 may both have DNA binding abilities(31, 32).  However, Rag-2 binds 
DNA with very low affinity and in a non-specific manner(31, 32).  In contrast, RAG-1 specifically 
recognizes the RSS, initially binding the nonamer via its nonamer-binding domain and later 
making contact with the heptamer(33-35).  RAG-2 may facilitate interaction of RAG-1 with the 
heptamer sequence(31, 32). It is thought that the bending action of the HMG proteins on DNA 
may also be required to allow for the joining of the more distantly separated heptamer and 
nonamer of a 23-bp RSS.  In agreement with this notion, the HMG proteins do not enhance RAG 
cleavage at the 12-bp RSS as significantly as they do at the 23-bp RSS in vitro(12).  Again, 
however, no role for the HMG proteins in vivo during V(D)J recombination has been 
demonstrated. 
Overall, RAG binds 12- or 23-bp RSSs with near equal affinity(36-38).   When RAG binds 
a single RSS (forming what is known as a signal complex or SC), single-stranded DNA nicks can 
occur.  The nick is made precisely at the junction of the heptamer and the coding region(39).  
RAG, however, does not make DNA DSBs in the setting of a SC in vivo(36-38).  DNA DSB 
generation occurs only when two gene segments with RSSs of different spacer lengths 
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individually bound to RAG are brought together in a pre-cleavage complex known as a paired 
complex or PC(36-38).  This requirement is known as the 12/23 rule and is important to allow for 
efficient joining of the resultant broken DNA ends and to ensure that the antigen receptor gene 
contains the right type and number of V, D, and J gene segments.  For example, a D gene 
segment flanked by 23-bp RSSs will recombine only with upstream V gene segments with 12-bp 
RSSs and downstream J gene segments with 12-bp RSSs.  Two V, two D, or two J gene 
segments will not recombine nor will a V gene segment recombine with a J gene segment when a 
D gene segment is required.  It is important to note that not all gene segment pairs consisting of 
12- and 23-base pair spacers can recombine.  An additional level of regulation must exist to 
govern the joining of different gene segments.  This is known as the Beyond 12/23 rule; however 
the mechanism by which this additional level of regulation occurs is not known(40, 41). 
Although RAG can bind and nick 12- or 23-bp RSSs with near equal efficiency, only 
rarely are 23-BP RSS-containing gene segments found with single-stranded nicks(36-38).  
Additionally, 12-bp RSS-containing SCs have a preference for binding 23-bp RSS-containing SCs 
over other 12-bp RSS-containing SCCs(42).  23-bp RSS-containing SCs do not exhibit such 
specificity.  Based on these observations, researchers have proposed a stepwise model for RAG 
cleavage that may explain the existence of the 12/23 rule(42, 43).  In this model, a 12-bp RSS-
containing SC with a single-stranded nick subsequently captures a 23-bp RSS forming a paired 
complex (PC)(7, 28, 38, 42). Then and only then does it introduce a single-stranded nick at the 
analogous location on the 23-bp RSS(38).  The -OH groups of the resulting nicks are activated by 
RAG-1 active site to undergo intra-molecular trans-esterification reactions resulting in two hairpin-
sealed DNA ends bordering the two coding regions of the gene segments to be recombined 
(coding ends or CEs) and two blunt phosphorylated ends at the ends containing the RSS (signal 
ends or SEs)(28, 43, 44). 
The two hairpin-sealed coding ends must be joined together to form a coding joint (CJ) in 
subsequent steps to complete V(D)J recombination.  The signal ends are likewise joined to from 
! 
7 
signal joints (SJs).  The processing of these DNA ends and the joining step are described in detail 
in subsequent sections.    
Regulation of RAG DNA DSB Generation 
Importantly, DNA exists in the context of chromatin that that does not generally allow for 
RAG binding or DSB generation.  Indeed, in experiments carried out in fibroblasts, the RAG 
endonuclease will cleave plasmid substrates existing as naked DNA but will not cleave at the 
endogenous antigen receptor locus or elsewhere in the genome(19, 45).  Thus, V(D)J 
recombination must be preceded by alterations in the chromatin environment that enable RAG 
binding and subsequent DNA DSB generation(19, 46).   These alterations are thought to be direct 
or indirect consequences of the germline transcription of the antigen receptor loci that occurs 
coincident with the initiation of V(D)J recombination(19, 45, 46).  For one, it is thought that 
transcription factor binding and the activity of transcriptional promoters and enhancers that drive 
germ-line transcription may directly influence RAG binding(19, 46, 47).  For example, Pax5 
binding to consensus sites in the distal V gene segments of the IgH locus has been proposed to 
facilitate binding of RAG to D gene segments(48-50).   Additionally, the types and extent of 
histone modifications in the surrounding chromatin distinguish transcriptionally active loci differ 
from transcriptionally inactive loci.  Histone acetylation and H3K4 methylation, for example, are 
increased in areas of the genome actively undergoing V(D)J recombination.  These post-
translational modifications of histone proteins might result in the alteration of chromatin structure 
that would reveal the RSS allowing for RAG binding.  The aforementioned PHD domain of Rag-2 
specifically recognizes H3K4me3 and may target RAG to transcriptionally active loci and may 
boost the catalytic activity of RAG(20-22).   Furthermore, chromatin remodeling complexes like 
the Swi-Snf remodeling complex may shift nucleosomes so as to reveal the RSS; an RSS 
situated on a nucleosome is resistant to RAG-mediated cleavage(51, 52).  The recruitment of 
RNA Pol II by these chromatin remodeling complexes and transcriptional elongation are likewise 
important(46, 53).  All of these activities that promote transcription would also affect the 
accessibility of a given antigen receptor locus to the activity of the RAG endonuclease.  
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Additionally, the antigen receptor loci condense and de-condense in a manner that correlates with 
their recombination.  A condensed locus allows for joining between gene segments separated by 
great distances(49, 54-57).  Finally, just as gene silencing can occur near the nuclear membrane, 
actively recombining antigen receptor loci may need to move away from these circumferential 
“silencing” environments(19, 41, 46, 57, 58).  All these changes occur in a highly regulated 
manner that enables tight regulation of the generation of RAG DNA DSBs(47).  The regulation of 
RAG activity and V(D)J recombination at each of these levels ensures that as few as possible 
DNA DSBs are present in the cell at any given time.   
These levels of regulation, in addition to preventing unnecessary and potentially 
dangerous RAG DNA DSBs, may allow for the multidimensional regulation of antigen receptor 
genetic recombination(19, 59).  Specifically, V(D)J recombination occurs in a cell-type- and 
developmental-stage-specific fashion(1).   The genetic loci encoding the BCR rearrange only in B 
cells.  Similarly, the TCR loci rearrange only in T cells.  Additionally, pro-B cells rearrange the IgH 
heavy chain.  It is not until the developing B cell produces a functional IgH heavy chain, 
progresses to the pre-B cell stage and undergoes proliferation that it begins to rearrange the light 
chain (IgL" or IgL!) components of the BCR.  Again, the same is true for the TCR.  The 
rearrangement of each locus is ordered with DJ rearrangement occurring before V to DJ 
rearrangement.  This is termed intra-allelic exclusion(1).  Finally, V(D)J recombination occurs at a 
single allele prior to rearrangement of the
 
second allele of a given antigen receptor locus.  This 
additional level of regulation is thought to ensure that each lymphocyte expresses a single 
antigen receptor with a single antigen specificity and is termed inter-allelic exclusion(1).   
Aberrant RAG DNA DSB Generation 
Despite these numerous critical safeguards, aberrant RAG break generation can and 
does occur within developing lymphocytes.  For instance, the RAG proteins can recognize DNA 
sequences elsewhere in the genome that resemble RSSs and cleave at these sites(60).  
Additionally, RAG can cleave at certain three-dimensional DNA structures, specifically at the 
junction of B and non-B DNA structures(60, 61).  Furthermore, the core RAG proteins retain some 
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of the activity of the transposases from which they have evolved in vitro under specific conditions; 
however, RAG-mediated transposition is not observed to any great extent in vivo(62).   
Defects in RAG DNA DSB Generation 
 As the expression of an assembled antigen receptor gene is absolutely required for 
lymphocyte development to proceed, defects in V(D)J recombination would be expected to lead 
to decreased numbers of lymphocytes.  Proliferation of this smaller cohort of lymphocytes would 
also lead to a decreased diversity of the adaptive immune system.  Thus, one would expect these 
defects to result in both lymphopenia and immunodeficiency.  Such is the case.  In fact, the 
inability to initiate V(D)J recombination as occurs in the absence of a functional RAG 
endonuclease leads to a complete absence of B and T cells known as severe combined 
immunodeficiency or SCID(63-65).    Deficiencies in RAG activity can lead to a less severe 
phenotype known as Omenn Syndrome(65-68).  
The DNA DSB Response 
The generation of DNA DSBs in such a programmed fashion within a cell is unique and is 
limited to V(D)J recombination and immunoglobulin class switch recombination (CSR) in the 
developing lymphocyte and to crossover in meiosis in all dividing cells.  Most often, we think of 
the DNA DSBs that occur in response to ionizing radiation, chemotherapeutic agents, and 
reactive oxygen species.  In contrast to physiologic DNA DSBs, these genotoxic DNA double-
strand breaks can only prove deleterious to the cells.  Indeed, their aberrant resolution can lead 
to chromosomal deletions, inversions, or translocations.   Such aberrant joints can, in some 
cases, lead to malignant transformation through, for example, the deletion of a tumor suppressor 
gene, the dysregulation of the expression of an oncogene via the proximity to a strong promoter 
sequence, or the creation of a fusion protein that has unique and harmful activities.  Indeed, 
defects in the various forms of DNA repair including DNA DSB repair are implicated in some 
human cancer syndromes(69).   
Cells are primed to rapidly activate a multifunctional signaling pathway in response to 
DNA DSBs that is commonly referred to as the DNA damage response(69).  The initiation of this 
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response requires sensors, transducers, and effectors(6).  The major sensor of DNA damage is 
G1-phase cells is the MRN complex consisting of Mre11, Rad50, and Nbs1(70).  The primary 
transducer is the ATM (ataxia-telangiectasia mutated) kinase that may phosphorylate over 700 
substrates in response to genotoxic DNA damage(71, 72).  Given their implication in cancer 
etiology and cancer treatment, the pathways activated in the cellular response to genotoxic DSBs 
have been extensively characterized(69).  This response encompasses pathways that promote 
DNA DSB repair, initiate cell cycle checkpoints and cell death pathways.  However, given the 
sheer number and variety of ATM substrates, the depth and breadth of the DNA damage 
response is likely far greater than we appreciate at this point(6, 69, 73, 74).   
Only recently has attention turned to the characterization of the cellular response to 
physiologic DNA DSBs such as the RAG DNA DSB.  The DNA damage response activated in 
developing lymphocytes in response to RAG-mediated DNA DSBs and that activated in all cells in 
response to genotoxic breaks exhibit significant similarities and differences that are addressed 
below and have important implications for both lymphocyte development and function.   
MRN as DNA Damage Sensor 
The sensor component of the DNA damage response must have two critical capabilities.  
First, it must be able to immediately recognize the presence of DNA damage and to localize to 
that site.  Secondly, it must be able to efficiently recruit and assist in the activation of the 
transducer components of the damage response.  These roles are fulfilled by a single complex 
consisting of three proteins, Mre11, Rad50 and Nbs1.  Importantly, the independent factors that 
constitute the MRN complex function only in the context of this holocomplex(75, 76).  The 
properties of these individual components as well as the unique three-dimensional structure of 
the resulting protein complex afford MRN the ability to translocate to a DNA break site rapidly 
during all phases of the cell cycle and to recruit ATM(77). 
The DNA binding ability of the MRN complex is mediated by Mre11 and Rad50 which 
form a heterotetramer (M2R2)(78-80).  The C-terminal domain of Mre11 contains a DNA binding 
domain and also enables association with Rad50(81).  The N-terminus of Mre11 contains a 
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phosphoesterase domain(81).  Rad50 consists of N- and C-terminal ATP-binding cassette 
(ABC)–ATPase domains (Walker A and B motifs), while the mid-section consists of two coiled-coil 
motifs oriented in an anti-parallel fashion and separated by a conserved CxxC motif.  The Walker 
A and B motifs come together and the coiled-coil motifs intertwine forming a three-dimensional 
structure that has a globular end with an extended arm containing a CxxC motif at the tip of that 
extension.  The CxxC motifs of individual Rad50 molecules can interact through the coordination 
of a zinc ion(79, 82-86).  When bound to ATP, the globular ends of Rad50 containing the Walker 
A and B motifs can dimerize and bind DNA(82, 87).   
The N-terminus of Nbs contains an FHA-BRCT-BRCT domain.  The C-terminus enables 
binding to both Mre11 and ATM(88, 89).  Thus, Nbs1 is the link between DNA damage 
recognition and localization and transducer recruitment(77).  The activation of ATM can be 
enhanced by the MRN complex(70, 75, 90-92).  
ATM as Transducer of DNA Damage Response 
 ATM, DNA-PKcs (DNA-dependent protein kinase catalytic subunit), and ATR (ATM- and 
Rad3-related) comprise a family of serine/threonine protein kinases that structurally resemble 
kinases that phosphorylate inositol phospholipids and are therefore termed phosphoinositide3-
kinase like kinases (PIKKs).  These PIKKs preferentially phosphorylate serine or threonine 
residues followed by glutamate (SQ or TQ motifs) (93, 94).  ATR is primarily activated by ssDNA 
during the S-G2-M phases of the cell cycle.  In contrast, DNA-PKcs and ATM are activated by 
DNA DSBs during all phases of the cell cycle but predominantly during the G1 phase(69, 71, 73).  
As RAG DNA DSBs are initiated in the G1 phase of the cell cycle, here we focus on ATM and 
DNA-PKcs activity and not ATR activity.  While these kinases have unique substrates, they also 
have overlapping cohorts of substrates and some overlapping functions(95-98).   
 ATM and other PIKK family members are large proteins; ATM is comprised of over 3000 
amino acid residues.  The catalytic region shared by PIKK family members is located in the far C-
terminal portion of the protein.  The functions of the various non-catalytic portions of the protein 
remain ill-defined but are required to promote the stability of this protein(99).  The non-catalytic 
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portions of ATM include multiple nuclear localization signals, a leucine zipper, a HEAT repeat 
(domain shared by Huntington (H), elongation factor 3 (E), ATM (A), and TRRAP (T) proteins), 
and FAT and FATC (domain shared by FRAP (F), ATM (A), and TRRAP (T) proteins) 
domains(73, 99).   
 ATM is recruited to DNA DSBs through the binding of protein components like MRN 
located at the break site(70, 75, 90-92).  ATM, however, does possess some intrinsic DNA 
binding capabilities(100).  At the site of a DNA DSB, ATM undergoes auto-phosphorylation which 
promotes a conversion from its inactive multimeric state to its active monomeric state(101).  ATM 
can be activated even when this auto-phosphorylation site (serine 1981) has been mutated 
however; thus auto-phosphorylation is not absolutely required for its activation(102).   
 Interaction with the MRN complex bound to broken DNA ends enhances ATM activity(70, 
75, 90-92).  Moreover, simply targeting ATM to DNA even in the absence of a DNA DSB can lead 
to its activation and the phosphorylation of downstream substrates(101, 103).  These two findings 
underscore the importance of localization and concentration of ATM at a break site in the 
activation of downstream pathways.  However, this requirement for localization of ATM at the site 
of a DNA DSB for activation is debated as ATM activation can be achieved in the absence of a 
functional MRN complex where localization of ATM is impaired(76, 104).  
 ATM activates hundreds of different proteins in response to DNA damage; these proteins 
function in numerous diverse cellular pathways.  Functional categorization of these 700 different 
potential substrates results in the identification of pathways that vary from DNA DSB repair to the 
initiation of cell cycle checkpoints and apoptotic pathways to cellular migration and 
metabolism(71, 72).    
Sensor and Transducer in the Response to RAG DNA DSBs 
NBS localizes to sites of RAG DNA DSBs (105).  Moreover, RAG DNA DSBs, similar to 
genotoxic DNA DSBs, activate ATM (106-110).  Thus, during V(D)J recombination in developing 
lymphocytes, ATM is likely the predominant regulator of the DNA damage response.  
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Phenotype of an Impaired DNA Damage Response 
 ATM is the kinase mutated in ataxia telangiectasia, a human disease characterized by 
cerebellar degeneration leading to ataxia and the development of both ocular and cutaneous 
telangiectasias.  In addition to these more visible characteristics, ATM patients exhibit retarded 
growth patterns and gonadal atrophy and undergo premature aging.  Furthermore, they have high 
rates of malignancies, especially lymphoid malignancies and breast cancer.  Cells isolated from 
these patients exhibit sensitivity to ionizing radiation and have large numbers of chromosomal 
aberrations indicating genomic instability(111-116).  Similarly, patients with deficiencies in 
components of the MRN complex have also been described.  Hypomorphic mutations in Mre11 
cause ATLD (ataxia telangiectasia like disease), deficiencies in Nbs cause Nijmegen break 
syndrome and mutations in Rad50 cause Nijmejen-break-syndrome-like-disorder (NBSLD).  Like 
A-T patients, these patients exhibit sensitivity to ionizing radiation and a propensity towards tumor 
development (6, 117-122).  Phenotypes shared by these patients underscore the importance of 
the DNA damage response and the roles of MRN and ATM as primary sensors and transducers 
of this response. 
Component Pathways of the ATM-dependent DNA Damage Response 
 Discussed in more detail below are three important pathways activated by ATM as 
components of the DNA damage response during the G1 phase of the cell cycle.  First and 
foremost, these pathways support the repair of the DNA DSB.  Secondly, they allow for the 
formation of a DNA repair focus.  Finally, ATM activates cell cycle checkpoint and initiates 
transcriptional pathways that ultimately determine cell survival versus death. 
DNA Repair Pathways 
 As the persistence or aberrant repair of DNA DSBs can lead to potentially oncogenic 
chromosomal lesions, it is critical that DNA lesions be repaired with both accuracy and efficiency.  
As such, numerous conserved cellular DNA repair pathways exist with each specifically tailored 
for a particular type of DNA damage.   DNA DSB repair pathways have historically been 
dichotomized into pathways that rely on homologous sequences to template repair (homologous 
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mediated repair or HR) and pathways that simply join two broken DNA ends (non-homologous 
end joining or NHEJ)(123). However, recent work has revealed a number of pathways that bridge 
that divide, requiring short tracts of homology to join the two ends.  Below we discuss these 
distinct DNA repair pathways.  
Homology-Mediated Repair 
Homologous recombination (HR) occurs primarily during post-replicative (S-G2-M) 
phases of the cell cycle when the replicated sister chromatid or paired homologous chromosome 
is readily available to serve as a template for repair and/or recombination respectively (124-126).  
HR begins with the 5’ to 3’ resection of the DNA end generating a long 3’ ssDNA overhang on the 
opposing strand that is bound by ssDNA binding proteins, replication protein A (RPA), and 
subsequently Rad51(125, 127, 128).   This end resection is initiated by Mre11, which possesses 
both endonucleolytic and exonucleolytic activities (3’ to 5’) and CtIP, a homologue of yeast 
endonuclease Sae2(76, 129-136).  Further resection is carried out by other nucleases and/or 
helicases including Exo1, Dna2, and the RecQ family members(137).  The resulting ssDNA 
overhang base-pairs with the homologous sequence on the sister chromatid or homologous 
chromosome known as the template strand, and, in doing so, disrupts that native DNA strand 
(138).  This results in the formation of a branched DNA structure known as a Holliday junction 
that is subsequently resolved into the two original, distinct DNA fragments(139). 
Variants of HR exist including break-induced repair (BIR) which is primarily used to repair 
DNA lesions that can occur at a stalled replication fork during the process of DNA replication and 
similarly requires long tracts of homology.  A second variant of HR is single-stranded annealing 
(SSA).  For SSA to occur, both broken DNA ends of a single break are resected to form ssDNA 
overhangs.  These overhangs do not invade homologous sequences in trans, that is on the sister 
chromatid or homologous chromosome.  Rather, the resection reveals long tracts of homology in 
cis that allow for intra-chromosomal joining.  Notably, this results in the deletion of the intervening 
sequence potentially leading to large chromosomal deletions depending on the amount of 
resection that took place(139).   
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Non-homologous End Joining 
During repair by NHEJ, the two broken DNA ends from a single DNA DSB are simply re-
joined.  Thus, unlike HR, NHEJ does not rely on long tracts of homology to mediate joining.  The 
ligation of the two ends must occur efficiently so as to limit processing of those DNA ends prior to 
their joining as such processing would result in the alteration or loss of genetic information(140).  
If multiple DNA DSBs occur simultaneously within the cell, these broken ends could theoretically 
be ligated together by NHEJ, forming chromosomal translocations.  The efficiency of NHEJ, 
effectively limiting the time and space that these broken ends occupy, is inversely related to the 
rate of formation of translocations(140).     
 NHEJ requires a cohort of factors:  the DNA-PK (DNA-dependent protein kinase) 
holoenzyme complex consisting of Ku70, Ku80, and DNA-PKcs and the DNA ligase complex 
including XRCC4, XLF, and DNA Ligase IV(140).  Artemis is another factor that is occasionally 
required for NHEJ(140).  Ku70 and Ku80 have no known enzymatic activity(140).  Rather, they 
possess sequence-independent affinity for broken DNA ends, preferentially binding those that are 
blunt or those with minimal overhangs but also binding single-stranded nicks and hairpin-sealed 
DNA ends(140-142).  The three-dimensional structure of the Ku heterodimer reveals a ring-like 
structure with a central cavitary pore well-suited for the binding of a DNA double-stranded 
helix(141).  Ku binding to the broken DNA end results in the recruitment of the final subunit of the 
DNA-PK holocomplex, the catalytic subunit of DNA-PK (DNA-PKcs)(140, 143).  Binding of DNA-
PKcs to the C-terminus of Ku80 causes the inward translocation of the Ku heterodimer onto the 
broken DNA strand and allows DNA-PKcs to also bind the broken DNA end and undergo the 
unique DNA-dependent activation of its kinase activity(42).  Interestingly, the region of Ku80 that 
binds DNA-PKcs is homologous to the region of Nbs that mediates binding of fellow PIKK family 
member ATM(4).  Among the key targets of DNA-PKcs kinase activity are DNA-PKcs itself and 
Artemis(42, 144).  The phenotype resulting from DNA-PKcs deficiency and kinase inactivity are 
different, suggesting that DNA-PKcs may also have structural roles in NHEJ(145).  DNA-PKcs 
can bridge broken DNA ends together through kinase-independent DNA binding; this may be 
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done in combination with the Ku proteins which also have DNA binding activity and bind DNA 
ends in such a way as to facilitate their alignment(146-149).   While this binding by the DNA-PK 
complex may initially facilitate the joining of two DNA ends, it may be subsequently inhibitory to 
joining.  Evidence suggests that the active removal of DNA-PKcs from the broken DNA end 
perhaps mediated by an auto-phosphorylation event is required for joining to take place(144, 
145).  This finding has interesting implications for DNA repair.  Specifically, as auto-
phosphorylation is thought to occur in trans, this requirement may function to ensure that a 
broken DNA end has another broken DNA end similarly bound to DNA-PKcs that is readily 
available to ligate to.  Furthermore, the DNA-PK holoenzyme complex may protect DNA ends 
from any processing or chemical modification up until the ligation event occurs. 
That ligation event is catalyzed by DNA Ligase IV, one of three known mammalian DNA 
ligases(140, 150, 151).  The DNA-PK holoenzyme complex recruits the ligase complex containing 
DNA Ligase IV, XRCC4 and XLF (XRCC4 like factor)(150-152).  XRCC4, like the DNA-PK 
holoenzyme complex components, may play some ill-defined role in aligning broken DNA ends.  
XRCC4, however, is also required to maintain Ligase IV levels within the cell; deficiency in 
XRCC4 is effectively a deficiency in Ligase IV(150, 151).  On the other hand, while XLF is 
structurally similar to XRCC4, XLF is not shown to have DNA binding abilities and its levels do not 
affect Ligase IV levels(153, 154).  Both XRCC4 and XLF can promote the activity of Ligase 
IV(152).  XRCC4 promotes the enzymatic activity of Ligase IV by facilitating the adenylation of its 
key catalytic residues(150, 151).  XLF, on the other hand, facilitates the joining of DNA ends with 
small ssDNA overhangs that are not otherwise immediately amenable to ligation by Ligase 
IV(155-157).  A final NHEJ factor, Artemis, has exonuclease activity but acquires endonuclease 
activity upon its phosphorylation by DNA-PKcs(158, 159).  Artemis activity is not required for the 
repair of all DNA DSBs; in fact, in the setting of ionizing radiation, all but ~10% of breaks are 
repaired efficiently in the absence of Artemis.  The remaining 10% of breaks are thought to have 
undergone chemical modifications that require Artemis-mediated processing prior to their 
joining(160-162). 
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Alternative End Joining 
The black and white view of DNA repair by either HR or NHEJ is being replaced by the 
notion that multiple additional pathways exist which have characteristics in common with both HR  
and NHEJ(163).  This is evidenced by the fact that most IR-induced breaks in NHEJ-deficient 
cells do eventually join in a manner that is not dependent on HR factors (140, 164-166).  AEJ is 
currently defined as joining that takes place in the absence of core NHEJ factors.  DNA ends 
undergo significant amounts of resection prior to joining.  Thus, the joints that form exhibit large 
deletions(163).  Secondly, AEJ is likely mediated by small regions of homology revealed by the 
end resection as the joints form at sequences shared by the two DNA ends(163).  In this regard, 
AEJ is similar to SSA.   The protein components required for and the mechanism of these 
potentially multiple AEJ pathways are unknown at this time.  As this joining occurs, by definition, 
in the absence of Ligase IV, one of the other two mammalian DNA ligases, Ligase I or Ligase III 
must function in AEJ(163, 167, 168).  Other proteins implicated in this pathway include Mre11 
and CtIP which are suggested to initiate the end resection that would reveal potential 
microhomologies as they do in homology mediated repair(80, 163, 169-171).   
AEJ has been implicated in the formation of translocations.  AEJ pathways are normally 
suppressed by classical NHEJ.  In the absence of classical NHEJ factors, both the frequencies of 
AEJ and translocations increase(163, 171, 172).  The sequences of translocations found in NHEJ 
deficient cells do not differ significantly from those that form in NHEJ-proficient (wild-type or WT) 
cells suggesting that even in WT cells, AEJ may be the primary mode of DNA repair that allows 
for translocations(172).   
DNA Repair Pathway Choice 
DNA repair pathway choice is largely determined by the stage of the cell cycle the cell 
occupies when that break occurs(139, 173).  HR is the predominant repair pathways during the 
S-G2- and M phases of the cell cycle where a sister chromatid or paired homologous 
chromosome is readily available.  NHEJ, on the other hand, occurs primarily during the G1-phase 
of the cell cycle but can function at all stages of the cell cycle.  All required DNA repair factors for 
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both HR and NHEJ are present throughout the cell cycle.  Thus, DNA repair pathway choice 
relies on both cell cycle-dependent and cell cycle-independent factors(139, 173).  Accessing the 
inappropriate repair pathway would have negative consequences.  For example, attempting HR 
during G1 in the absence of a sister chromatid or paired homologous chromosome could lead to 
loss of heterozygosity if a mutant homologous chromosome is used as a substrate or 
chromosomal deletions, inversions, or translocations if an unrelated but similar sequence is 
utilized for repair(139, 173). 
DNA repair pathway choice likely occurs early on during the repair process, perhaps 
depending on the proteins that initially recognize and bind the broken DNA end and the initial 
processing of that end (139, 143).  Ku deficiency rescues the embryonic lethality of Ligase IV 
deficiency, providing evidence for Ku binding as a key determinant of repair pathway choice(174).  
The absence of Ku in cells where NHEJ is crippled (Ligase IV-deficient cells) might allow broken 
DNA ends to access alternative repair pathways and enable the cell to escape the activation of 
apoptotic pathways(174).  Indeed, levels of homology-mediated repair are substantially increased 
in Ku70-deficient cells(175).  Secondly, end resection is thought to promote homology-mediated 
repair and simultaneously prevent NHEJ, as DNA ends with significant overhangs do not bind Ku 
efficiently(140-142, 176).  End resection can be regulated in a cell cycle-dependent fashion, as 
Sae2 (CtIP homologue) activity is enhanced upon phosphorylation of Ser267 (corresponding to 
T847 in CtIP) by the cyclin dependent kinase Cdc28 (CDK1)(130, 176-178).  The Sae2 mutant 
S267E exhibits end resection inappropriately during all stages of the cell cycle including G1 
disrupting NHEJ.  Conversely, the Sae2 mutant S267A is defective in end resection and is more 
apt to repair breaks by NHEJ even in the presence of sister chromatid or a paired homologous 
chromosome during the S-G2-M phases of the cell cycle(176). 
Repair of RAG DNA DSBs 
 Defects in the initiation of V(D)J recombination can lead to SCID as discussed above, but 
what occurs to developing lymphocytes when RAG-mediated DNA DSBs breaks are mishandled?  
Interestingly, subsets of patients with SCID have been identified that, in addition to profound 
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lymphopenia and immunodeficiency, also have a sensitivity to ionizing radiation and exhibit 
genomic instability and a propensity towards tumor development, specifically lymphoid tumors.  
This phenotype is known as radiosensitive SCID or RS SCID(65, 179).  These additional features 
indicate a defect in DNA repair pathways and suggest that defects in the repair of RAG DNA 
DSBs might contribute not only to lymphopenia and a resulting immunodeficiency but also to 
lymphoid tumor formation.  
 Analysis of V(D)J recombination in lymphocytes derived from RS SCID patients and in 
mouse models of these diseases have led to many important discoveries regarding the pathways 
by which RAG DNA DSBs are repaired.  In this regard, humans with RS SCID have been 
identified with mutations in Ligase IV, Artemis, DNA-PKcs, and Cernunnos(65, 150).  All are 
components of the NHEJ pathway of DNA DSB repair.  Moreover, mouse models with 
deficiencies in any of the core components of the NHEJ DNA repair pathway (collectively referred 
to here as NHEJ-deficient mice) exhibit a similar phenotype.  Notably, deletion of some NHEJ 
factors in mice leads to exhibit embryonic lethality; in these cases, conditional knockout mice 
have been shown to have defects in V(D)J recombination(150).  While RAG proteins are 
expressed exclusively in lymphocytes and RAG-mediated DNA DSBs occur only in developing 
lymphocytes, the repair of these breaks occurs via general DNA repair mechanisms, specifically 
non-homologous end joining.  
 Furthermore, just as the mishandling of genotoxic DNA DSBs can result in chromosomal 
deletions, inversions, and translocations, the mishandling of RAG DNA DSB can lead to 
chromosomal lesions with oncogenic potential.  Follicular lymphoma is caused by a translocation 
(t14:18) that results in the IgH promoter driving bcl-2 expression(179).  IgH to c-myc 
translocations (t8:14) in Burkitt’s lymphoma similarly dysregulates the expression of an oncogene 
leading to cellular transformation(179).  Furthermore, deletion of the tumor suppressor Mts1 in 
developing lymphocytes is a frequent cause of T-ALL(180).   
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 As discussed above, RAG-mediated DNA DSBs result in the formation of two hairpin-
sealed coding ends and two blunt phospohylated signal ends that must be joined together to form 
coding joints (CJs) and signal joints (SJs) respectively.   
 During V(D)J recombination, the unrepaired signal ends remain bound to RAG in a post-
cleavage complex(181, 182).  RAG must be actively removed from the signal ends to allow for 
joining(181, 182).  Just as occurs during the NHEJ-mediated repair of genotoxic DNA DSBs, 
these broken signal ends recruit the DNA-PK complex consisting of Ku70, Ku80 and DNA-PKcs.  
The blunt phosphorylated signal ends can be joined directly by the XRCC4/DNA Ligase IV 
forming a signal joint (SJ)(150).  
 Coding ends, do not bind RAG with the same affinity that signal ends do; thus, other 
factors would be required to keep the four free DNA ends tethered to one another(181, 182).  
Whether and how coding ends are maintained in the post-cleavage complex is unknown.  
Furthermore, coding ends cannot be joined in their native state; these hairpin-sealed ends must 
undergo processing(150).  As we discuss below, it is this processing that ultimately contributes to 
the incredible diversity of the resulting antigen receptors.  
 The processing of the hairpin-sealed coding ends is initiated by the non-core NHEJ factor 
Artemis.  As discussed above, the association of Artemis with DNA-PKcs confers endonuclease 
activity to Artemis that enables it to “open up” hairpin-sealed DNA ends(158).  Artemis creates a 
nick in the hairpin at a non-precise location causing it to open; although hairpin-opening does not 
occur at exactly the same nucleotide position each time, it more frequently occurs two nucleotides 
3’ of the tip(158, 159, 183).  In the absence of Artemis or DNA-PKcs, hairpin-sealed broken DNA 
ends accumulate and V(D)J recombination cannot be completed(150, 158, 161).  These data 
suggest that, although proteins such as RAG possess endonuclease activity in vitro, Artemis is 
the primary endonuclease that opens hairpin-sealed coding ends during V(D)J recombination in 
vivo(184, 185).  Importantly, Artemis is not required for SJ formation(186). 
 The asymmetric opening of the hairpin-sealed DNA end results in palindromic DNA 
sequences.  The nucleotides comprising these palindromic sequences of varying length are 
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termed p nucleotides(150).  Hairpin-opened coding ends are susceptible to the activity of 
nucleases presumably through those at the site of the RAG DNA DSB such as Artemis, terminal 
deoxynucleotidyl transferase (TdT), or RAG which has flap endonuclease activity(158, 187, 188).  
Finally, coding ends undergo a third form of processing.  Additional nucleotides can be added to 
hairpin-opened coding ends in a non-templated fashion though the addition of (N) nucleotides by 
TdT or polymerase µ (158, 189, 190).  The coding ends processed by these various modalities 
can subsequently be joined by the NHEJ ligase complex consisting of XRCC4 and DNA Ligase IV 
to form a coding joint (CJ)(150, 191).  The processing of coding ends prior to ligation is unique to 
NHEJ during V(D)J recombination.  
Some mutants of the RAG proteins are efficient in cleavage at the RSS-coding end 
junction in vitro but the resulting DNA ends do not join efficiently(192-194).  Moreover, RAG-1 can 
bind the Ku heterodimer; thus, RAG may participate in recruiting NHEJ factors to the break 
site(195).  These data suggest that the RAG endonuclease may also play some role in the joining 
step of V(D)J recombination.  Any role for RAG in DNA end joining would be unique to V(D)J 
recombination and not a general component of NHEJ as RAG is expressed only in developing 
lymphocytes undergoing V(D)J recombination. 
AEJ and RAG DNA DSB Repair 
 Though mice with deficiencies in core NHEJ factors are profoundly immunodeficient, they 
are not typically completely devoid of lymphocytes suggesting that alternative DNA repair 
pathways may allow for V(D)J recombination to take place at very low levels in these 
animals(140).  Some RAG mutants (core RAG-1, core RAG-2 and RAG-2 FS361) allow for 
especially high rates of CJ formation in NHEJ-deficient cells(196).  Interestingly, the CJs formed 
in these NHEJ-deficient cells exhibit significant deletions and microhomology at the site of the 
joint suggesting that they did indeed form via alternative end joining(196).  Furthermore, cells 
expressing these mutant RAG proteins but with intact NHEJ pathways also utilize alternative end 
joining to join coding ends at low rates(164).  These data suggest that alternative DNA repair 
pathways can function during V(D)J recombination(196-198).  The RAG proteins themselves may 
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function to protect cells from accessing these aberrant repair pathways(196-198).  Other cellular 
pathways may function to quell the use of alternative repair pathways.  Utilization of these 
pathways during V(D)J recombination could lead to increased frequency of translocation events.  
Furthermore, the utilization of microhomologies to mediate end joining would lead to a decreased 
diversity in the antigen receptor repertoire(197, 198). 
Deletional versus Inversional Rearrangement 
The primary goal of NHEJ is to rapidly ligate the two broken DNA ends so as to preserve 
as much genomic information as possible.  Deletions and inversions are both considered aberrant 
and potentially dangerous products of misguided DNA repair by NHEJ(140).  While utilizing 
components of the NHEJ pathway, the repair of RAG-mediated DNA DSBs does not simply join 
two DNA DSBs together.  In V(D)J recombination, rearrangement absolutely requires deletion 
(during rearrangement by deletion) or inversion (during rearrangement by inversion) of large 
regions of genomic  DNA.   Rearrangement by deletion or inversion occurs depending on the 
orientation of the RSS pair and the transcriptional orientation of the gene segments to be 
recombined.  Gene segments that are in the same transcriptional orientation recombine by 
deletion wherein the intervening sequence is simply excised from the chromosome.  The RSS 
pair remains on opposite ends of the segment that is excised from the chromosome; SJ formation 
leads to the formation of an episomal fragment of DNA that is subsequently lost during cellular 
division.  Importantly, during rearrangement by deletion, joining of coding ends, but not signal 
ends, is required to maintain the linear integrity of the chromosome.  Most rearrangements during 
V(D)J recombination occur by deletion.   However, some antigen receptor loci, such as the IgL 
kappa locus, utilize inversional rearrangement with significant frequency.   Gene segments that 
are in the opposite transcriptional orientation undergo rearrangement by inversion.  Upon RAG-
mediated cleavage, the segment of DNA located between the two RSSs must be inverted to allow 
for SJ and CJ formation.  Notably, during inversional rearrangement, both coding and signal joint 
formation occur within the chromosomal context; as such, both are required to maintain the linear 
integrity of the chromosome.  Two additional types of joints can occur that do not correctly pair 
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coding ends and signal ends and therefore do not result in functional antigen receptor genes.  
Importantly, these may exist as backup pathways that would function to preserve the linear 
integrity of the chromosome.  Occasionally, the coding and signal ends simply rejoin in the 
original configuration forming open-and-shut joints.  Additionally, hybrid joints can occur in which 
a signal end inappropriately joins to the other coding end.  During rearrangement by deletion, 
hybrid joint formation would require the inversion of the intervening gene segment.  During 
rearrangement by inversion, this would involve the inappropriate loss of the intervening gene 
segment(1, 150, 199). 
V(D)J recombination, then, is only successful when NHEJ pathways allow for a controlled 
mis-repair, one that allows for deletion or inversion.  The mechanism by which signal ends are 
joined to signal ends and coding ends to coding ends leading to these desirable deletions or 
inversions is not known.  However, the answer to this conundrum likely lies in the components of 
and the structure of the post-cleavage complex.  For example, RAG binding to signal ends may 
facilitate SJ formation and prevent open-and-shut and hybrid joint formation(181, 182). 
Antigen Receptor Diversity 
 The unique aspects of the V(D)J recombination reaction described above generates CJs 
that vary in both size and sequence.  This junctional diversity supplements combinatorial diversity 
and results in the diverse antigen receptor repertoire that is the cornerstone of adaptive immunity.  
As noted above, combinatorial diversity is a term used to denote the combination of different 
antigen receptor components for each functional antigen receptor and the different V, D, and J 
gene segments used to construct each receptor component.   Neither combinatorial nor junctional 
diversity is without constraint.  For example, it is clear that some gene segments are used more 
frequently than others.  Additionally, in some cases, for example in the mouse, more than 95% of 
the B cells utilize the kappa light chain(200).  With regards to junctional diversity, excessive 
deletion or addition of nucleotides to coding ends prior to joint formation would be deleterious.  
Some gene segments undergoing V(D)J recombination can be quite small, and large deletions 
could lead to the deletion of an entire gene segment and the formation of a non-functional antigen 
! 
24 
receptor(201).  Large nucleotide additions could similarly perturb the structure of the resultant 
antigen receptor such that it would no longer recognize antigen; this is especially true for the TCR 
which must recognize antigen in complex with an MHC molecule.  Additionally, as discussed 
above, end resection may be a critical determinant of DNA repair pathway choice.  Thus, 
excessive nuclease activity might allow RAG DNA DSBs to access homology-mediated 
alternative repair pathways that could potentially lead to the formation of a non-functional antigen 
receptor, limit the diversity or the resulting antigen receptor pool or lead to potentially oncogenic 
chromosomal lesions.  Pathways must exist to govern the processes and protein factors that 
generate both combinatorial and junctional diversity(201). 
A role for ATM in RAG DNA DSB Repair 
 Like RS-SCID patients, A-T patients exhibit characteristics suggesting deficiencies in the 
repair of RAG-mediated DNA DSBs in addition to the deficiencies in the repair of genotoxic DNA 
DSBs.  First, they are lymphopenic and susceptible to infection.  Secondly, they exhibit a high 
frequency of translocations involving the antigen receptor loci.  For example, translocations 
involving the human TCR% and the TCR& locus and inversions involving the human TCR% (V%) 
and TCR$ (J$) loci are found in circulating non-transformed peripheral T cells in the absence of 
ATM; translocations involving the TCR# locus can be found in up to 10% of circulating T cells in 
ATM-deficient mice(108, 113, 116, 202, 203).  Additionally, A-T patients almost invariably develop 
lymphoid tumors, and these tumors harbor translocations involving the antigen receptor loci(111).  
This phenotype is recapitulated in ATM-deficient mice(204).  These lymphoid tumors are likely a 
result of aberrant V(D)J recombination as they do not occur in mice unable to initiate 
recombination owing to an absence of RAG endonuclease components(114, 205).  Thus, ATM-
deficiency leads to decreased efficiency of RAG DNA DSB repair leading to lymphopenia and 
increased mis-repair leading to increased numbers of translocations and lymphoid tumor 
generation.    
 We have demonstrated a role for ATM in the repair of RAG DNA DSBs.  Specifically, 
ATM functions to maintain coding ends within the post-cleavage complex.  In its absence, we 
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note a decreased efficiency of RAG DNA DSB repair and an increase in the rates of aberrant 
repair including hybrid joint formation and translocations(107).  Like DNA-PKcs, ATM may have 
both kinase dependent and independent functions, and this described role in RAG DNA DSB 
repair may directly rely on one or more of the non-catalytic regions of ATM(95-98).  However, as 
this function requires ATM kinase activity, its role in maintaining DNA ends in the post-cleavage 
complex likely lies in the phosphorylation of one of its downstream substrates, possibly the MRN 
complex(107).  We discuss this further in Chapter 3. 
Formation and Function of DNA Repair Foci 
In addition to ATM and MRN, many additional proteins are recruited to the site of a 
genotoxic DNA DSB forming what is often referred to as a DNA repair focus.  The accumulation 
of factors at the break site occurs in a spatially and temporally regulated fashion(4).  Creation of 
the DNA repair focus is a critical feature of the DNA damage response functioning to recruit 
various repair factors, to tether the broken DNA ends together allowing for efficient repair, and to 
potentiate signaling pathways by concentrating the component enzymes and their substrates at 
the break site(4).   
The formation of the DNA repair focus begins with the phosphorylation of H2AX by 
ATM(206, 207).  H2AX is a variant of the histone protein H2A and represents about 10% of the 
H2A in the genome(206-208).  It is unknown whether H2AX is spread evenly throughout 
chromatin or whether it is concentrated in certain regions of the genome(208).  Among the 
differences between H2AX and its H2A counterpart is the presence of approximately twenty 
additional amino acids at its C-terminus; this unique carboxy-terminal tail protrudes from the 
nucleosome core around which the DNA is wound(208).  The serine residue four amino acids 
from the end of H2AX (-SQEY) comprises an SQ motif that is specifically phosphorylated by ATM 
(forming %'H2AX) (206).  While optimal phosphorylation relies on ATM, in its absence, DNA-PKcs 
can perform this function(209-211). 
The phosphorylation of H2AX in the chromatin flanking the break is directly or indirectly 
required for the maintenance of a large percentage of the factors comprising the DNA repair 
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focus at the break site(208, 212).  The initial re-localization of these factors to the break site can 
still occur in H2AX deficient cells, but in the absence of %-H2AX, they drift from the break site 
more rapidly(213).  A number of factors can bind phosphorylated tail of H2AX directly including 
Nbs1, 53BP1, and Mdc1(214-216).  However, Mdc1, through its C-terminal tandem BRCT 
domains, does so with the highest efficiency and stability(214).   How, then, are these other 
factors then retained in the DNA repair focus?  Mdc1 recruits Rnf8 upon its phosphorylation by 
ATM at four TQXF sites (T699, T719, T752, and T765) (217, 218).  Rnf8 is an E3 ubiquitin ligase 
that can catalyze the ubiquitylation of H2A and H2AX(219-221).  This ubiquitylation event leads to 
further histone modification through the recruitment of additional ubiquitin ligases such as Rnf168 
and also results in the direct recruitment of repair factors such as Rap80 and Brca1(222-224).  
However, these histone ubiquitylation events also alter the chromatin environment at the break 
site to reveal other histone marks making them available to bind factors such as 53BP1.  These 
other histone modifications might be generated de novo in response to DSBs, similar to H2AX 
phosphorylation.  Alternatively, they might exist constitutively in chromatin but be revealed only 
upon the chromatin rearrangement initiated by DNA damage responses(208, 225-227).  Through 
these various pathways, then, H2AX is directly or indirectly responsible for the recruitment of a 
large number of factors at the break site. 
Mdc1 binds %-H2AX.  However, it also binds ATM directly through its FHA-domain and 
indirectly by binding Nbs1 which can subsequently recruit ATM(228).  Nbs1 contains an N-
terminal FHA-BRCT-BRCT domain that binds the SDTD motifs of Mdc1 after the serine and 
threonine residues are phosphorylated by Ck2(229-231).  Mdc1 physically links ATM to its 
substrate H2AX.  This creates a feed-forward mechanism that would enable a cell to rapidly 
activate a large fraction of nuclear ATM and efficiently initiate ATM-dependent phosphorylation 
events and activate downstream pathways in the presence of a single DNA DSB(214, 217, 218, 
228).  As might be expected, %H2AX levels are lower in Mdc1 deficient cells(218, 228).  
Additionally, H2AX- and Mdc1-deficient cells are unable to efficiently activate cell cycle 
checkpoints in response to low dose irradiation, but both are able to do so effectively when the 
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number of DNA DSBs is increased using high dose irradiation(218, 228, 232).  These data 
suggest that a critical function of the DNA repair focus is the potentiation of DNA damage 
response signaling pathways. 
The DNA repair focus may also play a direct role in the repair of a DNA DSB.  Indeed, the 
phenotype of H2AX-deficient mice is consistent with H2AX having a role in the actual repair of 
DNA DSBs.  Specifically, this mouse is small in size, infertile, and exhibits genomic instability with 
sensitivity to ionizing radiation(208, 233-236).   Mice with deficiencies in other known components 
of DNA repair foci likewise share these characteristics with H2AX-deficient mice.  However, H2AX 
and these other components of DNA repair foci are not core components of any of the DNA repair 
pathways(140).  A primary theory is that %-H2AX and the resulting foci may function as a scaffold 
to hold broken DNA ends together, thereby facilitating efficient repair(237).  .   
DNA Repair Foci Formed at RAG DNA DSBs 
Just as genotoxic DNA DSBs promote H2AX phosphorylation and repair focus formation, 
RAG DNA DSBs also induce H2AX phosphorylation within the chromatin at the site of a DNA 
DSB and at significant distances (> 200 kb) from the break site, and other components of DNA 
repair foci can be found at RAG DNA DSBs including 53BP1(105, 211, 238-240).   Mice with 
deficiencies in some components of the DNA repair focus including H2AX and 53BP1 exhibit mild 
lymphopenia and an increased frequency of translocations involving antigen receptor genetic loci; 
when H2AX-deficient mice are bred onto a p53-deficient background, they exhibit lymphoid tumor 
formation(213, 233-235, 238, 241, 242).  Additionally, RIDDLE (radiosensitivity (R), 
immunodeficiency (I), dysmorphic features (D), learning disabilities (L)) syndrome patients have a 
defect in the ubiquitin ligase Rnf168; components of this phenotype are shared with the RS-SCID 
phenotype(222, 223).  All of these data suggest that whatever role that the DNA repair focus 
plays during the repair of genotoxic DNA DSBs, it likely also plays during V(D)J recombination.   
Indeed, persistent unrepaired coding ends in H2AX-deficient cells do more frequently 
irreversibly separate and form translocations, perhaps as a result of the scaffolding function of 
H2AX and the DNA repair focus(233-236, 243).   However, H2AX-deficient lymphocytes undergo 
! 
28 
efficient V(D)J recombination (233, 235).  Furthermore, H2AX-deficient lymphocytes do not show 
evidence of hybrid joint formation or the accumulation of unrepaired coding ends as we observe 
in the setting of ATM and MRN deficiency(243).  The exact role of H2AX in the V(D)J 
recombination is not completely understood.  In Chapter XX, we discuss an additional and novel 
role for H2AX in the repair of RAG DNA DSBs in preventing the resection of persistent unrepaired 
coding ends.   
Transcriptional Pathways Activated by ATM 
ATM activates a number of transcriptional pathways in response to genotoxic DNA 
damage.  These primarily include pathways that mediate cell cycle arrest or influence cell survival 
including p53 and NF"B(244-247).  The activation of p53 in response to DNA damage functions 
to halt cell cycle progression and to promote the death of cells with potentially dangerous 
chromosomal lesions.  In support of this notion, p53-deficient mice exhibit genomic instability and 
develop tumors; furthermore, mutations in p53 and defects in p53-dependent pathways have 
been implicated in a number of human cancer syndromes(234, 248-250).  On the other hand, 
NF"B is commonly described as a pro-survival transcription factor, as a large fraction of the 
genes regulated by NF"B have activities in promoting cell survival.  Cells deficient in NF"B 
signaling pathways exhibit increased cell death in response to ionizing radiation(247).  In 
response to many stimuli, however, NFkB promotes the expression of a large cohort of genes 
with diverse known activities(251-253). 
The activity of p53 and its downstream pathways is tightly regulated both through the 
regulation of p53 protein levels within the cell and through various post-translational 
modifications.  ATM activation of p53-dependent pathways relies on its ability to lead to the 
abnormal accumulation of p53 within the cell and as well as its ability to phosphorylate and 
activate p53(244).  Mdm2 is an ubiquitin ligase that normally maintains p53 at negligible levels 
within the cell by mediating its degradation(254, 255).  ATM phosphorylates Mdm2 in response to 
DNA damage and physically prevents its association with p53(244, 254, 255).    ATM additionally 
activates p53 primarily via the direct phosphorylation of p53 at Ser15 but also indirectly through 
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the phosphorylation of Chk2(244, 256).  Chk2 phosphorylation by ATM in response to DNA 
damage leads to the formation of catalytically active Chk2 dimers.   Dimerized Chk2 subsequently 
phosphorylates p53 at a unique site, Ser20, further activating its transcriptional activity(244, 249, 
256-260).    
This ATM-dependent activation of p53 results in the initiation of the G1-S checkpoint.  
Progression from the G1-phase of the cell cycle to S-phase requires the activation of the Cdk2-
cyclinE complex.  This complex is activated by de-phosphorylation of Cdk2 by the phosphatase 
Cdc25a.  Cdc25a, itself, is a target of the ATM-dependent kinase activity of Chk2, and 
phosphorylation of Cdc25a leads to its degradation(261).  Cdc25a is therefore unable to 
dephosphorylate and activate Cdk2(261).  The activation of p53 also affords transcriptional 
changes that contribute to the initiation of the G1-S checkpoint; specifically, the expression cyclin-
dependent kinase inhibitor (p21) which prevents binding to Cdk-2 to cyclinE is driven by p53 
transcription factor activity(94).   In addition to promoting the G1-S cell cycle checkpoint, the p53 
transcription factor also activates cell death pathways by promoting the transcription of pro-death 
factors including PUMA, Apaf1, NOXA, and Bax(262). 
In response to genotoxic DNA damage, ATM simultaneously activates NF"B-dependent 
transcriptional activity.  DNA damage induced activation of NF"B by ATM is unique as NF"B 
signaling is generally initiated through the binding of ligands to cell surface receptors(263, 264).  
The transcription factor NF"B, a dimer consisting of p50 and p65 subunits, resides in the 
cytoplasm as its nuclear localization signal is obscured by binding to I"B# (inhibitor of NF"B).  It 
is only upon the phosphorylation of I"B# and its subsequent degradation that the p50/p65 
heterodimer translocates to the nucleus, where it affects the transcription of a large cohort of 
genes(265-267).  The binding of ligands such as LPS and TNF to their cell surface receptors is 
normally the stimulus that activates the I"B# kinase (IKK) complex (consisting of IKK#, IKK$ and 
the regulatory IKK% (NEMO)) subunit through the phosphorylation of NEMO.  All of these 
activating events occur within the cytoplasm.  However, NEMO does shuttle in and out of the 
nucleus, and, interestingly, the balance of nuclear:cytoplasmic NEMO is shifted in response to 
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DNA damage by an unknown mechanism(268).  In response to DNA damage, the nuclear 
fraction of NEMO is phosphorylated by ATM.  The phosphorylated NEMO is subsequently 
monoubiquitinated and translocates back to the cytoplasm.  There it binds IKK#/IKK$, activates 
the IKK complex, and leads to the phosphorylation and degradation of I"B# and enables the 
translocation of the p50/p65 heterodimer to the nucleus(269).  Gene products with pro-survival 
activities whose transcription is regulated by ATM and NF"B in response to genotoxic DNA 
damage include, among others, Pim2 and Bcl3(247, 270). 
Activation of Transcriptional Pathways in Response to RAG DNA DSBs 
Like genotoxic breaks, RAG DNA DSBs also activate transcriptional pathways in an 
ATM-dependent manner.  ATM activates p53 in response to persistent RAG DNA DSBs(271).  As 
a result, ATM-deficient cells are defective in activating the G1-S checkpoint, and unrepaired 
coding ends are detectable in ATM-deficient cells even at post-replicative stages of the cell 
cycle(202, 272).  In fact, these unrepaired breaks remain even after the cell has undergone 
multiple cell divisions(202, 272).  The activation of p53 by persistent RAG DNA DSBs also 
activates robust pro-apoptotic pathways that eliminate cells harboring these potentially dangerous 
DNA lesions(271).  Although NHEJ-deficient mice cannot repair RAG-mediated DNA DSBs, they 
do not develop lymphoid tumors to any great extent(150).  However, mice with deficiencies in p53 
and NHEJ develop lymphoid malignancies at a young age(150, 271).  These observations 
illustrate the oncogenic potential of RAG-mediated DNA DSBs and the necessity of ATM- and 
p53-dependent apoptotic pathways.  In Chapter 5, we demonstrate that RAG DNA DSBs 
simultaneously activate NF"B transcriptional pathways.  The activation of NF"B by RAG DNA 
DSBs and the implications of activating such a pleiotropic transcription factor in these developing 
cells is discussed. 
Summary 
Indeed, RAG DNA DSBs, similar to genotoxic DNA DSBs, activate an ATM-dependent 
DNA damage response.  In the individual chapters that follow, we further define components of 
this response that occurs in developing lymphocytes undergoing V(D)J recombination.  
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Specifically, we discuss how ATM participates in the repair of the RAG DNA DSB (Chapter 3), 
how ATM regulates DNA end resection through modulation of H2AX phosphorylation and CtIP 
activity (Chapter 4) and, finally, how ATM significant alters gene expression patterns in 
developing lymphocytes undergoing V(D)J recombination (Chapter 5). 
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Chapter 2 
 
 
 
 
 
Materials and Methods
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Approach to Analyzing V(D)J Recombination 
The difficulty of studying V(D)J recombination in vivo is two-fold.  First, RAG DNA DSBs 
are made and repaired quickly in a non-synchronized fashion among the developing B cells in the 
bone marrow or T cells in the thymus; thus, to capture cells in bone marrow or thymus that are 
actively rearranging their antigen receptor loci is a daunting task.  Additionally, antigen receptor 
loci are complex with hundreds of different V, D, and J gene segments spanning great distances 
within the genome.  Though some segments are used preferentially, the sheer number of 
possible combinations that allows for the powerful adaptive immune system makes the analysis 
of rearrangement by methods such as Southern blotting impossible.  Southern blotting of DNA 
isolated from lymphocytes undergoing V(D)J recombination demonstrates a distinct band 
representing the germline state of the un-rearranged alleles and a smear of rearrangement 
products of various sizes that is non-interpretable for the most part.  An ideal system to analyze 
V(D)J recombination would allow for the synchronous induction of RAG DNA DSBs and would 
somehow limit the number of possible resultant recombination products.  Attempts to develop 
these model systems are described here. 
The rearrangement of plasmid substrates containing a single RSS pair (thus resulting in a 
single rearrangement product) can be analyzed in fibroblasts, CHO cell lines, or other non-
lymphoid cells transfected with the RAG endonuclease or transformed B cells that naturally 
express the RAG endonuclease(273, 274).  However, naked DNA (plasmid recombination 
substrates) does not recapitulate the natural chromatin environment that clearly plays a role in 
V(D)J recombination(46).  Not unexpectedly, numerous proteins have effects in chromosomal 
repair but have no demonstrable defect in the repair of these plasmid substrates.  In this regard, 
while multiple studies were unable to detect defects in CJ formation in Atm
-/-
 cells by analysis of 
V(D)J recombination of extra-chromosomal substrates, we have clearly demonstrated a role for 
ATM in the repair of chromosomal RAG DNA DSBs(107, 275-277).  Furthermore, assaying repair 
in lymphocytes rather than fibroblasts transfected with the RAG proteins is paramount as it is has 
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been demonstrated that the requirements for some NHEJ factors (notably XLF) for the repair of 
RAG DNA DSBs is different in these two cell types(278).   
Significantly improved methods for studying V(D)J recombination have addressed these 
major weaknesses.  These methods utilize B cells transformed with a temperature sensitive 
Abelson murine leukemia virus(279).  This virus preferentially targets pre-B cells that are primed 
to undergo rearrangement of the endogenous IgL loci.  However, once infected with the 
temperature sensitive Abelson virus (abl pre-B cells), these cells rapidly cycle and do not express 
the RAG proteins or undergo V(D)J recombination(279).  Culturing them at non-permissive 
temperatures however, turns off abl kinase activity, arrests the cells in G1 where they begin to 
express the RAG proteins and undergo V(D)J recombination at the endogenous IgL kappa and 
lambda loci(279).  The system utilized in the studies detailed in subsequent chapters is an 
adaptation of the above.  Instead of infecting pre-B cells with the temperature sensitive Abelson 
leukemia virus, we introduce the abl kinase to bone marrow cultures via a retrovirus that similarly 
transforms the pre-B cell population.  Instead of varying culture temperatures, we use a small 
molecule inhibitor of the abl kinase, STI571 or Gleevac, to stop cell division, arrest the cells in G1, 
and induce RAG endonucleolytic activity and V(D)J recombination(107, 280).  Instead of 
analyzing rearrangement of the complex endogenous antigen receptor loci, we utilize retroviral 
recombination substrates that are integrated into the chromosome of these cells.  These retroviral 
chromosomal recombination substrates, similar to the extrachromsomal plasmid substrates, 
contain a single pair of RSSs (Figure 1 and 2A).  These retroviral recombination substrates can 
rearrange by deletion (pMX-DEL) or inversion (pMX-INV) based on the orientation of the RSS 
pairs just as in the endogenous antigen receptor loci.  Additionally, they enable us to study both 
CJ and SJ formation in the context of a chromatinized environment.  We have developed 
Southern blotting strategies to analyze rearrangement of these retroviral recombination 
substrates that enable us to not only detect products resulting from the normal repair of a RAG 
DNA DSB, but also aberrant repair products as well as V(D)J reaction intermediates as depicted 
in Fig 2a(107). Based on findings from initial studies utilizing chromosomal recombination 
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substrates in these transformed pre-B cell lines, we can go on to analyze rearrangement of the 
endogenous loci in these transformed cells or in primary cell cultures or bone marrow or thymic 
extracts.  The complexity of the endogenous antigen receptor loci, however, remains an obstacle 
to the analysis of V(D)J recombination.  We have circumvented this problem in some instances 
by utilizing mice with genetically modified antigen receptor loci(108, 276).  The TCR SJ# mouse 
has a TCR# locus containing a single functional J# gene segment to which the V# gene 
segments can recombine.  This modified allele enables us to detect unrepaired J# coding ends, 
but analyzing joints that do form is still limited by the number of possible V# partners(108).   
 
Specific materials and methods pertinent to each chapter are included below, but 
importantly have been published exactly as printed here. 
 
Relevant to Chapter 3 (as published(276)) 
Cell lines and culture conditions: Nbs1
m/m
 (lines 675.3 and 737.3), Mre11
ATLD1/ATLD1 
(line 48.1), 
wild type (WT) (line A70.2), Atm
-/-
 (lines Atm2E and Atm2F), Artemis
-/-
 (lines 5.1, 0.1), Atm
-/-
:Artemis
-/-
 (line 0.1), Nbs1
m/m
:Artemis
-/-
 (lines 37.1, 37.3) and Mre11
ATLD1/ATLD1
:Artemis
-/-
 (lines 
61.3, 64.1) v-abl-transformed pre-B cells were generated by culturing bone marrow of 3-5 week 
old mice with the pMSCV v-abl retrovirus, as described previously(107).  All cells were generated 
from mice harboring the Eµ-Bcl-2 transgene(281).  All Abl pre-B cells (10
6
/mL) were transduced 
with retroviral recombination substrates by co-centrifugation at 1800 rpm for 90 minutes.  Clonal 
populations of cells with single pMX-INV integrants were isolated by limiting dilution of WT:INV 
(A70.2-2 and -5), Atm
-/-
:INV (Atm2E-26 and Atm2F-6), Mre11
ATLD1/ATLD1
:INV 
 
(48.1-1 and -3) and 
Nbs1
m/m
:INV (675.3-2 and 737.3-6) Abl pre-B cell lines.  Cells were treated with 3µM STI571 
(Novartis) for the indicated times at 10
6
 cells/ml.  KU-55933 (Sigma) was used at 15µM. 
Southern blot and PCR analyses:  Southern blot analyses were carried out on genomic DNA 
from cells harboring pMX-INV using the indicated restriction enzymes and the C4 probe, as 
previously described(107).  Southern blot analyses of thymocytes from mice expressing the 
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TCR#
sJ
 allele were carried out using the StuI restriction enzyme and the C#I probe, as reported 
previously(108, 282).  Southern blot analyses for IgL" locus J" coding ends was carried out on 
SacI and EcoRI digested genomic DNA using the J"III probe as previously described(270).  pMX-
INV coding joints were amplified using the pA and pB oligonucleotides and pMX-DEL
SJ
 signal 
joints were amplified used primers pB and pC oligonucleotides as previously described(107).  
V&5, V$14 and V"6-23 coding and hybrid joints, and the IL-2 gene, were amplified by PCR as 
previously described(107). 
Western blot and EMSA analyses:  Western blots were done on whole cell lysates using 
antibodies to mouse KAP-1 (GeneTex), phosphorylated KAP-1 (Bethyl Labs), Mre11 (Novus), 
and Nbs1 (Cell Signaling).  The secondary reagents were horseradish peroxidase (HRP)-
conjugated goat anti-mouse IgG (Zymed) or donkey anti-rabbit IgG (GE Healthcare).  NF!B 
EMSA were run as described previously and were analyzed with a Li Cor Odyssey Infrared 
Scanner(270). 
Immunofluorescent detection of %-H2AX foci:  Nuclear %-H2AX foci were detected using 
standard protocols with minor modifications(105, 283).  Briefly, cells were cyto-spun onto poly-L-
lysine coated slides (Sigma), fixed in 4% paraformaldehyde for 10 min, washed in phosphate-
buffered saline (PBS), permeabilized with 0.15% Triton X-100 in PBS, and blocked in PBS with 
2% bovine serum albumin. Cells were incubated in anti "-H2AX antibody (Upstate Biotechnology) 
at 1-2 #g/ml concentration for 3 hours at 37
o
C in a moist chamber, washed with PBS, and further 
incubated with anti-mouse-FITC conjugate (Vector Labs) for 45 minutes. After washing with PBS 
slides were mounted in Vectashield mounting medium with DAPI (Vector Labs). Foci were 
observed and imaged as described before on Carl Zeiss Axioplan 2 microscope using 
Metasystems In situ Imaging System (ISIS) imaging software(283).  
 
Relevant to Chapter 4 
Southern blotting:   Southern blot analysis of genomic DNA analyzing rearrangement of the  
pMX-DEL
CJ
 retroviral substrate was performed as described previously utilizing an EcoRV 
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restriction enzyme digest and the C4b probe(107).  Southern blot analyses of coding ends 
generated during rearrangement of the IgL-" locus was performed as described previously on 
genomic DNA digested overnight with SacI and for 5 hours with EcoRI utilizing the J"III 
probe(270).  
Urea-Agarose Gel Electrophoresis:  The denaturing gels were run as described previously(284) 
with the following modifications:  Briefly, 40ug of genomic DNA was digested overnight with 
EcoRV in a 400ul volume and concentrated to 30ul. The DNA was then re-suspended with the 
addition of 5 volumes 8M Urea, 1% NP-40, 1mM Tris pH 8.0 and 0.5 mg/ml bromophenol blue.  
This DNA solution was divided in two, with one half heated at 90 degrees Celsius for 8 min to 
denature while the other half was incubated on ice.  After 8 min the heated DNA samples were 
placed on ice.  All samples were ran on a 1.2% agarose gel made with 1X TAE with 1M urea at 
50 volts for ~24hrs in at 4°C in TAE buffer also containing 1M urea. 
TdT-assisted PCR: TdT-assisted PCR analysis of pMX-DEL
CJ 
coding ends was performed as 
described previously using the IRES REV5 oligo for the primary PCR reaction, the IRES REV4 
oligo for the secondary PCR reaction and the I4 oligo as a probe(238). Primers IRESrev5 and 
T17 UNIV  (Table 1) were used for the primary PCR reaction and 15 cycles of the PCR program 
described above were used.  A secondary PCR was then carried out using primers IRESrev4 and 
UNIV (Table 1).  30 cycles were used for the secondary PCR. Conditions for PCR were as 
follows:  92°
 
for 1 minute, 58° C for 1.5 min, and 72° C for 1.5 min.  Similar conditions were used 
for PCR analyses of coding ends generated during rearrangement of the endogenous IgL! locus, 
using the J!2 ds oligo for amplification and the J! oligo as a probe. IL2 gene PCR, which is 
provided as a DNA loading control, was performed as described previously(238). 
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Table 1.  Oligos used in TdT assisted PCR. 
IRES REV5 CTCGACTAAACACATGTAAAGC 
IRES REV4 CCCTTGTTGAATACGCTTG 
T17 UNIV GTAAAACGACGGCCAGTCGAC-T17 
UNIV GTAAAACGACGGCCAGTCGAC 
IRES4 probe TAAGATACACCTGCAAAGGCG 
J"2 ds 200 CCACAAGAGGTTGGAATGATTTTC 
J"2 probe GTAGTCTTCTCAACTCTTGTTCACT 
 
Western blotting:  Western blotting was performed as described previously(276).   Primary 
antibodies used were mouse monoclonal 14-1 (1:40)(285) and H2AX (1:3000) Millipore, Erk2 
(1:2500) Santa Cruz and GAPDH (1:2500) Santa Cruz.  Dilutions used are provided in 
parentheses.  Secondaries were goat anti-mouse (Invitrogen) and donkey anti-rabbit F(ab’)2 
Fragment (Fisher).  
Retroviral reconstitution and lentiviral knock-down:  Reconstitution of 
Artemis
-/-
:H2AX
-/-
 and Ligase IV
-/-
:H2AX
-/-
 abl preB cells was performed by 
retroviral transduction with either empty retrovirus or retrovirus containing cDNAs 
encoding H2AX or H2AX
S139A
. A cDNA encoding H2AX
S139A
 (serine 139 
changed to alanine) was generated by PCR-based site-directed mutagenesis of 
WT H2AX cDNA. cDNAs encoding WT H2AX and H2AX
S139A
 were cloned into 
the pMX-PIE retroviral vector and cells were transduced by co-centrifugation as 
described previously.  Cells expressing the retroviral construct were obtained by 
flow cytometric cell sorting of cells expressing GFP using a FACSVantage (BD 
Biosciences).  
shRNA-mediated knockdown: Generation of lentiviral shRNAs vectors was carried using the 
previously described pFLRU:YFP lentiviral vector(286, 287). CtIP-specific and nontargeting(NT) 
shRNAs were cloned into the pFLRU:YFP lentiviral vector.  Sequences targeted by the shRNA 
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are shown in Table 2.  4 µg of these PFLRU:shRNA:YFP vectors were individually co-transfected 
with 4 µg pHR’(8.2R packaging vector and 1 µg of pCMV-VSVg envelope plasmid into HEK293T 
cells plated at approximately 80% confluency in 6 cm
2
 plates using Lipofectamine 2000 
(Invitrogren). Media was replaced at 12 hours post-transfection.  Supernatants were harvested 24 
hours later.  Transduction of abl pre-B cells was performed by co-centrifugation with viral 
supernatant at 1800 rpm for 90 min with polybrene added at 5 µg/mL.  Cells expessing the 
pFLRU-shRNA vectors were obtained by flow cytometric cell sorting gating on cells expressing 
YFP using a FACSVantage (BD Biosciences). 
Table 2.  Target sequences for shRNA mediated knockdown. 
CtIP shRNA target 6 GAGCAGACCTTTCTCAGTA 
Non-targeting (NT) shRNA  GGTTCGATGTCCCAATTCTG 
 
PCR Amplification of CJs: pMX-DEL
CJ
 coding joints were amplified using oligos pC and IRES 
REV5 flanking the coding joint as shown in Figure 21a.  300 ng of genomic DNA was used in the 
original amplification with serial 5-fold dilutions.   Oligo IRES REV4 was used as a probe.  Cloning 
and sequencing of pMX-DEL
CJ 
coding joints was performed as described previously(276).   P-
values were calculated by Student’s t-test with Welsh’s correction for unequal variances. 
Table 3.  Oligos used to PCR amplify pMX-DEL
CJ
 coding joints. 
pC GCACGAAGTCTTGAGACCT 
IRES rev5 CTCGACTAAACACATGTAAAGC 
IRES rev4 CCCTTGTTGAATACGCTTG  
pA CACAGGATCCCACGAAGTCTTGAGACCT 
pB ATCTGGATCCGTGCCGCCTTTGCAGGTGTATC 
pD AGACGGCAATATGGTGGA 
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Relevant to Chapter 5 (as published(270)) 
Cell culture: Three independently derived RAG-2
-/-
 (R.1, R.2 and R.3), three independently 
derived Artemis
-/-
 (A.1, A.2 and A.3), two independently derived Artemis
-/-
:Atm
-/- 
(AA.1 and AA.2) 
and individual Scid and Ku-70
-/-
 v-abl-transformed pre-B cell lines containing the EµBcl-2 
transgene were generated.  The three Artemis
-/-
:I"B#-(N cells (A.3(N1, A.3(N2, A.3(N3) were 
generated through standard transfection of the A.3 cells with a cDNA encoding an N-terminally 
truncated I"B# (I"B#-(N)(288).  Expression of the I"B#-(N protein in these cells was confirmed 
by western blotting.  STI571 treatments were carried out with 3µM STI571, as previously 
described(107).  The KU-55933 Atm inhibitor (Sigma) was used at 15µM, the BAY-11-7085 
inhibitor (Calbiochem) was used at 20µM.  Irradiation was carried out with a Cs
137
 source, at 
doses of either 0.5 or 4 Gy.   
Western blotting and EMSA: Western blotting was carried out as described previously, using an 
antibody to Pim-2 (Santa Cruz, 1D12)(276).  The secondary reagent was horseradish peroxidase 
(HRP)-conjugated goat anti-mouse IgG (Zymed).  EMSAs were run as described previously, and 
analyzed using a Li-Cor Odyssey Infrared scanner(289). Supershifts were performed using anti-
p50 and anti-p65 antibodies (Santa Cruz, sc-114 X and sc-372 X).  
Generation of the NF"B reporter:  To generate pMSCV-NRE-GFP, the NF"B responsive 
elements and TATA box from pNF-"B-Luc (Stratagene) were amplified using the following 
oligonucleotides: pNRE-f: CCAAACTCATCAATGTATCTTATCATG; pNRE-r: 
TACCAACAGTACCGGAATGC.  This PCR product was cloned upstream of a cDNA encoding 
enhanced GFP (Clontech) on the bottom strand of pMSCV containing an IRES upstream of the 
Thy1.2 cDNA.  
Gene expression profiling:  All Abl pre-B cells were harvested 48 hours following treatment with 
STI571.  RNA was isolated using Qiagen RNeasy technology following the manufacturer’s 
instructions.  Gene expression analysis was conducted using Affymetrix Mouse Genome 2.0 
GeneChip) arrays (Mouse 430 v2, Affymetrix, Santa Clara, CA).  One µg of total RNA was 
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amplified as directed in the Affymetrix One-Cycle cDNA Synthesis protocol. Fifteen µg of 
amplified biotin-cRNAs were fragmented and hybridized to each array for 16 hours at 45
o
C in a 
rotating hybridization oven using the Affymetrix Eukaryotic Target Hybridization Controls and 
protocol.  Array slides were stained with streptavidin/phycoerythrin utilizing a double-antibody 
staining procedure and then washed using the EukGE-WS2v5 protocol of the Affymetrix Fluidics 
Station FS450 for antibody amplification.  Arrays were scanned in an Affymetrix Scanner 3000 
and data was obtained using the GeneChip) Operating Software (GCOS; Version 1.2.0.037).  
Data pre-processing, normalization, and error modeling was performed with the Rosetta Resolver 
system (Version 6.0)(290).  
In order to identify differentially expressed genes between the RAG-2
-/-
 and Artemis
-/-
 Abl 
pre-B cells, an error-weighted analysis of variance (ANOVA) utilizing the Benjamini Hochberg 
false discovery rate was performed using Rosetta Resolver (www.rosettabio.com).  At p-value $ 
0.05, this analysis yielded 1578 probe sets.  Fold changes were generated in Resolver, based on 
the ratio of each individual cell line relative to the average of the three RAG-2
-/-
 cells with 100-fold 
being the maximum change that Resolver can report.  Of the 1578 probes found using the 
ANOVA analysis, only those that had a fold-change % 2.0 (not including anti-correlated genes) in 
all ratios for a given genotype were considered for further analysis.  A Venn diagram of the 
resulting ANOVA and fold-change data sets for each genotype comparison to RAG-2
-/-
 was then 
used to determine which expression changes were dependent on ATM and NF!B.   
For gene expression profiling of primary developing B cells, B220
+
 cells were isolated 
from RAG-1
-/-
:IgHtg and Art
-/-
:IgHtg bone marrow using Mouse Pan B (B220) Dynabeads from 
Invitrogen.  RNA was isolated using the Qiagen RNeasy Mini Kit.  Microarrays were treated as 
described above for the Abl pre-B cells.  For the probe sets that were identified as being 
differentially regulated in response to RAG DSBs in the abl-pre-B cells, we compared the average 
expression in the two RAG-1
-/-
:IgHtg samples to the each of the two Art
-/-
:IgHtg samples.  The 
probe sets that were not anti-correlated and changed *1.5-fold in the average of these 
comparisons were included. 
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Flow cytometry: Flow cytometric analyses were performed on a FACSCaliber (BD Biosciences) 
with the normalized geometric mean fluorescence intensity (MFI) calculated as the difference 
between the geometric mean fluorescence for the specific antibody and the isotype control.  Flow 
cytometric cell sorting was performed using a FACSVantage (BD Biosciences).  Flow cytometric 
analyses were performed using fluorescein isothiocyanate (FITC)-conjugated anti-CD45R/B220, 
allophycocyanin (APC)-conjugated anti-IgM, phycoerythrin (PE)-conjugated anti-CD40, PE-
conjugated anti-CD62L, PE-conjugated anti-CD69, and the appropriate isotype controls (BD 
Biosciences).  
Analysis of pMX-DEL
CJ
 rearrangement:  PCR was carried out as described previously on 4-fold 
dilutions of genomic DNA(107).  IL-2 PCR primers were IMR42 and IMR43, and the product was 
probed with IMR042-2, all of which have been described previously(107).  Primer sequences for 
pMX-DEL
CJ
 are included above in Table 3. 
RT-PCR gene expression analysis: Quantitative real-time PCR (RT-PCR) was performed using 
a Stratagene Mx3000P real-time PCR machine and Platinum® SYBR® Green qPCR SuperMix-
UDG (Invitrogen).  PCRs were carried out using the following program: 95°C, 30 sec; 55°C, 60 
sec; 72°C, 30 sec; 40 cycles.  Relative expression is calculated as the difference between beta-
actin expression (C1) and expression of the gene of interest (C2), using the following equation: 
relative expression = 2
-(C1-C2)
.  C is the PCR cycle where the product detection curve becomes 
linear.  
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Table 4.  Primers used for RT-PCR. 
Gene Forward Reverse 
B-actin AGTGTGACGTTGACATCCGTA GCCAGAGCAGTAATCTCCTTCT 
Bcl3 TCCAGAATAACATAGCCGCTGT CATGCCAGGTGAATTGCAGTC  
Cd40 GCTGGTCATTCCTGTCGTGAT ACTGGAGCAGCGGTGTTATG 
Cd69 TGGTGAACTGGAACATTGGA CAGTGGAAGTTTGCCTCACA 
IL12!  CTGTGCCTTGGTAGCATCTATG GCAGAGTCTCGCCATTATGATTC 
CD62L TCTGGGAAATGGAACGATGACG CCGTAATACCCTGCATCACAGAT 
Pim-2 CGGGTGTGATACGCCTTCTTG GCCCCTTCTCTGTGATATAGTCG 
Swap70 ATGAGGGGGTTGAAAGACGAA AGGTTATGGGAAAGGACCTTGA 
Cd80 TCAAAAGAAGGAAAGAGGAACG CGGAAGCAAAGCAGGTAATC 
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Chapter 3 
 
 
 
 
 
 
A Requirement for MRN for the 
Proper Repair of RAG DNA DSBs  
(reprinted with modification(276)) 
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ATM-deficient mice and humans have a predisposition to lymphoid tumor formation 
including a subset resulting from the aberrant repair of RAG DNA DSBs during V(D)J 
recombination(111).  Interestingly, mice with combined deficiencies in checkpoint pathways and 
DNA repair pathways develop lymphoid tumors while mice singly deficient in either do not exhibit 
the same frequency or onset of tumor generation(150, 248, 250).  In lymphocytes, ATM is known 
to activate p53 in response to persistent DNA damage(73, 244).  However, given the phenotype 
of increased lymphoid tumor formation, it seemed likely that ATM, in addition to promoting 
checkpoints and mediating apoptosis, might additionally play a direct role in repair of the RAG 
DSB.   
In this regard, we have demonstrated that ATM-deficient cells have a defect in the repair 
of chromosomal RAG DNA DSBs with an increased frequency of aberrant hybrid joint (HJ) 
formation during rearrangements that occur by inversion and a decrease in the efficiency of 
coding joint (CJ) formation(107, 108).  The unrepaired coding ends drift from one another in the 
absence of ATM and are frequently resolved as translocations(107).  Taken together (as 
discussed later), these data suggest that ATM plays a role in the stabilization of the post-
cleavage complex thereby facilitating repair of the break and preventing unrepaired ends from 
causing translocations.  However, how ATM carries out this function is unknown.  Most known 
functions of ATM including the promotion of repair, however, require its kinase activity(73, 107).   
Interestingly, mice and patients with deficiencies in components of the MRN complex 
exhibit phenotypes similar to those deficient in ATM exhibiting a mild lymphopenia and sensitivity 
to ionizing radiation(117, 291-298).  The MRN complex is recognized as a sensor of DNA 
damage as it has DNA binding abilities and functions to recruit ATM to the break site(70, 77, 90, 
91, 104, 291, 299).  ATM, in turn, phosphorylates all three components of the MRN complex(71, 
300-302).  Although the MRN complex is required for HR, until this point, no known role for the 
MRN complex in NHEJ during V(D)J recombination has been clearly defined(75, 76, 277, 299, 
303, 304).  However, we considered the possibility that MRN might play a role downstream of 
ATM in the repair of RAG DNA DSBs functioning to maintain un-repaired coding ends within the 
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post-cleavage complex via its unique DNA end alignment and tethering abilities(75, 76, 78, 81, 
83, 86).  To begin to address this hypothesis, we analyzed the repair of RAG DNA DSBs in MRN-
deficient v-abl transformed pre-B cell lines and mice. 
Generation of MRN-deficient v-abl transformed pre-B cell lines. 
Mice with homozygous-null mutations at the Mre11, Nbs1, or Rad50 loci all exhibit early 
embryonic lethality(291, 296-298); thus, we were unable to generate Abl pre-B cells completely 
deficient in any of these proteins.  However, we were able to generate Abl pre-B cell lines from 
mice homozygous for hypomorphic Mre11 (Mre11
ATLD1
) and Nbs1 (Nbs1
m
) alleles.  The 
Mre11
ATLD1
 allele has a gene-targeted point mutation that generates a premature stop codon, 
resulting in a C-terminal truncation of the Mre11 protein, mimicking a mutation in that causes 
ataxia-telangiectasia–like disease (ATLD)(294).  The Nbs
m/m 
mice were generated by replacing 
exons 2 and 3 of the Nbs1 allele with a neomycin resistance gene generating the Nbs1
m
 allele, 
which encodes a truncated Nbs1 protein(292).  Importantly, the three MRN components are 
thought to function only as a holocomplex; thus, deficiencies in any one component would impact 
the function of the entire complex(77).  The Mre
 ATLD1/ ATLD1
 and the Nbs
m/m
 mice may be generally 
referred to here as MRN-deficient.   We have additionally developed WT and Atm
-/-
 Abl pre-B cell 
lines(107).  
MRN-deficient cells have defects during rearrangement by inversion. 
Atm-deficient pre-B cells have defects in repair during rearrangement by inversion with a 
decrease in overall recombination frequency and an increased formation of aberrant hybrid joints 
detectable in chromosomal recombination substrates as well as the endogenous IgL-! and TCR" 
and # loci(107, 108).  Given that MRN-deficient mice and patients have similar phenotypes as 
those deficient in ATM, we decided to assay for defects in rearrangement by inversion in the 
MRN-deficient cells.  To this end, we introduced pMX-INV into the MRN-deficient Abl pre-B cells 
(Mre
ATLD1/ATLD1
 Abl pre-B and Nbs
m/m
 Abl pre-B) and assayed for recombination by Southern 
blotting.  We purified populations containing pMX-INV integrants by sorting for the expression of 
human CD4 that is also encoded by the retrovirus.  These bulk populations contain numerous 
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pMX-INV integrants at broadly heterogeneous locations thus eliminating potential contributions of 
integration effect on recombination.  We also isolated clones from these bulk populations by 
limiting dilution that each contained a single integrant of the retroviral substrate.  Work presented 
here is done on the clonal populations though we detected no difference in results of analyses in 
these clones and the original bulk populations. 
We treated the Abl pre-B cells with STI to induce RAG expression, and this led to 
rearrangement of pMX-INV in all cell lines assayed.  Analysis of EcoRV/Nco1-digested genomic 
DNA from WT Abl pre-B cells reveals a decrease in the 2 kb band representing un-rearranged 
substrate and an accumulation of a 3 kb species representing a normal coding joint (CJ) upon 
STI treatment (Figure 2a-b).  In ATM-deficient Abl pre-B cells, we note an accumulation of CJs, 
but we also detect a 4 kb species representing an aberrant hybrid joint (HJ) following STI 
treatment (Figure 2a-b).  This is in agreement with previously published work in the lab(107).   In 
the MRN-deficient cells, we detect a similar accumulation of both HJs and CJs following STI 
treatment.  Thus, MRN-deficient Abl pre-B cells also have a defect in repair by inversion when 
using recombination substrates with an increased production of aberrant hybrid joints (Figure 2b). 
In ATM-deficient mice, we can also detect defects in rearrangement by inversion in vivo 
at the endogenous TCR# and TCR" loci as well as the endogenous IgL! locus by PCR(107, 
108).  Specifically, we detected both CJ and aberrant HJ formation for rearrangements that occur 
between V#5 and DJ#1 and V"14 and DJ"2.7 in thymic DNA preparations (Figure 3a) and 
between V!6-23 and J!1 in splenic DNA samples (Figure 3b) from Atm
-/-
 mice(107, 108).   We 
isolated thymic and splenic DNA from the Mre
ATLD1/ATLD1 
and Nbs
m/m
 mice and used the same 
PCR-strategy to assay for in vivo defects in rearrangement by inversion.  In all cases, we detect 
aberrant hybrid joints in the MRN-deficient cells that are also observed in Atm
-/-
 cells but not 
observed in WT cells (Figure 3).  Thus, we detect aberrant hybrid joint formation during the 
rearrangement of pMX-INV in our Abl pre-B cell lines but also in both primary B and T cells in the 
MRN-deficient mice.   
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Efficiency of CJ formation is decreased in MRN-deficient cells. 
ATM-deficient cells also have a deficiency in CJ formation, and unrepaired coding ends 
are readily detectable in ATM-deficient cells undergoing V(D)J recombination at chromosomally 
integrated substrates as well as the endogenous antigen receptor loci(107, 108).  We decided to 
assay for CE accumulation in the MRN-deficient cells as well.   Whereas no coding end 
intermediates are detected in genomic DNA isolated from WT Abl pre-B cells (WT:INV) upon STI 
treatment, these reaction intermediates are readily detectable in samples from Atm
-/-
  Abl pre-B 
cells and in Mre
ATLD/ATLD 
and Nbs
m/m
 Abl pre-B cells, although to a lesser extent (Figure 4).  These 
coding ends are visualized by a 2.2 kb hybridizing fragment in EcoRV-digested genomic samples 
from pMX-INV rearrangement (Figure 2a and 4).   Next, we wished to determine whether the 
MRN-deficient mice also exhibited defects in coding joint formation in vivo.   
We have previously demonstrated that ATM-deficient mice have a defect in thymocyte 
development, more specifically a decrease in thymocyte counts with the most significant 
decrease in the number of CD4+ and CD8+ (single positive SP) thymocytes (Figure 5a)(108).  
Furthermore, we have demonstrated a decreased number of pre-selection $"-TCR expressing 
(TCR-" intermediate) CD4+CD8+ (double positive, DP) thymocytes in Atm
-/-
 mice(108).  This 
defect is visualized by FACS analysis by staining for the surface expression of TCR"; compared 
to wild-type mice, Atm
-/-
 mice have decreased numbers of cells expressing intermediate and high 
levels of TCR" (48% as compared to 9.5% of DP thymocytes) population (Figure 5b)(108).  In 
characterizing the Nbs
m/m 
mice, we note a similar, though less severe, decrease in total 
thymocyte number with the most significant decreases again in the numbers of CD4+ and CD8+ 
SP thymocytes (Figure 5a).  Furthermore, we note the same block at the DP stage with only 21% 
of DP cells expressing intermediate levels of TCR" (Figure 5b).  This suggested to us that MRN-
deficient mice likely have a similar defect in thymocyte development that we see in the ATM-
deficient mice.  Cells at the DP stage of thymocyte development are actively assembling their 
TCR$ genes in an attempt to generate a functional $"-TCR.  Production of a successful TCR, 
that is, one that binds peptide-MHC with sufficient affinity to mediate positive selection, but does 
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not afford self-reactivity, is a rare occurrence(108).  As such, it is rather advantageous that the 
TCR$ allele is arranged such that it can undergo multiple rounds of recombination.  Specifically, 
the locus has over 100 V gene segments and 61 J gene segments all of which undergo 
rearrangement by deletion.  The initial rearrangements involve the most 3’ V segments and most 
5’ J gene segments.  If coding joint formation during this first attempt at rearrangement is not 
successful, additional rounds of rearrangement are possible utilizing an upstream V and a 
downstream J segment.  The requirement for multiple rearrangements at this locus might explain 
the particular block in thymocyte development seen in the ATM- and MRN-deficient mice(108).   
Increasing the number of breaks that must be repaired to generate a functional antigen receptor 
would increase the chances that both alleles would be inactivated due to the aberrant repair of 
RAG DNA DSBs, and as a result, no $"-TCR expressing DP thymocyte would develop.  Thus, 
defects in coding joint efficiency might be manifested as a specific decrease in the number of $"-
TCR expressing DP thymocytes(108). 
Similar to the endogenous kappa locus, the noted complexity of the endogenous TCR$ 
locus prevents us from quantitatively determining the extent of a defect in CJ formation by 
Southern blotting.  To detect a possible defect in CJ formation at the TCR$ locus in the ATM- and 
MRN-deficient mice, we generated mice with a modified TCR$ allele containing two rather than 
61 J$ gene segments(108).  While any of the 100 V gene segments can be utilized, all TCR$ 
rearrangements must utilize one of two J$ gene segments, enabling us to detect the 
accumulation of unrepaired coding ends (Figure 6a)(108).   To assay for the accumulation of 
unrepaired ends during recombination of this modified TCR$ allele in ATM- and MRN-deficient 
mice, we developed WT:TCR-!
sJ/sJ
, Atm
"/"
:TCR!
sJ/sJ
, Mre
A/A
:TCR$
SJ/SJ 
and Nbs
m/m
:TCR!
SJ/SJ 
mice, isolated thymic DNA, and performed Southern blot analyses as diagrammed in Figure 6a 
(Figure 6a).  Southern blotting revealed a smattering of non-germline bands that are indicative of 
successful V$ to J$ rearrangement in these thymocytes (Figure 6b).  However, in contrast to 
WT:TCR!
SJ/SJ 
cells, the Atm
"/"
:TCR-!
sJ/sJ
, Nbs1
m/m
:TCR-!
sJ/sJ
, and Mre11
ATLD1/ATLD1
:TCR!
sJ/sJ
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thymocytes each have a distinct 5.9-kb band that represents unrepaired J!56 coding ends(108).  
As observed in the Abl pre-B cells, however, the phenotype of the MRN-deficient cells was less 
severe than that of Atm
-/-
 cells, as we detect more J$-56 CEs in the Atm
-/-
:TCR-!
SJ/SJ 
thymocytes 
than either the Nbs1
m/m
:TCR-!
sJ/sJ
 or the Mre11
ATLD1/ATLD1
:TCR!
sJ/sJ
 thymocytes.  Importantly, 
equivalent levels of DNA were ran on the Southern as shown by the loading control (Figure 6b).  
Based on these data, we believe that the block in thymocyte development seen in the Nbs-
deficient mice (Figure 5) is a result of a decrease in efficiency of CJ formation during 
rearrangement of the TCR$ locus as previously demonstrated for ATM-deficient mice(108).
 
MRN-deficiency does not lead to global defects in ATM activation. 
The observed defect in repair of RAG DNA DSBs in the MRN-deficient cells and mice is 
remarkably similar to that we described for ATM-deficient cells(107, 108).  Given the role for MRN 
in recruiting ATM to the site of a DNA DSB and the ability of MRN to augment ATM activity in 
vitro, it was important to demonstrate that the phenotype of MRN-deficient cells was not simply 
due to decreased ATM-activity in these cells(77).  We decided to assay for the phosphorylation of 
known substrates of ATM in response to DNA damage to determine whether or not ATM was 
capable of being activated in the absence of a functional MRN complex during V(D)J 
recombination. 
We reasoned that the assays available to detect ATM activity would not be sensitive 
enough to detect signaling events following the induction of a small number of RAG DNA DSBs 
that are made and repaired quickly as they are in WT cells.  Thus, to better assess signaling 
downstream of RAG DNA DSBs, we utilized cells deficient in components of the NHEJ-pathway.  
Specifically, we used Artemis
-/-
 Abl pre-B cells.  Artemis is the endonuclease required to open the 
hairpin-sealed coding ends during V(D)J recombination, and in its absence, coding ends 
accumulate unrepaired(150, 158, 161).  As mentioned above, in our Abl pre-B cells, 
rearrangement at the endogenous IgL! locus occurs upon STI treatment.  Cleavage at the 
endogenous kappa locus in NHEJ-deficient cells generates four distinct J! coding ends that are 
readily detectable by Southern blotting providing evidence that RAG DNA DSBs are being made 
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but not repaired in these cells (Figure 7).   To assess the status of ATM activity in the absence of 
a functional MRN-complex, we generated Abl pre-B cells from Artemis
-/-
, Artemis
-/-
:Atm
-/-
, Artemis
-
/-
:Mre
ATLD1/ATLD1
, and Artemis
-/-
:Nbs
m/m
 mice.   Differences in the number of unrepaired coding 
ends could potentially lead to changes in the activation of ATM.  Thus, it was important to 
demonstrate that all cells used in these assays had similar accumulation of unrepaired RAG DNA 
DSBs upon STI treatment as assayed by Southern blotting for J! coding ends (Figure 9a).  
ATM, in response to DNA damage, phosphorylates a large number of proteins including 
histone variant H2AX and Kap1(71, 206, 305, 306).  Furthermore, it is known to lead to NF"B 
activation (as further discussed in Chapter 5)(263, 270).   We chose to assess ATM activity in the 
MRN-deficient cells using these particular substrates and ATM-dependent functions as readouts.  
In Artemis
-/-
 Abl pre-B cells, we detect RAG dependent phosphorylation of H2AX as assayed by 
immunostaining of these cells with an antibody specific to the phosphorylated form of H2AX (%-
H2AX).  We detect %-H2AX foci formation in 60% of the Artemis
-/-
 cells at 24 hours of STI 
treatment and less than 5% of the Artemis
-/-
:Atm
-/-
 cells (Figure 8a); thus, the phosphorylation of 
H2AX in response to persistent Rag DNA DSBs is predominantly mediated by ATM.   We detect 
levels of H2AX phosphorylation in the Artemis
-/-
:Mre
ATLD1/ATLD1 
and Artemis
-/-
:Nbs
m/m 
cells similar to 
those deficient in Artemis alone; furthermore, incubating these cells with a kinase inhibitor of ATM 
decreases %-H2AX foci formation demonstrating that ATM is active in these cells (Figure 9b).  We 
also detect Kap1 phosphorylation by Western blotting in response to RAG DNA DSBs in Artemis
-/-
 
but not Artemis
-/-
:Atm
-/-
 cells (Figure 8b).  Neither Artemis
-/-
:Mre
ATLD1/ATLD1 
nor Artemis
-/-
:Nbs
m/m 
 
exhibit a significant defect in Kap1 phosphorylation following RAG DNA DSBs (Figure 9c).  
Finally, we are able to detect activation of NF"B in response to RAG DNA DSBs in STI-treated 
Artemis
-/-
 (as discussed in Chapter 5) Abl pre-B cells by EMSA which detects translocation of the 
active p50:p65 NF#B heterodimer to the nucleus (Figure 8c).  NF"B similarly readily translocates 
to the nucleus following RAG DNA DSBs in the Artemis
-/-
:Mre
ATLD1/ATLD1
 and Artemis
-/-
:Nbs
m/m 
cells 
but not in the Artemis
-/-
:Atm
-/- 
cells (Figure 9D and Figure 8c).   Each of these assays suggest that 
ATM is being activated in the absence of the MRN complex.  Moreover, the addition of the ATM-
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inhibitor to the MRN-deficient cells increases the severity of the joining phenotype discussed 
above leading to an increase in the amount of unrepaired coding ends and further demonstrating 
that ATM is active in these MRN-deficient cells (Figure 10). Thus, we conclude that ATM activity 
is not grossly defective in the absence of a fully functional MRN complex.   
Conclusion 
Here, we demonstrate that MRN-deficient cells exhibit a defect in repair by NHEJ during 
V(D)J recombination that is similar to the repair defect previously described for ATM with an 
increase in aberrant hybrid joint formation during rearrangement by inversion and a decrease in 
the efficiency of coding joint formation(107, 108).  While we cannot rule out isolated defects in the 
phosphorylation of specific targets of ATM that might affect repair, we demonstrate that ATM is 
activated in these cells.  These data suggest, then, that the MRN complex might have important 
roles downstream of ATM in these cells.  
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Figure 1.  Assaying the repair of RAG DNA DSBs with Abl pre-B cells. (a) Schematic demon-
strating the creation of Abl pre-B cell lines.  Infection of BM samples with a retrovirus encoding the 
v-abl kinase transforms a pre-B cell population causing them to cycle rapidly.  Upon STI treatment, 
these cells arrest in G1, express the Rag proteins and begin to undergo V(D)J recombination (as 
indicated by the deletion of the intervening sequence between the V and J gene segments and 
their subsequent joining).  (b)  FACS analysis of Abl pre-B cells before and after STI treatment 
demonstrating G1-arrest.  Cells were either treated or not treated with STI571 for 48 hours and 
incubated with Hoechst dye to assay for DNA content.  % of cells in G1 and S phase are indicated. 
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Figure 2.  ATM- and MRN-deficient Abl pre-B cells have defects in rearrangement by 
inversion. (a) Schematic of the pMX-INV retroviral recombination substrate, rearrange-
ment intermediates, and products.  The retroviral packaging signal (ψ), GFP cDNA, and 
IRES-human CD4 (I-hCD4) cassette are labeled.  The viral LTRs (open arrows) and the 
RSSs (open triangles) are shown.  The non-rearranged (NR) pMX-INV and pMX-INV 
coding ends (CE), coding joint (CJ) and hybrid joint (HJ) are indicated.  The relative 
position the C4 probe (bar) and EcoRV (E) and NcoI (N) endonuclease restriction sites are 
shown as are the expected sizes of hybridizing fragments.  (b)  Southern blot analysis of 
EcoRV/NcoI digested genomic DNA from wild type (WT), Atm-/-, Mre11ATLD1/ATLD1 (Mre11A/A) 
and Nbs1m/m abl pre-B cell clones containing the pMX-INV (INV) retroviral recombination 
substrate that had been treated with STI571 for the indicated time (hours, h). The abl pre-B 
cell clones analyzed each have single pMX-INV integrants and were derived from parental 
lines as indicated (parental line – clone number).  Expected sizes for bands generated by 
non-rearranged pMX-INV (NR), coding joints (CJ), hybrid joints (HJ) and coding ends (CE) 
are indicated.  
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Figure 3.  Defects in rearrangement by inversion at endogenous antigen receptor loci 
in ATM- and MRN-deficient mice.  (a) PCR analysis of Vδ5DδJδ1 coding joints (Vδ5 CJ), 
Vδ5Dδ1 hybrid joints (Vδ5 HJ), Vβ14DβJβ2.7 coding joints (Vβ14 CJ) and Vβ14Dβ2 hybrid 
joints (Vβ14 HJ) in wild type (WT), Atm-/-, Nbs1m/m and Mre11ATLD1/ATLD1 thymocytes.  (b) PCR 
analysis of Vκ6-23 to Jκ1 coding joints (Vκ6-23 CJ) and hybrids joints (Vκ6-23 HJ) in WT, 
Atm-/-, Nbs1m/m and Mre11ATLD1/ATLD1 splenocytes.  The IL-2 gene PCR is shown as a DNA 
quantity control.  
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Figure 4.  Defects in CJ formation in ATM- and MRN-deficient Abl pre-B cells.  EcoRV 
digested genomic DNA from wild type (WT), Atm-/-, Mre11ATLD1/ATLD1 (Mre11A/A) and Nbs1m/m 
abl pre-B cell clones containing the pMX-INV (INV) retroviral recombination substrate that 
had been treated with STI571 for the indicated time (hours, h). The abl pre-B cell clones 
analyzed each have single pMX-INV integrants and were derived from parental lines as 
indicated (parental line – clone number).  Expected sizes for bands generated by non-
rearranged pMX-INV (NR), coding joints (CJ), hybrid joints (HJ) and coding ends (CE) are 
indicated.  
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Figure 5.  Block in thymocyte development in Atm-/- and Nbsm/m mice.  (a) Number of 
thymocytes in Atm-/- (n=16) and Nbs1m/m (n=9) mice at the indicated stages of develop-
ment expressed as a percentage of the number of thymocytes found at each stage in 
wild type Atm+/+ (n=12) and Nbs1+/+ (n=3) littermate controls.  Calculations were done 
using mean numbers of thymocytes from mice of each genotype and propagated error. 
DN: CD4-CD8- (double negative); DP: CD4+CD8+ (double positive); SP: single positive.  
(b) Representative flow cytometric analysis of +CD8+ double 
positive thymocytes from wild type, Nbs1m/m and Atm-/- mice.  Numbers indicate percent-
age of DP cells that are int.  
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Figure 6.  Accumulation of unrepaired TCRα coding ends in ATM- and MRN-deficient 
mice.  (a)  sJ allele.  The 
constant region is the grey rectangle.  
bar) used for analysis are also shown.  (b) Southern blot analysis of 
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Figure 8.   Evidence of ATM activation in NHEJ-deficient Abl pre-B cells.  (a) Quantification of 
γ−H2AX nuclear foci following 24 hours of STI571 treatment.  Shown is the percentage of cells 
containing 1, 2, or 3-5 foci γ−H2AX foci.  Total number of cells analyzed for each genotype was 500 
and p-values were calculated using a two-tailed Fischer’s Exact test.  Note that γ−H2AX foci were not 
detected in any of the STI571-treated Rag-/- abl pre-B cells. (b) Western blot analysis of phospho-
treated cells shown.  (c) NFκB EMSA of 
nuclear lysates from Rag2-/-, Artemis-/- and Artemis-/-:Atm-/- abl pre-B cells treated with STI571 for the 
indicated number of hours.  NFY EMSA is shown as a control.  
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Figure 9.   ATM is activated in MRN-deficient Abl pre-B cells.  (a) Southern blot analysis 
showing Jκ1 and Jκ2 coding ends (CE) generated in Artemis-/-, Nbs1m/m:Artemis-/-, and 
Artemis-/-:MreA/A abl pre-B cells treated with STI571 for the indicated times (hours, h).  The 
bands corresponding to the IgLκ locus in the germline configuration (GL) and Jκ1 and Jκ2 
CEs are indicated.  (b) Percentage of Artemis-/- , Nbs1m/m:Artemis-/-,  and 
Mre11ATLD1/ATLD1:Artemis-/-
treatment with STI571 for 24 hours and either DMSO (-) or the Atm inhibitor (iAtm) 
KU-55933 (+).  Total number of cells analyzed for each genotype was 500 and p-values 
were calculated using a two-tailed Fischer’s Exact test.  (c) Western blot analysis for 
Artemis-/- , Nbs1m/m:Artemis-/-, and 
Mre11ATLD1/ATLD1:Artemis-/- abl pre-B cell lines treated with STI571 for 96 hours and either 
DMSO (-) or the Atm inhibitor (iAtm) KU-55933 (+).    (d)  of nuclear lysates 
from Artemis-/-, Atm-/-: Artemis-/-, and two independent Nbs1m/m :Artemis-/- and 
Mre11ATLD1/ATLD1:Artemis-/- abl pre-B cell lines treated with STI571 for 36 hours.  NFY EMSA 
is shown as a control. 
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Figure 10.  ATM functions during repair of Rag DNA DSBs in MRN-deficient cells.  
Atm inhibition in MRN-deficient cells leads to increased coding end accumulation.  
Southern blot analysis of EcoRV digested genomic DNA from wild type, Atm-/-, and two 
Mre11ATLD1/ATLD1 (labeled as Mre11A/A) and Nbs1m/m abl pre-B clones containing pMX-INV.  
Cells were treated with STI571 for the indicated time (hours, h) and either DMSO (-) or 
the ATM inhibitor (iAtm) KU-55933 (+).  Expected sizes for bands generated by non-
rearranged substrate (NR), coding joints (CJ), hybrid joints (HJ) and coding ends (CE) 
are indicated.
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Chapter 4  
 
 
 
 
 
ATM Regulates the Processing of Persistent Coding 
Ends by Phosphorylating Histone H2AX 
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Previous work has demonstrated that ATM plays a critical role in the repair of RAG-
mediated DNA DSBs by maintaining unrepaired ends in a post-cleavage complex thereby 
promoting their efficient joining, suppressing hybrid joint formation and preventing 
translocations(107).  Furthermore, we show here that ATM may perform these functions via the 
phosphorylation of downstream substrates such as the MRN-complex.  Interestingly, ATM also 
phosphorylates histone H2AX at the site of a RAG DNA DSB; we detect phosphorylation of H2AX 
in chromatin flanking the RAG DNA DSB up to 200 kb from the site of the break(211).  The 
phosphorylation of H2AX is required for the accumulation of repair and signaling factors at the 
site of a break.  Furthermore, H2AX-deficient mice have a mild defect in lymphocyte development 
and an increase in lymphoid tumors involving antigen receptor loci.  Thus, we considered the 
possibility that H2AX might also play a critical role downstream of ATM in the repair of RAG DNA 
DSBs.  However, in contrast to MRN-deficient cells, we and others have shown that there is no 
overt defect in V(D)J recombination in H2AX-deficient cells(233, 235, 243). 
Millions of RAG DNA DSBs are generated each day.  Although most RAG DNA DSBs are 
repaired efficiently, if even a fraction of those persist unrepaired, it could have significant 
deleterious effects on genomic stability.  We reasoned that ATM might have additional roles in the 
response to or repair of DSBs that persist for some period of time.  We reasoned that ATM might 
function in ensuring that the cells harboring these persistent breaks activate p53-mediated 
apoptosis rather than accessing alternative repair pathways that would lead to aberrant resolution 
and result in genomic instability.  Furthermore, the substrates downstream of ATM that might 
carry out these functions might differ from those that are required for repair during V(D)J 
recombination.  H2AX
-/- 
mice have a high degree of genomic instability that is much increased in 
the absence of p53(234, 236); thus H2AX is a putative candidate for enabling this ATM-
dependent effector function.   
We considered the possibility that the phosphorylation of H2AX in response to persistent 
RAG DNA DSBs is required to prevent persistent coding ends from accessing aberrant repair 
pathways.  As mentioned in the introduction, a key determinant in repair pathway choice is 
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whether and how the DNA ends are resected.  Ends that are resected even a few base pairs are 
poor substrates for NHEJ, but end resection is required for homology mediated repair(140-142, 
176).  Therefore, we designed experiments to analyze the processing of persistent RAG DNA 
DSBs in the absence of H2AX. 
Determining the outcome of unrepaired breaks in the absence of H2AX. 
To determine whether H2AX affects the processing of persistent RAG DNA DSBs, we 
again made use of our Abl pre-B cell lines deficient in components of the NHEJ pathway; 
specifically, we generated cell lines deficient in Artemis or Artemis and H2AX and additionally 
lines deficient in DNA Ligase IV (Lig IV) or Ligase IV and H2AX and isolated clones containing 
single integrants of the pMX-DEL
CJ
 retroviral recombination substrate (Artemis
-/-
:DEL
CJ
, Artemis
-/-
:H2AX
-/-
:DEL
CJ
 and Lig IV
-/-
:DEL
CJ
, Lig IV
-/-
:H2AX
-/-
:DEL
CJ
).  Artemis is the endonuclease required 
to open hairpin-sealed coding end intermediates produced by RAG cleavage, while Ligase IV is 
the DNA ligase responsible for joining both SEs and CEs to form the SJ and CJ respectively.  
Deficiencies in Artemis lead to the accumulation of hairpin-sealed coding ends while deficiencies 
in Ligase4 lead to the accumulation of unrepaired SEs as well as hairpin-open coding ends.  
pMX-DEL
CJ
 differs from pMX-INV in the orientation of the RSSs such that rearrangement occurs 
by deletion of the intervening sequence with the coding joint being formed within the 
chromosomal context (Figure 2a and Figure 11a).  
STI induction in WT:DEL
CJ
 cells leads to the robust rearrangement of pMX-DEL
CJ
; this is 
evidenced by the presence of a 4 kb band on Southern blot, the size expected for a normal CJ 
(Figure 11).  STI induction in the NHEJ-deficient cells leads to the accumulation of un-repaired 
coding ends with variable but low levels of CJ formation in the Artemis
-/-
:DEL
CJ
 Abl pre-B cells but 
no accumulation of CJs in the LigIV
-/-
 Abl pre-B cells.  The unrepaired coding ends in Artemis
-/-
:DEL
CJ
 and Lig IV
-/-
:DEL
CJ
 Abl pre-B cells are homogenous in size as depicted by the distinct 2.2 
kb band detectable by Southern blotting (Figure 11).  In striking contrast, coding ends in Artemis
-/-
:H2AX
-/-
:DEL
CJ 
and Lig IV
-/-
:H2AX
-/-
:DEL
CJ
 Abl pre-B cells are heterogenous in size with many 
significantly smaller (>1kb) than those in Artemis
-/-
:DEL
CJ
 and Lig IV
-/-
:DEL
CJ
 Abl pre-B cells 
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(Figure 11b and 11c).  This demonstrates that unrepaired coding ends are aberrantly processed 
in the absence of H2AX.  It additionally suggests that H2AX-deficiency permits hairpin-sealed 
coding ends to be opened and resected in an Artemis-independent manner, as we note 
degradation of the unrepaired coding ends in the Artemis
-/-
:H2AX
-/-
:DEL
CJ
 Abl pre-B cells but not 
the Artemis
-/-
:DEL
CJ
 Abl pre-B cells. 
Hairpin-sealed ends are aberrantly opened in the absence of H2AX. 
To determine whether the hairpin-sealed coding ends in Artemis
-/-
:H2AX
-/-
:DEL
CJ
 Abl pre-
B cells are being opened aberrantly, we needed to develop assays whereby hairpin-sealed 
coding ends can be distinguished from open coding ends.  We developed two techniques, 
Southern blotting after denaturation and TdT-assisted PCR, that have enabled us to differentiate 
between these two recombination intermediates.   
First, we decided to analyze DNA isolated from STI-treated Artemis
-/-
:H2AX
-/-
:DEL
CJ
 Abl 
pre-B cells by Southern blotting following denaturation.  Denaturing an open hairpin forms two 
single-stranded fragments that migrate at a lighter molecular weight than the non-denatured 
duplex as evidenced by analysis of Lig IV
-/-
 Abl pre-B cells, where hairpin-sealed coding ends are 
efficiently opened by the Artemis endonuclease (Figure 12a and b).  In contrast, a denatured 
closed hairpin migrates similarly to the non-denatured duplex as evidenced by analysis of 
Artemis
-/-
:DEL
CJ
 Abl pre-B cells where coding ends are predominantly hairpin-sealed (Figure 12a 
and b).  Strikingly, denaturation of coding ends in Artemis
-/-
:H2AX
-/-
:DEL
CJ 
Abl pre-B cells 
revealed that 35-78% are open at early time-points after RAG induction (Figure 12a and b).   
A second method developed in our lab to differentiate between hairpin-sealed and open 
coding ends is TdT-assisted PCR.  This technique utilizes an enzyme, terminal deoxynucleotidyl 
transferase (TdT), an enzyme that adds nucleotides in a non-templated fashion to free 3’-hydroxyl 
groups but is unable to access hairpin-sealed coding ends.  Briefly, we incubate genomic DNA 
with dATP and TdT; TdT then adds a string of adenosine molecules only to DNA ends with 
opened hairpins. This labeling step is followed by PCR using oligo-dT and substrate-specific 
primers as depicted in Figure 13a.  Utilizing TdT PCR, we detect a robust Artemis-independent 
! 
67 
opening of the hairpin-sealed DNA ends in the Artemis
-/-
:H2AX
-/-
:DEL
CJ
 Abl pre-B cells (Figure 
13c).  We conclude that hairpin-sealed coding ends in Artemis
-/-
:H2AX
-/-
 Abl pre-B cells are 
efficiently opened and resected by a nucleolytic pathway that cannot efficiently access these DNA 
ends in Artemis
-/-
:DEL
CJ
 Abl pre-B cells. 
H2AX prevents end processing in primary pre-B cell cultures. 
To eliminate the possibility that this requirement for H2AX in regulating DNA end 
processing is unique to our Abl pre-B cell lines, we decided to perform the same analyses in 
primary pre-B cell cultures.  Bone marrow cultures were generated from Artemis
-/-
 and Artemis
-/-
:H2AX
-/-
 mice.  Developing B lymphocytes in NHEJ-deficient mice normally do not progress to the 
pre-B cell stage as they are unable to undergo V(D)J recombination to form a heavy chain and a 
functional pre-B cell receptor.  However, we introduced an IgH transgene (IgHtg) that drives the 
pro-B to pre-B transition.  Thus, these cells are arrested at a pre-B cell stage where they will 
attempt rearrangement of the endogenous kappa locus.   These cultures proliferate in the 
presence of IL-7, but upon withdrawal of IL-7, these cells arrest in G1 of the cell cycle, induce 
RAG and undergo recombination at the IgL! locus (Figure 14b).  In the NHEJ-deficient cells, just 
as we see in the Abl-pre B cells, induction of V(D)J recombination leads to the accumulation of 
unrepaired (J!) coding ends (Figure 14).  
Withdrawal of IL-7 and the induction of RAG cleavage generates 4 distinct J! coding 
ends that are readily detectable by Southern blotting in the Artemis
-/-
:IgHtg pre-B cells (Figure 14a 
and b).  In Artemis
-/-
: H2AX
-/-
 IgHtg pre-B cells as compared to Artemis
-/-
:IgHtg pre-B cells, we 
note that the ends are partially degraded as indicated by products of sizes intermediate to each of 
the four distinct coding end bands (Figure 15a). TdT-assisted PCR using primers downstream of 
J!2 corroborates this observation.  We detect two bands corresponding to open coding ends 
produced from cleavage at either J!1 or J!2 in Artemis
-/-
:H2AX
-/-
:IgHtg pre-B cells but not 
Artemis
-/-
:IgHtg pre-B cells (Figure 15b).  Furthermore, we detect PCR products at sizes between 
the expected bands of J!1 and J!2 and some smaller than the product expected for cleavage at 
J!2 demonstrating that the hairpins are open and the ends are resected in the absence of H2AX 
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(Figure 15b).  Thus, we note a requirement for H2AX in preventing hairpin-opening and resection 
of the unrepaired coding ends in Artemis
-/-
:H2AX
-/-
 in our Abl pre-B cell lines and in primary pre-B 
cell cultures. 
The phosphorylation of H2AX and Mdc1 is required to prevent aberrant end processing. 
During DNA damage responses, most H2AX-depndent processes are linked to its 
phosphorylation on serine 139 (forming "-H2AX) in chromatin flanking DNA DSBs including those 
generated by RAG.  To determine whether the phosphorylation of H2AX is required to prevent the 
opening and resection of persistent unrepaired coding ends, we reconstituted the Lig IV
-/-
:H2AX
-/-
:DEL
CJ
 and Artemis
-/-
:H2AX
-/-
:DEL
CJ
 Abl pre-B cells with either WT H2AX or H2AX mutated at 
Ser139 (S139A), the site known to be phosphorylated by ATM in response to DNA damage.  We 
verified the expression of H2AX and equivalent levels of WT and H2AX
S139A 
mutants in these cells 
by Western blotting (Figure 16).  We used an empty retrovirus as a control.  We find that the 
reconstitution of Lig IV
-/-
:H2AX
-/-
:DEL
CJ
 or Artemis
-/-
:H2AX
-/-
:DEL
CJ
 Abl pre-B cells with wild type 
H2AX prevents coding end resection in these cells as we no longer see the degradation of coding 
ends by Southern blot that we see in the control cells (Figure 16).  These ends are now distinct 
bands similar to what was observed in the Lig IV
-/-
: DEL
CJ
 or Artemis
-/-
:DEL
CJ
 Abl pre-B cells 
demonstrating that the end degradation we see is due to H2AX deficiency (Figure 11). However, 
reconstitution with the serine 139 to alanine mutant of H2AX (H2AX
S139A
) does not prevent this 
resection (Figure 16). Thus, the function of H2AX in modulating DNA end resection in G1-phase 
lymphocytes relies on the formation of "-H2AX. 
Several DNA damage response proteins associate with "-H2AX in chromatin flanking 
DNA breaks including Mdc1, which directly binds "-H2AX through its BRCT domain, and 
functions to amplify DNA damage responses.  To determine whether Mdc1 is also required to 
prevent hairpin-sealed coding ends from being opened and resected in an Artemis-independent 
fashion, we developed Artemis
-/-
:MDC-1
-/-
:DEL
CJ
 Abl pre-B cells.  Upon STI treatment and the 
induction of RAG, we note that, similar to what was observed in the Artemis
-/-
:H2AX
-/-
:DEL
CJ
 Abl 
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pre-B cells, the unrepaired hairpin-sealed coding ends in the Artemis
-/-
:MDC-1
-/-
:DEL
CJ
 Abl pre-B 
cells are degraded (Figure 17).  
ATM activates antagonistic pathways that regulate end processing. 
As ATM is required to generate  "-H2AX in chromatin flanking RAG DSBs and MDC-1 
amplifies DNA damage response signals, in part, by recruiting ATM to the site of a DSB, we 
reasoned that ATM would be required to prevent the nucleolytic resection of coding ends in G1-
phase cells.  To test this hypothesis, we treated the Artemis
-/-
:DEL
CJ
 Abl pre-B cells with an 
inhibitor of ATM kinase activity (KU-55933).  Interestingly, however, inhibition of ATM kinase 
activity did not lead to the resection of un-repaired coding ends in Artemis
-/-
:DEL
CJ
 Abl pre-B cells 
(Figure 18a).  This seemed at odds with our hypothesis as H2AX should not be phosphorylated in 
these cells and therefore, based on the evidence above, we would have predicted to see 
degradation of the unrepaired coding ends.  We verified that the kinase inhibitor was working by 
assaying for NF!B activation in these cells as described in Chapter 3, and determined that it was,  
in fact, preventing ATM kinase activity.  Additionally, we do not see degradation of unrepaired 
coding ends in the Artemis
-/-
:Atm
-/-
 cells although H2AX is abrogated in these cells (Figure 7b).   
We therefore reasoned that ATM might also be required to promote this end processing.  
To test this hypothesis, we similarly treated the Artemis
-/-
:H2AX
-/-
:DEL
CJ
 Abl pre-B cells with KU-
55933.  This resulted in a near complete block in end resection (Figure 18a).  Additionally, by 
analyzing these ends by Southern blotting following denaturation, we note that many of these 
DNA ends are now hairpin-sealed (Figure 18b).  Thus, ATM is required to promote Artemis-
independent hairpin-opening and end resection in the Artemis
-/-
:H2AX
-/-
:DEL
CJ
 Abl pre-B cells.   
We conclude that ATM inhibits DNA end resection through the generation of "-H2AX; 
however, ATM activity is also required to promote this resection. Thus, ATM activates 
antagonistic pathways to regulate the resection of un-repaired DNA ends in G1-phase cells. 
Hairpin-opening and end resection are mediated by CtIP. 
During HR, Mre11 and CtIP coordinate to regulate the end resection required to generate 
the 3’ ssDNA overhang that is subsequently used for strand invasion.  We demonstrate in 
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Chapter 3 that Mre11, as a component of the MRN complex, functions during V(D)J 
recombination.  While CtIP activity is thought to be regulated at the level of protein abundance 
and CtIP levels are low in our G1-arrested cells, it is still expressed at a level detectable by 
Western.  CtIP activity is also regulated by ATM, and we demonstrate that end resection in our 
cells is ATM-dependent.  Finally, and perhaps most importantly, CtIP and Mre11 have hairpin-
opening activity in vitro.  Therefore, based on these data, we hypothesized that the Artemis-
independent hairpin-opening in the absence of H2AX might be mediated by CtIP.   
To investigate this possibility, we generated lentiviral shRNA constructs specific for CtIP 
and knocked down CtIP in Artemis
-/-
:H2AX
-/-
:DEL
CJ
 Abl pre-B cells.  The knockdown in these cells 
was confirmed by Western blotting (Figure 19a).  Analyses of un-repaired coding ends generated 
in cells depleted in CtIP revealed a dramatic reduction in DNA end resection as compared to cell 
lines transduced with a non-targeting shRNA (Figure 19a and b).  Moreover, we analyzed these 
ends by Southern blotting following denaturation and show that many of the DNA ends in the 
Artemis
-/-
:H2AX
-/-
:DEL
CJ
 in which CtIP levels had been depleted are hairpin-sealed (Figure 19c).  
These data demonstrate that CtIP promotes the endonucleolytic opening and resection of hairpin-
sealed coding ends in Artemis
-/-
:H2AX
-/-
 cells.   Furthermore, depletion of CtIP similarly abrogates 
end resection in the Lig IV
-/-
:H2AX
-/-
:DEL
CJ
 Abl pre-B cells (Figure 20a and b).  The low level of 
resection observed in the CtIP-deficient cells (both Lig IV
-/-
:H2AX
-/-
:DEL
CJ
  and Artemis
-/-
:H2AX
-/-
:DEL
CJ
) might reflect the activity of additional nucleolytic pathways inhibited by H2AX or the 
activity of the residual CtIP in these cells (Figure 19a, b and 20).  We conclude that H2AX 
prevents CtIP from efficiently promoting hairpin opening and resection of un-repaired DNA ends 
in G1-phase lymphocytes.  
H2AX prevents homology-mediated joining in G1-phase cells. 
Coding ends opened by CtIP in Artemis
-/-
:H2AX
-/- 
Abl pre-B cells DNA are not efficiently 
joined by NHEJ as evidenced by the abundance of unrepaired coding ends in these cells even at 
late time-points (Figure 11).  This is surprising given that all core components of the NHEJ 
pathway are present in these cells, and Artemis is only required for the opening of the hairpin-
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sealed end prior to joining and cells deficient in Artemis do not have a general defect in NHEJ as 
evidenced by normal SJ formation in Artemis
-/- 
cells.  The single strand overhangs generated by 
CtIP-dependent processing in S-G2-M are essential for homologous recombination; however, in 
G1, these ends would be poor substrates for classical NHEJ possibly explaining why we do not 
see robust levels of CJ formation in these cells following the opening of the hairpin-sealed end.    
We reasoned, though, that if DNA ends processed by CtIP in G1-phase cells are joined 
efficiently primarily by homology-mediated pathways, then we might expect to find joints with 
significant deletions due to the use of homologous sequences in cis to promote joining.  To 
address this possibility, we designed PCR primers to detect coding joints with significant deletions 
(" 600 bp) in our retroviral recombination substrate (Figure 21a).  These analyses revealed that 
the coding joints formed in Artemis
-/-
:H2AX
-/-
:DEL
CJ
 Abl pre-B cells are heterogenous in size as 
compared to Artemis
-/-
:DEL
CJ
 and WT:DEL
CJ
 Abl pre-B cells (Figure 21b).  Sequence analyses 
confirmed that these coding joints have significant deletions (Figure 21c and Table 5).   
 While NHEJ does not require homologous sequences to join broken DNA ends, 
alternative pathways exist that do require varying degrees of homology to mediate end joining.  
We decided to clone and sequence individual CJs from Artemis
-/-
:H2AX
-/-
:DEL
CJ
, Artemis
-/-
:DEL
CJ
 
and WT:DEL
CJ 
Abl pre-B cells to determine whether the CJs that form in the Artemis
-/-
:H2AX
-/-
:DEL
CJ
 Abl pre-B cells more frequently exhibit homologous sequences at the joint.  These 
sequence analyses revealed that a higher fraction of the coding joints formed in Artemis
-/-
:H2AX
-/-
:DEL
CJ
 cells use microhomologies (# 1 base pairs) as compared to coding joints generated in 
WT:DEL
CJ 
and Artemis
-/-
:DEL
CJ
 Abl pre-B cells (Figure 21d and Table 5).  Moreover, coding joints 
formed in Artemis
-/-
:H2AX
-/-
:DEL
CJ
 Abl pre-B cells have generally longer tracts of microhomology 
(Figure 21d and Table 5).   
Notably, the homologous LTR sequences that flank pMX-DEL
CJ
 could be used for 
homology-mediated joining if the 5’ and 3’ coding ends were resected as much as 1kb and 2kb, 
respectively (Figure 22a).  We reasoned, that in the absence of H2AX, we might detect repair 
mediated by the homology of these repeats.  To address this possibility, we determined the 
! 
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location of the retroviral integration site for each of the cell lines.  Then, we designed primers to 
genomic regions flanking the integration sites of pMX-DEL
CJ 
in these cells (Figure 22a).  PCR 
with these primers revealed products of a size expected from LTR-LTR homology mediated 
joining.  These products increased in abundance after RAG induction in an ATM-dependent 
manner in Artemis
-/-
:H2AX
-/-
:DEL
CJ
, but not in Artemis
-/-
:DEL
CJ
, Abl pre-B cells (Figure 22b).  
These data further demonstrate that homology-mediated repair occurs more frequently in the 
Artemis
-/-
:H2AX
-/-
:DEL
CJ
 cells. 
Conclusion 
We demonstrate that, in G1-phase lymphocytes, the ATM-dependent formation of "-
H2AX inhibits the robust CtIP-dependent opening and resection of hairpin-sealed broken DNA 
(coding) ends generated by the RAG endonuclease.  The DNA ends that have undergone 
aberrant CtIP-dependent processing are not efficiently joined by NHEJ.  Furthermore, the joints 
that do form exhibit large deletions that would preclude the formation of a functional antigen 
receptor gene and usage of homology-mediated repair, which in G1-phase cells, would promote 
genomic instability and possibly lead to cellular transformation. 
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Figure 11.  Aberrant processing of persistent coding ends in the absence of H2AX.  
(a) Schematic of the pMX-DELCJ retroviral recombination substrate.  Shown are the 
un-rearranged substrate (UR), hairpin sealed (hCE) and open (oCE) coding end (CE) 
intermediates and coding joints (CJ).  The RSs (open triangles), ψ sequence, IRES-hCD4 
cDNA (i-hCD4) and the LTRs are indicated.  Relative positions of EcoRV sites and the 
C4b probe (black bar) are shown.  (b) Southern blot analysis of EcoRV-digested genomic 
DNA from WT:DELCJ-119, Artemis-/-:DELCJ-81 and Artemis-/-:H2AX-/-:DELCJ-124 abl pre-B 
cells treated with STI571 for the indicated time.  Bands reflecting pMX-DELCJ UR, CE and 
CJ are indicated.  Cβ probe hybridization is shown as a DNA loading control and molecu-
lar weight markers (kb) are indicated.  Dotted arrow indicates hybridization to resected 
CEs.   (c)  Southern blot analysis of pMX-DELCJ rearrangement on EcoRV-digested 
genomic DNA from Rag-/-:DELCJ-35, WT:DELCJ-119.6, LigIV-/-:DELCJ-10 and LigIV-/-:H2AX-/-
:DELCJ-168 abl pre-B cell lines. 
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Figure 12.  Persistent hairpin-sealed coding ends are opened in the absence of H2AX.  
(a) Southern blot analysis of non-denatured (n) or denatured (d) EcoRV-digested genomic 
DNA from Lig IV-/-:DELCJ-10, Artemis-/-:DELCJ-81 and Artemis-/-:H2AX-/-:DELCJ-95 abl pre-B 
cells treated with STI571 for 48 hours as well as from Lig IV-/-:DELCJ-10 abl pre-B cells not 
treated with STI.  Hybridizing bands reflecting non-denatured hairpin-sealed CEs (hCEn), 
denatured hairpin-sealed CEs (hCEd), non-denatured open CEs (oCEn), denatured open 
CEs (oCEd), non-denatured UR (URn), denatured UR (URd), non-denatured CJ (CJn) and 
denatured CJ (CJd) pMX-DELCJ are indicated.  (b) Quantification of denaturing Southern 
showing the percentage of coding ends that are open in LigaseIV-/-:DELCJ, Artemis-/-:DELCJ, 
and Artemis-/-:H2AX-/-:DELCJ treated with STI571 for 48 or 96 hours as indicated.
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Figure 13.  Detection of open coding ends by TdT-assisted PCR.  (a) Schematic of South -
ern blotting strategy for TdT-assisted PCR for pMX-DELCJ rearrangement.  Open coding ends 
have an accessible 3’-hydroxyl group and a series of adenosine residues will be added to the 
3’ end  upon incubation with TdT and dATP.  PCR with a poly-dT primer and a substrate specific 
primer will yield the PCR product  shown.  Relative position of oligo probe is also shown.   
Coding ends that are open and degraded will yield PCR products of smaller size.  Hairpin-
sealed ends are not accessible to TdT labeling and therefore, will yield no product.  (b) Southern 
blot analysis of pMX-DELCJ rearrangement on EcoRV-digested genomic DNA from WT:DELCJ-
119, Artemis-/-:DELCJ-13 or Artemis-/-:H2AX-/-:DELCJ-95 abl pre-B cells treated with STI571 for the 
indicated amount of time.  Southern blots were carried out as described in Figure 11 (c) South-
ern blot of PCR products from TdT-assisted PCR of pMX-DELCJ coding end intermediates from 
Artemis-/- and Artemis-/-:H2AX-/- abl pre-B cells shown in (b) treated with STI571 for 0 or 48h.  
Arrow indicates the expected position of an un-processed open coding end.  PCR products from 
samples not treated with TdT are shown as a negative control.  IL2 is provided as a loading 
control. 
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Figure 14.  Utilizing IL7-dependent pre-B cell cultures to analyze V(D)J recombination.  (a) 
Schematic demonstrating Southern blotting strategy for analyzing rearrangement at the endogenous 
IgL-κ locus.  Shown is the un-rearranged or germline configuration (GL) as well as the four possible 
coding ends (CE) corresponding to cleavage at each of the four Jκ gene segments (Jκ1 CE, Jκ2 CE, 
Jκ4 CE, and Jκ5 CE).  Gene segments are indicated by boxes and RSSs by triangles.  The relative 
positions of the EcoRI and SacI restriction  enzyme sites as well as the 3’ Jκ probe used (JκIII) are 
shown.  (b) Demonstration of usage of IL7 pre-B cell cultures.  Bone marrow from Rag-/- or Artemis-/- 
mice harboring an IgH transgene that promotes development to the pre-B cell stage is harvested 
(B220+, IgM-).  These cells preferentially proliferate in the presence of IL-7 and following 5-10 days in 
culture are the predominant cell type (see FACS plot). Upon withdrawal of IL7, these cells arrest in 
G1, express Rag and undergo rearrangement of the endogenous kappa light chain locus.  Southern 
blot analysis of recombination at the IgL-κ locus in Rag-/-:IgHtg and Artemis-/-:IgHtg is provided demon-
strating the accumulation of unrepaired coding ends following IL7 withdrawal in the Artemis-/- but not 
the Rag-/- cells.  
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Figure 15.  H2AX prevents resection of persistent coding ends in primary cells.  
(a)  Southern blot analysis of recombination at the IgL-κ locus in Artemis-/-:IgHtg and 
Artemis-/-:H2AX-/- :IgHtg IL7 pre-B cell cultures while in IL7 or following removal of IL7 for 
the indicated amount of time.  (b) Southern blot of TdT-assisted PCR products of IgLκ 
CE intermediates in bone marrow pre-B cells from two Artemis-/-:IgHtg and Artemis-/-
:H2AX-/-:IgHtg mice 48 hours after IL-7 withdrawal.  Expected products for Jκ1 and Jκ2 
CEs are indicated.  PCR products from samples not treated with TdT are shown as a 
negative control.  IL2 gene PCR is provided as a DNA loading control. 
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Figure 16.  Phosphorylation of H2AX is required to prevent aberrant resection of persis-
ten coding ends.  (a) Western blot analysis showing H2AX levels in LigIV-/-:H2AX-/-:DELCJ-128 
abl pre-B cells reconstituted with WT (H2AX) or mutant H2AX (H2AXS139A) and Southern blot 
analysis of pMX-DELCJ rearrangement in these cells.  (b) As in (a) but for Artemis-/-:H2AX-/-
:DELCJ-124 reconstituted with WT (H2AX) or mutant H2AX (H2AXS139A). 
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Figure 17.  Mdc is required to prevent resection of persistent hairpin-sealed coding ends.  
Southern blot analysis of pMX-DELCJ rearrangement on EcoRV-digested genomic DNA from 
WT:DELCJ-119.6, Artemis-/-:DELCJ-81 and Artemis-/-:Mdc-/-:DELCJ-2 and -23 Abl pre-B cells treated 
with STI571 for the indicated amount of time.  Southern blots were carried out as described in 
Figure 11.
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Figure 18.  ATM activity is required to promote end resection.  (a) Analysis of pMX-
DELCJ rearrangement in two Artemis-/- (Artemis-/-:DELCJ-81 and -7) and two Artemis-/-
:H2AX-/- (Artemis-/-:H2AX-/-:DELCJ-124 and -95) abl pre-B cells treated with STI571 for the 
indicated amount of time and treated with either the ATM-specific inhibitor KU55933 (+) or 
a DMSO vehicle control (-).  (b) Southern blot analysis of pMX-DELCJ rearrangement on 
non-denatured (n) and denatured (d) EcoRV-digested genomic DNA samples from 
Artemis-/-:H2AX-/-:DELCJ-94 Abl pre-B cells treated with STI571 for 48 hours. 
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Figure 19.  CtIP mediates opening and resection of persistent hairpin-sealed coding ends.  (a) 
Western blot analysis of Artemis-/-:H2AX-/-:DELCJ-124 and -95 Abl pre-B cells expressing CtIP-
specific shRNA.  GAPDH or Erk2 are shown as loading controls.  (b) Southern blot analysis of 
pMX-DELCJ rearrangement in Artemis-/-:H2AX-/-:DELCJ-124 and -95 Abl pre-B cells expressing either 
non-targeting (NT) or CtIP-specific (CtIP) shRNAs and treated with STI571 for the indicated amount 
of time.  (c) Southern blot analysis of pMX-DELCJ rearrangement in Artemis-/-:H2AX-/-:DELCJ-95 cells 
treated with STI571 for 48 hours.  DNA was run under non-denaturing (n) and denaturing (d) condi-
tions.
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Figure 20.  CtIP mediates resection of persistent open coding ends in the absence of H2AX.  
(a) Western blot analysis demonstrating CtIP knockdown for LigIV-/-:H2AX-/-:DELCJ-128 and -168 
expressing CtIP-specific or  non-targeting shRNA constructs.  GAPDH is shown as a loading 
control.  (b) Southern blot analysis of pMX-DELCJ rearrangement in LigIV-/-:H2AX-/-:DELCJ-128 and 
-168 expressing either non-targeting (NT) or CtIP-specific (CtIP) shRNAs and treated with STI571 
for the indicated amount of time.
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Figure 21.  Coding joints formed exhibit significant deletions and usage of microhomolo-
gies.  (a) Schematic of pMX-DELCJ showing relative positions of the oligonucleotides used to 
amplify aberrant pMX-DELCJ joints and the oligonucleotide used as a probe.  (b) PCR of pMX-
DELCJ coding joints in WT:DELCJ-119.6, Artemis-/-:DELCJ-81 and Artemis-/-:H2AX-/-:DELCJ-124 and 
-95 abl pre-B cells treated with STI571 for 0 (-) or 96 (+) hours using the pC and IRES REV5 
oligonucleotides.  PCR products were probed with the IRES REV4 oligonucleotide. Bands 
representing un-rearranged pMX-DELCJ substrate (UR) and an unprocessed coding joint (CJ) are 
indicated.  Coding joints with deletion are visualized as hybridizing fragments lower in molecular 
weight than the CJ species.  IL2 is shown as a loading control. (c-d) Nucleotide deletions (c) and 
microhomologies (d) in pMX-DELCJ coding joints formed in WT:DELCJ, Artemis-/-:DELCJ and 
Artemis-/-:H2AX-/-:DELCJ Abl pre-B cells treated with STI571 .
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Figure 22.  Detection of coding joint formation mediated by the homologous LTR 
sequences.  (a) Schematic of pMX-DELCJ showing relative positions of the oligonucle-
otides used to amplify joints formed due to the homology of the LTRs and the oligonucle-
otide used as a probe.  (b) PCR of pMX-DELCJ coding joints in Artemis-/-:DELCJ and 
Artemis-/-:H2AX-/-:DELCJ abl pre-B cells not treated (-) or treated (+) with STI571 and 
vehicle or KU-55933 (iATM) using integration specific primers designed to detect 
homology-mediated joining that deletes pMX-DELCJ leaving a single LTR. 
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# Lost 5' CE N/P 3' CE # Lost # Lost 5' CE N/P 3' CE # Lost
GAACGTCTG CAGCCTACAATTCC TAGGAACGTCTG AGCCTACAATTCCC
1 GAACGTCT ACAATTCC 6 4 TAGGAACG CCGC CAATTCCG 7
TAGGAACGTCTG CAGCCTACAAT TAGGAACGTCTG GCCTACAATTCCCG
4 TAGGAACG CCTACAAT 3 4 TAGGAACG CCG CAGCCTAC 8
GGAACGTCTG CAGCCTACAA TAGGAACGTCTG ACAATTCCGCCCCC
2 GGAACGTC GCCTACAA 2 4 TAGGAACG C CCGCCCCC 12
GAACGTCTG CAGCCTAC TATTAGGAACGTCT CAGCCTAC
1 GAACGTCT CAGCCTAC 0 7 TATTAGGA GAGTCT CAGCCTAC 0
GAACGTCTG CAGCCTACA TATTAGGAACGTCT CAGCCTACAAT
1 GAACGTCT AGCCTACA 1 7 TAATAGGA CGCTGCC CCTACAAT 3
AACGTCTG CAGCCTACAATTCC AAAAATATTAGGAA CAGCCTACAAT
0 AACGTCTG ACAATTCC 6 13 AAAAATAT CCTGGGA CCTACAAT 3
AACGTCTG CAGCCTACAATTC ACTGCCGGATCTCG AAGCCGCTTGGAAT
0 AACGTCTG TACAATTC 5 89 ACTGCCGG GTCTCGCGGCCGC CTTGGAAT 46
GGAACGTCTG CAGCCTAC GACTCTAGAATC
2 GGAACGTC CAGCCTAC 0
AACGTCTG CAGCCTACA
0 AACGTCTG AGCCTACA 1
AACGTCTG CAGCCTAC
0 AACGTCTG CAGCCTAC 0 *13
AACGTCTG CAGCCTAC
0 AACGTCTG G CAGCCTAC 0
AACGTCTG CAGCCTAC
0 AACGTCCG CTG CAGCCTAC 0
AACGTCTG CAGCCTAC
0 AACGTCTG CCTTG CAGCCTAC 0
AACGTCTG CAGCCTACA
0 AACGTCTG A AGCCTACA 1
AACGTCTG CAGCCTACA
0 AACGTCTG G AGCCTACA 1
AACGTCTG CAGCCTACAA
0 AACGTCTG C GCCTACAA 2 *3
AACGTCTG CAGCCTACAA
0 AACGTCTG GG GCCTACAA 2 *4
AACGTCTG CAGCCTACAAT
0 AACGTCTG A CCTACAAT 3
AACGTCTG CAGCCTACAAT
0 AACGTCTG CA CCTACAAT 3
AACGTCTG TACAATTCCGCCCC
0 AACGTCTG AG TCCGCCCC 11
GAACGTCTG CAGCCTAC
1 GAACGTCT A CAGCCTAC 0
GAACGTCTG CAGCCTAC
1 GAACGTCT TG CAGCCTAC 0
GAACGTCTG CAGCCTAC
1 GAACGTCT ACCCCCT CAGCCTAC 0
GAACGTCTG CAGCCTACA
1 GAACGTCT A AGCCTACA 1
GAACGTCTG CAGCCTACAA
1 GAACGTCT CCTTACG GCCTACAA 2
GAACGTCTG CAGCCTACAAT
1 GAACGTCT C CCTACAAT 3
GGAACGTCTG CAGCCTAC
2 GGAACGTC G CAGCCTAC 0
GGAACGTCTG CAGCCTAC
2 GGAACGTC CTTG CAGCCTAC 0
GGAACGTCTG CAGCCTAC
2 AGAACGTC CCC CAGCCTAC 0 *3
GGAACGTCTG CAGCCTAC
2 GGAACGTC GAGATG CAGCCTAC 0
GGAACGTCTG CAGCCTACA
2 GGAACGTC TGA AGCCTACA 1
GGAACGTCTG CAGCCTACAA
2 GGAACGTC CGCG GCCTACAA 2
GGAACGTCTG GCCTACAATTCCCG
2 GGAACGTC CA AATTCCCG 8
AGGAACGTCTG CAGCCTAC
3 AGGAACGT G CAGCCTAG 0
TAGGAACGTCTG CAGCCTAC
4 TAGGAACG GGTG CAGCCTAC 0 *3
AGGAACGTCTG CAGCCTAC
3 AGGAACGG G CAGCCTAC 0
AGGAACGTCTG CAGCCTAC
3 AGGAACGT TG CAGCCTAC 0
AGGAACGTCTG CAGCCTAC
3 AGGAACGT CG CAGCCTAC 0
AGGAACGTCTG CAGCCTAC
3 AGGAACGT TTG CAGCCTAC 0
AGGAACGTCTG CAGCCTAC
3 TAGGAACG GTG CAGCCTAC 0
AGGAACGTCTG CAGCCTAC
3 AGGAACGT TTTG CAGCCTAC 0
AGGAACGTCTG CAGCCTAC
3 AGGAACGT CCCGTG CAGCCTAC 0
AGGAACGTCTG CAGCCTACAA
3 AGGAACGT TTGAG GCCTACAA 2
TAGGAACGTCTG CAGCCTAC
4 TAGGAACG G CAGCCTAC 0
TAGGAACGTCTG CAGCCTAC
4 TAGGAACG CCG CAGCCTAC 0
TAGGAACGTCTG CAGCCTAC
4 TAGGAACG CCCG CAGCCTAC 0
TAGGAACGTCTG CAGCCTAC
4 TAGGAACG CTTCTG CAGCCTAC 0
TAGGAACGTCTG CAGCCTACA
4 TAGGAACG GCTGG AGCCTACA 1
TAGGAACGTCTG CAGCCTACAAT
4 TAGGAACG GCTAAGG CCTACAAT 3
TAGGAACGTCTG CAGCCTACAATT
4 TAGGAACG G CTACAATT 4
TAGGAACGTCTG CAGCCTACAATTCC
4 AACGTCTG A ACAATTCC 6
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Table 5.  Coding joint sequences in Artemis-/-:H2AX-/- Abl pre-B cells show significant 
deletions and microhomologies .  Coding joints sequences from WT:DELCJ-119.6, Artemis-/-
:DELCJ-81 and Artemis-/-:H2AX-/-:DELCJ-124 and -95 abl pre-B cells treated with STI571 for 96 
hours and amplified using the pB and pC oligonucleotides described in Chapter 4. PCR products 
were cloned and sequenced.
WT:DELCJ
# Lost 5' CE N/P 3' CE # Lost # Lost 5' CE N/P 3' CE # Lost
GAGCGCCGGTCGCT TGGCCGAAGCCGCT AACGTCTG CAGCCTACAATT
50 GAGCGCCG AAGCCGCT 40 0 AACGTCTG ATG CTACAATT 4
GGAAAGGACCTTAC CTTGGAATAAGGCC CTACCATTACCAAC GCCGAAGCCGCTTG
210 GGAAAGGA ATAAGGCC 49 40 CTACCATT G GCCGCTTG 40
GTCGCTACCATTAC CGTTACTGGCCGAA CTCAAAGTAGACGG GGTCTGTTGAATGT
44 GTCGCTAC TGGCCGAA 32 169 CTCAAAGT TCTTA TTGAATGT 197
GCCGGTCGCTACCA TGGCCGAAGCCGCT AACGTCTG CCCCCCCCCTAACG
46 GCCGGTCG AAGCCGCT 40 0 AACGTCTG CG CCCTAACG 22
ATAGGAACGTCTG CGTTACTGGCCGAA CTTGTCTGGTGTCA CAGCCTAC
5 ATAGGAAC TGGCCGAA 34 25 CTTGTCTG CC CAGCCTAC 0
GCCGGTCGCTACCA TGGCCGAAGCCGCT GGAACGTCTG CCCCCCCCTAACGT
46 GCCGGTCG AAGCCGCT 40 2 GGAACGTC G CCTAACGT 23
GAACGTCTG CAGCCTACAATTCC GGAACGTCTG ACAATTCCGCCCCC
1 GAACGTCT ACAATTCC 6 2 GGAACGTC CCG CCGCCCCC 15
GAACGTCTG CAGCCTACAATTCC AACGTCTG AATTCCGCCCCCCC
1 GAACGTCT ACAATTCC 6 0 AACGTCTG CAGG GCCCCCCC 14
TGGTGTCAAAAATA ACGTTACTGGCCGA CCATTACCAACTTG TACTGGCCGAAGCC
21 TGGTGTC A CTGGCCGA 31 35 CCATTACC GACTTGTC CCGAAGCC 37
CAAAAATAATAGGA CCCTAACGTTACTG AGGAACGTCTG CAGCCTAC
14 CAAAAATA CGTTACTG 26 3 AGGAACGT TG CAGCCTAC 0
ACCAACTTGTCTGG CAGCCTACAATTCC AACGTCTG CAGCCTACA
32 ACCAACT T ACAATTCC 6 0 AACGTCTG AA AGCCTACA 1
AGTAGACGGCATCG TGAATGTCGTGAAG TGGTGTCAAAAATA TTCCGCCCCCCCCC
165 AGTAGACG TCGTGAAG 203 19 TGGTGTCA GGACCTA CCCCCCCC 16
TAGGAACGTCTG CAGCCTACAAT AAAATAATAGGAAC ATTCCGCCCCCCCC
4 TAGGAACG CCTACAAT 3 11 AAAATAAT CT CCCCCCCC 15
GAACGTCTG TACAATTCCGCCCC TCTGGTGTCAAAAA TGGCCGAAGCCGCT
1 GAACGTCT TCCGCCCC 11 21 TCTGGTGT CCGG AAGCCGCT 40
AACGTCTG ATTCCGCCCCCCCC ATAATAGGAACGTC CGCCCCCCCCCCTA
0 AACGTCT G CCCCCCCC 15 8 ATAATAGG GG CCCCCCTA 19
AACGTCTG CAGCCTACAAT CTGGTGTCAAAAAT CAGCCTACAAT
0 AACGTCT G CCTACAAT 3 20 CTGGTGTC C CCTACAAT 3
TCTGGTGTCAAAAA CAGCCTACAATTCC CCGACCCCGGGGGT CTCGCCAAAGGAA-
21 TCTGGTG T ACAATTCC 6 117 CCGACCCC TCG AAAGGAAA 179
AACTTGTCTGGTGT CCCCCCCTAACGTT CAACTTGTCTGGTG GATTTTCCACCATA
27 AACTTGT C CTAACGTT 24 28 CAACTTGT GA CCACCATA 87
GCCCACGTGAAGGC TGGAATAAGGCCGG CTGGTGTCAAAAAT GCCCCCCCCCCTAA
133 GCCCACGT AAGGCCGG 54 *2 20 CTGGTGTC G GGCCGAAG 35
AACTGAGCGCCGGT CGTTACTGGCCGAA GGAACGTCTG ACAATTCCGCCCCC
50 AACTGAGC TGGCCGAA 34 2 GGAACGTC CCG CCGCCCCC 12
AGGACCTTACACAG GTGCGTTTGTCTAT TGCCGGATCTCGCG GGCCGGTGTGCGTT
206 AGGACCTT TTGTCTAT 69 87 TGCCGGAT TA TGTGCGTT 62
TGAGCGCCGGTCGC CGTTACTGGCCGAA TCGCTACCATTACC TGGAATAAGGCCGG
51 TGAGCGCC TGGCCGAA 35 40 TCGCTACC G AAGGCCGG 54
GGCCGCGACTCTAG ATGCAAGGTCTGTT GCCGACCCCGGGGG AAGCCGCTTGGAAT
75 GGCCGCGA GGTCTGTT 190 118 GCCGACCC GCC CTTGGATT 46
CCCTCAAAGTAGAC GATTTTCCACCATA CGACTCTAGAATTC TTCCGCCCCCCCCC
171 CCCTCAAA CCACCATA 87 69 CGACTCTA AGT CCCCCCCC 16
AACGTCTG AGCCTACAATTCCG AGGAACGTCTG CAGCCTAC
0 AACGTCTG CAATTCCG 7 3 AGGAACGT AGGCTG CAGCCTAC 0
CCAACTTGTCTGGT CGCCCCCCCCCCTA GTCAAAAATAATAG CAGCCTAC
29 CCAACTTG CCCCCCTA 19 15 GTCAAAAA G GCCTACGA 3
ATAATAGGAACGTC CCCGCCCCCCCCCC GCTGCCGACCCCGG GTGATTTTCCACCA
8 ATAATAGG CCCCCCCC 17 *2 121 GCTGCCGA AGGA TTCCACCA 85
TCGCTACCATTACC GCCGCTTGGAATAA AGGAACGTCTG CAGCCTAC
41 TCGCTACC TGGAATAA 48 3 AGGAACGT CCGCTG CAGCCTAC 0
ACTTGTCTGGTGTC AGCCTACAATTCCG AACGTCTG CAGCCTACA
26 ACTTGTCT CAATTCCG 7 0 AACGTCTG A AGCCTACA 1
AATAATAGGAACGT ACGTTACTGGCCGA AATAGGAACGTCTG CCTACAATTCCGCCC
9 AATAATAG CTGGCCGA 33 6 AATAGGAA TAGG TTCCGCCC 9
AAATAATAGGAACG CAGCCTACAATT ACCAACTTGTCTGG CTTGGAATAAGGCCG
10 AAATAATA CTACAATT 4 30 ACCAACTT T TAAGGCCG 53
AACGTCTG TTCCGCCCCCCCCC
0 AACGTCTG CCCCCCCC 16
GTCAAAAATAATAG ACAATTCCGCCCCC
15 GTCAAAAA CCGCCCCC 12
TCGCGGCCGCGACT CCGGTGTGCGTTTG
78 TCGCGGCC TGCGTTTG 64
CCAACTTGTCTGGT GCCTACAATTCCGC
29 CCAACTTG AATTCCGC 8
AATAGGAACGTCTG GTTACTGGCCGAAG
6 GATAGGAA GGCCGAAG 35
AGAATTCCAACTGA CGCTTGGAATAAGG
62 AGAATTCC GAATAAGG 50
AACGTCTG CAGCCTACA
0 AACGTCTG AGCCTACA 1
AACGTCTG CAGCCTAC
0 AACGTCTG CAGCCTAC 0 *6
ACTGAGCGCCGGTC TATGTGATTTTCCA
55 ACTGAGCG GCTATTTGTT ATTTTCC- 80
ACTGAGCGCCGGTC GTTTGTCTATATGT
55 ACTGAGCG G CTATATGC 71
CCAACTTGTCTGGT TTTTCCACCATATT
31 CCAACTTG G ACCATATT 87
CCGGATCTCGCGGC GCCGGTGTGCGTTT
87 CCGGATCT GG GTGCGTTT 61
CCAACTTGTCTGGT TACAATTCCGCCCC
16 CCAACTTG AAACTG TCCCGCCC 8
CACGCCGCCCACGT CCGCTTGGAATAAG
161 CACGCCGC TCACGTGAAGGC GGAATAAG 47
GGCTGCCGACCCCG TCTATATGTCTATA
124 GGCCGCCG CGGGAATAAGGC TGTCTATA 76
CGGTGCGCGTT
CTGGTGTCAAAAAA CAGCCTACAATTCC
22 CTGGTGTC G ACAATTCC 6
GTCTGGTGTCAAAA CAGCCTACAATTC
25 GTCTGGTG CCCT TACAATTC 5
AAAATAATAGGAAC CAGCCTACAATT
13 AAAATAAT CT CTACAATT 4
AACGTCTG AATTCCGCCCCCCC
0 AACGTCTG CA GCCCCCCC 12
86
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# Lost 5' CE N/P 3' CE # Lost # Lost 5' CE N/P 3' CE # Lost
AGACCTCTGGCGGC CCCTCTCGCCAAAG GTGTCAAAAATAAT ATTCCGCCCCCCCC
333 AGACCTCT CGCCAAAG 171 17 GTGTCAAA CCCCCCCC 16
CTGGCGGCAGCCTA TGCGGCCAAAAGCC TCTAGACTGCCGGA CCCTAACGTTACTG
326 CTGGCGGC CAAAAGCC 306 94 TCTAGACT CGTTACTG 28
CCTCAAAGTAGACG CCAAAGGAATGCGA CTCGCGGCCGCGAC TTGCCGTC-TTTGA
175 CCT CAAAG GAATGCAA 178 81 CTCGCGGC TCTTTTGA 99
AGTAGACGGCATCG TTGACGAGCATTCC GGTGTCAAAAATAA AATTCCGCCCCCCC
168 AGTAGACG AGCATTCC 145 18 GGTGTCAA GCCCCCCC 14
ACCATTACCAACTT CGTTACTGGCCGAA TGCTGACCACCCCC TCTGTTGAATGTCG
40 ACCATTAC TGGCCGAA 30 189 TGCTGACC GAATGCCG 199
CGACTCTAGAATTC TGTCTATATGTGAT ACACGCCGCCCACG TGATTTTCCACCAT
69 CGACTCTA TATGTTAT 76 135 ACACGCCG TCCACCAT 86
GCAGCTTGGATACA TTCTTGACGAGCAT GTGAAGGCTGCCGA GAATGTCGTGAAGG
151 GCAGCTTG ACGAGCAT 146 142 GTGAAGGC CGTGAAGG 205
CCACCGCCCTCAAA CTCGCCAAAGGAAT CAGTCCTGCTGACC CGCCAAAGGAATGC
177 CCACCGCC AAAGGAAT 177 195 CTGTCCTG AGGAATGC 190
CCAACTTGTCTGGT CGCTTGGAATAAGG ACCTCGCTGGAAAG CTCGCCAAAGGAAT
35 CCAACTTG GAATAAGG 48 218 ACCTCGCT AAAGC-AT 178
TTGTCTGGTGTCAA TACTGGCCGAAGCC CAAAGTAGACGGCA AAGGAATGCAAGGT
26 TTGT CTGG CCGAAGCC 35 169 CAAAGTAG TGCAAGGT 185
GTCTGGTGTCAAAA AATGTGAGGGCCCG GCCCTCAAAGTAGA GTCTGTTGAATGTC
25 GTCTG GTG AGGGCCCG 113 174 GCCCTCAA TGAATGTC 196
ACCGCCCTCAAAGT ATTCCTAGGGGTCT ACCGCCCTCAAAGT GTTGAATGTCGTGA
178 ACCGCCCT AGGGGTCT 155 198 ACCGCCCT TGTCGTGA 202
GCCCACGTGAAGGC TGCCGTCTTTTGGC CTGACCACCCCCAC TCTGCGGCCAAAAG
134 GCCCACGT CTTTTGGC 101 187 CTGACCAC GCCAAAAG 95
CGGCCGCGACTCTA TGTGCGTTTGTCTA AAAAATAATAGGAA AACGTTACTGGCCG
75 CGGCCGCG TTTGTCTA 68 14 AAAAATAA ACTGGCCG 30
GCATCGCAGCTTGG AATGCAAGGTCTGT TAGGAACGTCTG CCCCTAACGTTACT
159 GCATCGCA AGGTCTGT 187 4 TAGGAACG ACGTTACT 25
TCGCAGCTTGGATA GACCCTTTGCAGGC CGCGGCCGCGACTC TTCCTAGGGGTCTT
153 TCGCAGCT TTGCTGGC 265 77 CGCGGCCG GGGGTCTT 160
TGTCTGGTGTCAAA ACCTGGCCCTGTCT GAAGGCTGCCGACC TGGCAATGTGAGGG
24 TGTCTG GG CCCTGTCT 132 125 GAAGGCTG TGTGAGGG 112
TACCATTACCAACT GGAATAAGGCCGGT AGCTTGGATACACG CCCTCTCGCCAAAG
37 TACCAT TA AGGCCGGT 54 149 AGCTTGGA CGCCAAAG 175
AGGAACGTCTG GCCGGTGTGCGTTT CACGCCGCCCACGT TTCCTAGGGGTCTT
3 AGGAACGT GTGCGTTT 62 139 CACGCCGC GGGTCTTT 160
TCTAGACTGCCGGA CAGCCTACAATTCC AACGTCTG CAGCCTAC
98 TCTAGA CT ACAATTCC 6 0 AACGTCTG CAGCCTAC 0
AAGTAGACGGCATC GGAAACCTGGCCCT GAACAACTGGACCG TCTGTTGAATGTCG
167 AAGTAGAC CTGGCCCT 129 304 GAACAACT A GAATGTCG 199
CCACGTGAAGGCTG TGACGAGCATTCCT AGAACCTAAAACAG CTTTCCCCTCTCGC
133 CCACGT GA GCATTCCT 148 222 AGAACCTA AACCT CCTCTCGC 168
GCCGGTCGCTACCA TGGCCGAAGCCGCT CGCCCTCAAAGTAG ATAAGGCCGGTGTG
46 GCCGGTCG AAGCCGCT 40 173 CGCCCTCA C CCGGTGTG 82
AAGTAGACGGCATC GGAAACCTGGCCCT ATTCCAACTGAGCG GCCCCCCCCCCTAA
165 AAGTAGAC CTGGCCCT 129 59 TTTCCAAC CGA CCCCCTAA 20
ATCGCAGCTTGGAT TATTGCCGTCTTTT TAGAATTCCAACTG CGAGCATTCCTAGG
154 ATCGCAGC CGTCTTTT 99 63 TAGAATTC G TTCCTAGG 153
CGACTCTAGAATTC ACGTTACTGGCCGA TGGTGTCAAAAATA CCCCCCCCCTAACG
71 CGACTC TA CTGGCCGA 31 19 TGGTGTCA GA CCCTAACG 22
AACTGAGCGCCGGT AGCCGCTTGGAATA AATTCCAACTGAGC ATGTGATTTTCCAC
56 AACTGAGC TTGGAATA 49 60 AATTCCAA GG TTTTCCAC 83
CTGCCGGATCTCGC GGCCGAAGCCGCTT AATAATAGGAACGT GGCCGAAGCCGCTT
90 CTGCCGGA AGCCGCTT 39 10 AATAATAG GT AGCCGCTT 41
GCCGGTCGCTACCA CCTAGGGGTCTTTC GCTGCCGACCCCGG CCCTAACGTTACTG
47 GCCGGTCG GGTCTTTC 160 121 GCTGCCGA GT CGTTACTG 28
GCCGGTCGCTACCA GCAAGGTCTGTTGA ACTGAGCGCCGGTC CGCCCCCCCCCCTA
47 GCCGGTCG TCTGTTGA 192 53 ACTGAGCG GT CCCCCCTA 20
GCCGCCCACGTGAA TTCCTAGGGGTCTT CCATCCTCTAGACT GCCGAAGCCGCTTG
136 GCCGCCCA GGGGTCTT 159 100 CCATCCTC CGG GCCGCTTG 42
CTGGAAAGGACCTT GGAATGCAAGGTCT CCGGATCTCGCGGC TCTATATGTGATTT
212 CTGGAAAG CAAGGTCT 188 85 CCGGATCT G TGTTATTT 78
ATAGGAACGTCTGC CAGCCTACA CAACTTGTCTGGTG ACGTTACTGGCCGA
5 ATAGGAAC     AGCCTACA 1 28 CAACTTGT GGG CTGGCCGA 33
TTGTCTGGTGTCAA CCGAAGCCGCTTGG CCCCGGGGGTGGAC CCGTCTTTTGGCAA
24 TTGTCTG G CCGCTTGG 43 113 CCCCGGGG A TTTGGCAA 104
ACTTGTCTGGTGTC TAACGTTACTGGCC GGTGGACCATCCTC CATTCCTAGGGGTC
26 ACTTGTC T TACTGGCC 31 106 GGTGGACC CCA TAGGGGTC 158
TAAGAACCTAGAAC GAATGCAAGGTCTG ACCACCCCCACCGC CGGAAACCTGGCCC
231 TAAGAACC AAGGTCTG 188 184 ACCACCCC AG CCTGGCCC 128
GCGGCCGCGACTCT CCCCCCCCTAACGT GTCAAAAATAATAG GTTACTGGCCGAAG
76 GCGGCCGC CCTAACGT 23 15 GTCAAAAA C GGCCGAAG 35
TGTCTGGTGTCAAA TACAATTCCGCCCC AACGTCTG CTACAATTCCGCCC
23 TGTCTGG T TCCGCCCC 11 0 AACGTTTG CAGC TTCCGCCC 10
GCCGGATCTCGCGG GGCAGCGGAACCCC TGGTGTCAAAAATA TACAATTCCGCCCC
86 GCCGGATC GGAACCCC 276 19 TGGTGTCA CACA TCCGCCCC 11
ATTACCAACTTGTC CTTGGAATAAGGCC GTGAAGGCTGCCGA ACCTGGCCCTGTCT
33 ATTACCA A ATAAGGCC 52 127 GTGAAGGC GTC CCCTGTCT 133
CGCGACTCTAGAAT CGAAGCCGCTTGGA
71 CGCGACTC CGCTTGGA 44
GGCATCGCAGCTTG GGGGTCTTTCCCCT
157 GGCATCGC TTT-CCCT 165
TACCGAGTCGGCGA GAGCATTCCTAGGG
272 TACCGAGT TCCTAGGG 153
CCTTACACAGTCCT AGGGCCCGGAAACC
202 CCTTACA C CGGAAACC 122
TGACCACCCCCACC GGAAGCAGTTCCTC
186 TGACCACC AGTTCCTC 217
AGCGCCGGTCGCTA CCGAAGCCGCTTGG
51 AGCGCCGG CCGCTTGG 40
CCGGTCGCTACCAT CCCCCCCCCTAACG
47 CCGGTCGC CCCTAACG 18
AACCTAGAACCTCG GGTCTTTCCCCTCT
226 AACCTAGA TCCCCTCT 167
ACCGGTGGTACCTC CAGTTCCTCTGGAA
290 ACCGGTGG CTCTGGAA 222
CGGCATCGCAGCTT CCTCTCGCCAAAGG
161 CGGCATCG GCCAAAGG 176
TCCAACTGAGCGCC GAATAAGGCCGGTG
57 TCCAACTG GGCCGGTG 56
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Chapter 5  
 
 
 
 
 
 
 
 
ATM Activates a Broad Genetic Program  
in Response to RAG DNA DSBs 
(reprinted with modification(270)) 
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The relatively mild defect in the repair of RAG DNA DSBs during V(D)J recombination in 
ATM-deficient cells does not likely entirely account for the lymphopenia observed in ataxia 
telangiectasia.  We considered the possibility that the more global effects of ATM activation in 
response to DNA damage, specifically its ability to activate gene transcription, might also affect 
lymphocyte development(73).   
ATM, in response to genotoxic DNA damage, promotes cell cycle checkpoint activation 
and apoptosis through the activation of p53(244-247).  It is known that ATM similarly activates 
p53 in response to persistent physiologic RAG DNA DSBs in developing lymphocytes, but 
whether it does so in response to all RAG DNA DSBs, including those in wild-type cells that are 
transient in nature, is not known(271).  ATM also activates NF!B, a transcription factor with 
targets that promote survival, in response to genotoxic damage, and the balance of the NF!B and 
p53 pathways is thought to mediate cell outcome following genotoxic DNA damage(263, 264).  If 
RAG DNA DSBs promote the ATM-mediated activation of p53, it is possible that ATM might 
simultaneously promote the transcription of pro-survival factors via the activation NF!B.  The sum 
of these two pathways could be important for negotiating a balance between survival and 
apoptosis in the developing lymphocyte following a RAG DNA DSB, essentially affording the cell 
a window of opportunity in which to repair the break.  Furthermore, while NF!B may solely be 
acting to promote the transcription of pro-survival factors, it is more likely that this multi-functional 
transcription factor would simultaneously modulate the expression of other genes that might be 
important for the developing lymphocyte.   
Deficiencies in ATM, then, would eliminate the activation of these transcriptional 
programs and thereby potentially negatively impact lymphocyte development.  We wished to 
determine whether ATM activates NF!B in response to transient RAG DNA DSBs and to fully 
characterize the transcriptional program initiated by ATM in response to these breaks.  
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Persistent RAG DNA DSBs activate NF!B via the classical pathway. 
RAG DNA DSBs in a WT cell are transient in nature, and, as such, signals emanating 
from those breaks might also be transient in nature.  As discussed in Chapter 3, we reasoned that 
the analysis of cells with persistent DSBs would increase our ability to detect the activation of 
transcriptional pathways in response to RAG DNA DSBs.  We chose initially to compare the 
activation of NF!B in response to RAG DNA DSBs in cells deficient in components of the NHEJ-
pathway, Artemis
-/-
 Abl pre-B cells, where breaks are made but not repaired in response to STI 
treatment to similarly treated Rag
-/-
 Abl pre-B cells where breaks are never made due to the lack 
of a functional RAG-holocomplex.  NF!B activation was assessed by EMSA (electrophoretic 
mobility shift assays) wherein labeled oligo probes consisting of NF!B binding sites are incubated 
with nuclear extracts from the cells of interest and ran on a poly-acrylamide gel.  If NF!B is 
activated in these cells, it should be present in the nucleus and will bind to the oligo probe.  This 
binding will retard the flow of the oligo in the gel leading to a “shift” of the oligo probe(289).  By 
EMSA, we detect robust NF!B activation in the Artemis
-/-
 Abl pre-B cell lines but not the Rag
-/-
 
lines at 48 hours of STI treatment (Figure 23a).  Importantly, this is at the same time that we see 
an accumulation of unrepaired J! coding ends in the Artemis
-/-
 deficient cells (Figure 23b).  Also, 
we do not see activation in cells deficient in both Artemis and ATM (Figure 23a) or in Artemis
-/-
 
cells treated with a small molecule inhibitor of ATM though breaks are clearly present in these 
cells (Figure 23b), demonstrating that ATM is mediating this DSB-dependent NF!B activation.   
NF!B activation by ATM in response to genotoxic DNA damage occurs through the 
classical pathway in a manner dependent on the phosphorylation of NEMO(263).  We carried out 
a number of tests to determine whether NF!B is similarly activated in response to RAG DNA 
DSBs.  One way to characterize the activation of NF!B is to add antibodies specific for the two 
components of the classical NF!B heterodimer (p50:p65) to the nuclear extracts prior to EMSA.  
The binding of these antibodies to their respective proteins will cause a further retardation 
(“super-shift”) of the oligo during PAGE(289).  Indeed, we find that both p50 and p65 antibodies 
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cause a super-shift in the EMSA with lysates from the Artemis
-/-
 cells.  This is visualized as a 
disappearance of the band seen in the Artemis
-/-
 lanes upon addition of antibodies specific for p50 
or p65 and the detection of higher molecular weight species in these lanes (Figure 24a).  
Additionally, we find that NF!B activation, as read-out by EMSA, is completely blocked in  
Artemis
-/-
 cells transfected with a N-terminally truncated dominant negative version of I!B" which 
primarily affects the classical pathway(307) (Figure 24b).  Finally, incubating cells with a cell-
permeable mutant NEMO binding domain peptide that prevents the association of NEMO with 
IKK" and IKK# thereby preventing the activation of the IKK complex(308) inhibits NF!B activation 
by EMSA while a mutant peptide does not (Figure 24c).  These data are all consistent with the 
idea that ATM activates NF!B via the classical pathway in response to RAG DNA-DSBs as it 
does in response to genotoxic DNA damage.  
Characterizing RAG DNA DSB-dependent transcriptional changes by microarray analysis. 
We wished to determine what genes are affected by the activation of NF!B in response 
to RAG DNA DSBs in the developing lymphocyte and whether ATM or other transducers might 
additionally activate other transcription factors in response to these physiologic breaks.  Thus, we 
designed the microarray-based experiments described below to more fully characterize the 
transcriptional program(s) activated in response to these physiologic DNA DSBs.   
As with the EMSA analyses, we began by comparing the transcriptional profiles of STI-
treated Artemis
-/-
 Abl pre-B cells to STI-treated Rag
-/-
 Abl pre-B cells.  The Rag
-/- 
Abl pre-B cells 
serve as a critical control in our microarray analyses as STI is known to cause many changes in 
gene expression(280).  By comparing the transcriptional profiles of similarly treated Rag
-/-
 and 
Artemis
-/-
 cells, we are able to distinguish STI-induced changes in transcription from those caused 
by the formation of RAG DNA DSBs.   
ATM is thought to be the primary transducer of the DNA damage response in G1 of the 
cell cycle(73).  However, we considered the possibility that other transducers might also activate 
pathways downstream of RAG DNA DSBs.  To determine which of the transcriptional changes 
were dependent on ATM signaling, we compared the transcriptional response to RAG DNA DSBs 
! 
92 
in STI-treated Artemis
-/-
 Abl pre-B cells to those deficient in both Artemis and ATM.  Finally, ATM 
in response to DNA damage is known to activate primarily p53 and NF!B(244-247, 263, 264).  
Considering that other transcriptional regulators such as Stat3 and FOXO-1 are also 
phosphorylated by ATM in response to DNA damage, it is likely that ATM modulates the activity 
of other transcriptional pathways as well(71).  To begin to address this possibility, we transfected 
Artemis
-/-
 cells with a dominant negative version of I!B" that is N-terminally truncated and 
functions as a dominant negative preventing activation of primarily the classical pathway(307).  
We simultaneously performed microarray analysis on these STI treated Artemis
-/-
:IkB!-"N Abl 
pre-B cells. 
All cell lines (Rag
-/-
, Artemis
-/-
, Artemis
-/-
:Atm
-/-
 and Artemis
-/-
:I#B!-"N) were treated with 
STI for 48 hours prior to RNA isolation.  Furthermore, we confirmed that all Artemis
-/- 
cells used  
had similar level of breaks by Southern blot prior to microarray analysis to minimize differences in 
transcription due to the differential accumulation of un-repaired breaks.  Three independently 
derived cell lines of each genotype were analyzed preventing us from inappropriately identifying 
differences in transcription due to cell line variation as RAG DNA DSB-dependent changes and 
furthermore to give us confidence in picking out any small but relevant changes in gene 
expression.  
Results of the microarray analysis yielded a relatively concise cohort of genes (364) 
whose expression was modulated in response to RAG DNA DSBs, as they exhibited a !2-fold 
change in expression in all three Artemis
-/-
 cell lines, as compared to the mean expression level in 
the three RAG-2
-/- 
cell lines (Figure 25a).  Of these, approximately half (189) of these genes 
depended on ATM as expression was diminished in the Artemis
-/-
:Atm
-/-
 Abl pre-B cells as 
compared to the Artemis
-/-
 Abl pre-B cells (Figure 25a).  Finally, 75 of the 364 genes exhibited 
transcriptional changes that were dependent on NF!B (Figure 25a).  A large fraction of the 
microarray data was confirmed by qrtPCR and by protein analysis where possible (Figure 25b 
and Figure 26).   Specifically, we note an increase in the expression of Bcl-3, Pim-2, CD40, 
CD62L, CD69 and common $-chain upon STI treatment in the Artemis
-/-
 but not Rag-2
-/-
  or 
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Artemis
-/-
:Atm
-/-
, or Artemis
-/-
:I#B!-"N (with the exception of CD62L) Abl pre-B cells (Figure 25b).  
Also, we detect increases in Pim-2 protein levels (all three isoforms) in Artemis
-/-
 but not Rag-2
-/-
  
or Artemis
-/-
:Atm
-/-
 Abl pre-B cells upon STI treatment (Figure 26a).  Finally, we note that the 
surface expression of CD40 and CD69 is similarly selectively increased in the Artemis
-/-
 Abl pre-B 
cells in response to STI treatment (Figure 26b).  Furthermore, we performed qrtPCR on Abl pre-B 
cells treated for varying amounts of time with STI to establish kinetic profiles of RAG-induced 
transcriptional changes (Figure 27).  We noted that the transcription of each of these genes had 
different kinetic profiles.  Interestingly, some like CD69 had a very transient increase in 
transcription and protein expression peaking at 48 hours and disappearing by 72 h even though 
the inciting stimulus (unrepaired RAG DNA DSB) was still present.  Others like CD40 show slow 
and gradual increases in expression but hit a plateau near 48 hours and still others, like Pim-2 
and Bcl-3, gradually increase throughout the 96-hour STI treatment.   
It was important to confirm that these gene changes were not due to Artemis-deficiency 
alone.  We analyzed the expression of a cohort of the genes in Rag
-/-
:Artemis
-/-
 cell lines (Figure 
28a) reasoning that these cells, while deficient in Artemis would not make DNA DSBs.  
Importantly, we did not note significant changes in the expression of the RAG DNA DSB-
dependent genes in these cells in upon STI treatment (Figure 28a).  Secondly, we also analyzed 
the expression of this cohort of RAG DNA DSB-dependent genes in Abl pre-B cell lines derived 
from mice deficient in other components of the NHEJ pathway (Ku80
-/- 
and scid).  These cells 
contain unrepaired RAG DNA DSBs but contain a functional Artemis protein.  Importantly, these 
cells do exhibit similar RAG-induced transcriptional changes (Figure 28b) as was seen in the 
Artemis
-/-
 Abl pre-B cells.  Thus, these genetic changes are not likely due to Artemis-deficiency 
per se. 
These data demonstrate that, in response to RAG-induced DSBs, ATM activates NF!B 
but additionally other transcription factors that lead to the promotion of a broad transcriptional 
program.  Notably, while some genes up-regulated in response to RAG DNA DSBs such as Pim-
2 and Bcl-3 have known roles in promoting survival, many of the genes (CD40, CD69, Cd62L) 
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breaks have no known function in the canonical DNA damage response.  Rather, the known 
functions of these gene products implicate them in lymphocyte development and function. For 
example, a number of genes belonging in this category have been implicated in migration and 
trafficking (Swap70(309), CD69(310, 311), L-Selectin(312)) in mature lymphocytes.  Importantly, 
then, this program transcends the canonical DNA damage response, activating genes whose 
expression could have important ramifications for the developing lymphocyte. 
Persistent RAG DNA DSBs activate a similar genetic program in vivo. 
To determine whether a similar genetic program is activated by RAG DSBs in vivo, we 
isolated bone marrow from Rag
-/-
:IgHtg and Artemis
-/-
:IgHtg mice.  As described in Chapter 4, 
lymphocyte development in these mice is arrested at the pre-B cell stage, being promoted to this 
stage by the immunoglobulin heavy chain transgene; however, as these cells are unable to 
undergo V(D)J recombination, they do not progress to the immature pre-B cell stage (Figure 29a).  
The Rag
-/-
:IgHtg mice cannot initiate V(D)J recombination because they cannot make DNA DSBs, 
while the Artemis
-/-
:IgHtg mice cannot complete V(D)J recombination because they cannot repair 
RAG DNA DSBs.  We were able to isolate RNA from the bone marrow of these mice and submit 
it for microarray analysis just as was done for the Abl pre-B cells.  In doing so, we determined that 
109 of the 364 RAG DSB-responsive genes were also up-regulated at least 1.2 fold in the 
Artemis
-/-
:IgHtg mice as compared to samples from Rag
-/-
:IgHtg mice (Figure 29a). The 
asynchronous nature of RAG break induction in these cells in vivo likely explains the generally 
lower changes in gene transcription in these cells.  However, and importantly, although these 
changes were less dramatic, they were confirmed by qrtPCR and additionally led to the expected 
relevant changes in protein expression with surface expression of CD40, CD69, CD62L and 
CD80 all significantly higher in the Artemis
-/-
:IgHtg bone marrow pre-B cells as compared to Rag
-/-
:IgHtg mice bone marrow pre-B cells (Figure 29b).  Thus, we conclude that RAG DNA DSBs in 
vivo activate a similar genetic program. 
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Transient RAG DNA DSBs activate NF!B. 
All data presented thus far supports the notion that persistent RAG DNA DSBs can 
activate a cohort of genes as all studies were performed in NHEJ-deficient cells.  That these 
persistent DSBs might activate signaling pathways not generally activated during V(D)J 
recombination in WT cells where breaks are efficiently repaired was a distinct possibility.  In this 
regard, we did not detect NF!B activation by EMSA in WT Abl pre-B cells that had been 
incubated with STI (Figure 30).  For the gene changes we have identified to generally affect 
lymphocyte development, it is important that they be activated by all RAG DNA DSBs, not just 
those that persist unrepaired.  
To determine whether transient RAG DNA DSBs can similarly activate NF!B and thus 
likely other components of this transcriptional program, we decided to introduce an NF!B reporter 
into WT cells that would enable us to detect NF"B activation on a cell-by-cell basis.  Our reporter 
is a retrovirus containing 5-tandem NF!B-responsive elements driving the expression of GFP on 
the antisense strand.  Thus, GFP would be produced only upon activation of NF"B.  The 
production of GFP could be analyzed by FACS (Figure 31a).  We further reasoned that, as these 
cells are arrested in G1 of the cell cycle, that any GFP produced would remain in that cell, and 
thus we could detect activation of NF"B that had occurred at any point in time even after the 
repair of the break (Figure 31b).   
We began by introducing our retroviral reporter into a Rag-2 deficient cell Abl pre-B cell 
line (RAG-2
-/-
 NRE, Figure 31b).  We show that, in these lines, there is very little NF!B activation 
upon STI treatment in the absence of RAG proteins (Figure 31b, 32, and 33a).   However, 
irradiation of these RAG-deficient lines, which induces a large number of DSBs, led to a robust 
GFP expression (Figure 32) demonstrating that this reporter enabled us to detect NF!B activation 
in response to DNA damage.  GFP production in these cells is ATM- and NF!B dependent as it 
does not occur when these irradiated cells are treated with the ATM inhibitor or the BAY inhibitor 
that prevents the phosphorylation of I!B" thereby preventing NF!B activation(263).   
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At this point, confident that our reporter system was working, we retrovirally introduced 
Rag-2 back into the RAG-2
-/-
 NRE cells thus creating a system wherein breaks could be made 
and repaired normally upon STI treatment (RAG-2
-/-
 NRE R2, Figure 31b).  Upon reconstitution of 
the RAG complex, STI treatment leads to DSB induction and efficient repair of the RAG DNA 
DSBs.  A significant fraction of cells turn GFP+ indicating that transient RAG DNA DSBs that are 
repaired normally do activate NF"B (Figure 33a).  Again, this GFP production was dependent on 
both ATM and NF!B as it was prevented by both the iATM and the BAY inhibitor (Figure 33a).  
Next, we sorted these GFP+ cells and GFP- cells by flow-cytometric assisted cell sorting.  The 
GFP+ cells isolated had a 5-fold greater amount of CJ formation as compared to the GFP- 
population as assayed by PCR analysis, demonstrating that the cells that had activated NF!B 
had undergone rearrangement (Figure 33b and c).  Furthermore, we detect changes in the 
expression of the RAG-dependent genes in the GFP+ cells as compared to the GFP- cells.  
Therefore, we conclude that RAG-DNA DSBs that are made and repaired normally do, in fact, 
activate the transcriptional program we had observed initially using the NHEJ-deficient Abl pre-B 
cells.   
Further supporting the notion that transient breaks activate the described transcriptional 
program is our ability to detect significantly higher levels of CD40, CD69, and CD62L (genes 
known to be activated by ATM in response to persistent RAG DNA DSBs) on the surface of WT 
pre-B cells (B220
+
:IgM
-
) by FACS as compared to Atm
-/-
 cells at a similar developmental stage 
(Figure 34).  This B220
+
:IgM
-
 population consists primarily of pre-B cells that would be actively 
rearranging the endogenous kappa locus.  Thus, we have identified a RAG-DNA DSB dependent 
transcriptional program that includes genes with no known function in the canonical DNA DSB 
response.  Furthermore, these changes are observed in WT cells, not just those with persistent 
DSBs.  
Conclusion 
Following a genotoxic insult, ATM activates transcriptional pathways that mediate the 
balance between cell survival and death, namely NF"B and p53.   In response to RAG DSBs in 
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the developing lymphocyte (both WT and NHEJ-deficient cells), we demonstrate that ATM, 
through the activation of NF!B and other transcription factors, activates a broad genetic program 
that transcends this canonical DNA damage response and includes genes whose known 
functions are integral to lymphocyte development.  We hypothesize that these signals emanating  
from a RAG DNA DSB are integrated with the numerous other cellular cues to overall guide 
lymphocyte development. 
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Figure 23.  Persistent RAG DNA DSBs activate NFκB.  (a) NFκB EMSA of nuclear 
lysates from Rag2-/-, Artemis-/- and Artemis-/-:Atm-/- abl pre-B cells treated with STI571 
for the indicated number of hours.  NFY EMSA is shown as a control.  (b) Southern blot 
analysis of Rag DSBs (coding ends, CEs) generated at the Jκ gene segments in the 
IgLκ locus in cells treated with STI571 for the indicated number of hours. Bands 
generated by the germline (GL) IgL-κ locus and Jκ1 and Jκ2 CEs are indicated. The 
schematic of the products shows the relative positions of the restriction sites (EcoRI 
and SacI) and probe (filled rectangle) used for analysis.  
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Figure 24. RAG DNA DSBs activate NFκB via the classical pathway.  (a) NFκB supershift 
using antibodies to p50 or p65. (b) NFκB EMSA of nuclear lysates from Artemis-/- Abl pre-B  
cell lines that express an IκBα−dominant negative, IκBα-ΔN, generated by transfection of the 
parent Artemis-/- line as indicated treated with STI571 for either 0 or 48 h. (c) NFκB EMSA of 
nuclear lysates from Artemis-/- Abl pre-B cell lines treated with STI571 in the presence of 
increasing concentrations of either a cell-permeable NEMO binding domain peptide (NBD) or 
a control cell-permeable NBD mutant peptide (MUT).  NFY EMSAs are shown as loading 
controls.
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Figure 25.  Global changes in gene expression in response to RAG DNA DSBs.  (a) Schematic 
of gene expression changes in response to Rag DSBs by microarray analyses.  (b) RT-PCR analysis 
of mRNA isolated from Rag2-/- (white bars), Artemis-/- (red bars), Artemis-/-  (blue bars) and 
Artemis-/-:Atm-/- (grey bars) abl pre-B cells treated with STI571 for 0 or 48 hours.  Mean and standard 
deviation from two experiments.  P values calculated using a one-tailed t-test. 
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Figure 26.   RAG-dependent gene expression changes cause changes in protein expres-
sion.  (a) Western blot analysis of Pim-2 expression in abl pre-B cells treated with STI571 for 48 
hours.   The three isoforms of Pim-2 are shown.   Erk2 is shown as a protein loading control.   
(b) Flow cytometric analysis of CD40 and CD69 protein expression on abl pre-B cells treated 
with STI571 for 48 or 96 h.   Red histogram represents cells treated with STI571 alone;  blue 
histogram represents cells treated with STI571 and KU-55933 (iATM).
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Figure 27.  Time course of gene expression changes in response to RAG DNA DSBs.  
RT-PCR analysis of gene expression in abl pre-B cells treated with STI571 for different 
periods of time.  Asterisks indicate that the difference between the Rag2-/- and Artemis-/- 
cell lines is significant (p<0.05).
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Figure 28.  Gene expression changes are not a result of Artemis-deficiency per se.  RT-PCR 
analysis of expression of the indicated genes in untreated and STI571-treated (a) Rag2-/-, Artemis-/-, 
and Artemis-/-:Rag2-/-  or (b) Rag2-/-, scid, and Ku70-/- abl pre-B cells. Values are mean and standard 
deviation from two experiments. P values were calculated using a one-tailed t-test. 
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Figure 29.  Gene expression changes downstream of RAG DNA DSBs in primary cells.  (a) 
Schematic of gene expression analysis carried out on bone marrow pre-B cells.  Gene expression 
profiling was carried out on RNA isolated from purified B220+:IgM- cells from the bone marrow of 
Rag1-/-:IgHtg and Artemis-/-:IgHtg mice.  (b) Flow cytometric analyses of CD40, CD69, CD80 and 
CD62L expression by B220+:IgM- bone marrow B cells (primarily pre-B cells) from Rag1-/-:IgHtg and 
Artemis-/-:IgHtg mice (gated cells in a).  Histograms for specific antibodies (red) and isotype controls 
(blue) are shown.
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Figure 30.  NFκB is not detectable in response to transient Rag DNA DSBs by EMSA.  
NFκB EMSA of nuclear lysates from wild type (WT) and Artemis-/- abl pre-B cells treated with 
STI571 for the indicated times.  NFY EMSA is shown as a control.
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Figure 31.  A reporter to detect NFκB activation in response to transient DNA DSBs.  (a) 
Schematic of the pMSCV-NRE-GFP retrovirus, showing the Thy1 cDNA (T), the five tandem NFκB 
responsive elements (NRE), and the GFP cDNA in the anti-sense orientation.  (b) Schematic of 
pMSCV NRE-GFP activation and GFP expression by treated and untreated Rag2-/-:NRE and 
Rag2-/-:NRE:R2 cells. Transcription of the NRE-GFP cassette is indicated by the filled arrow from 
NRE and green shading of the GFP cDNA rectangle. The cessation of GFP transcription, as 
indicated by the white filled GFP cDNA rectangle, after repair of Rag-mediated DSBs is presumed. 
The presence of GFP in the cell is indicated by green shading of the cell. Rag DSBs are indicated 
by the discontinuity between the V and J gene segment, and a coding joint is indicated by the 
juxtaposition of the V and J gene segment. The retrovirally introduced Rag2 cDNA in Rag2-/-
:NRE:R2 cells is shown (R2). 
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Figure 32.  NFκB reporter detects activation of NFκB by genotoxic agents.  Activation of 
NFκB in Rag2-/-:NRE cells in response to IR induced DSBs. Rag2-/-:NRE abl pre-B cells were 
treated with STI571 for 24 hours, then either not irradiated (no IR) or irradiated with 0.5 Gy (IR) 
and treated with vehicle alone, the Atm inhibitor KU-55933 (iAtm), or the inhibitor of IκB phos-
phorylation, BAY 11-7085 (BAY). Cells were analyzed for GFP expression from pMSCV-NRE-
GFP by flow cytometry 12 hours post-irradiation.
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Figure 33.  Transient Rag DNA DSBs activate NFκB.  (a) Flow cytometric analysis of GFP 
expression in Rag2-/-:NRE and Rag2-/-:NRE:R2 cells treated with STI571 for 48 hours in the pres-
ence or absence of the Atm inhibitor KU-55933 (iAtm).  The percentage of GFP+ cells is indicated.  
(b) Schematic of the pMX-DELCJ retroviral recombination substrate.  Shown is the GFP cDNA in the 
anti-sense orientation flanked by RSs (open triangles).  Also shown are the IRES-human CD4 
(I-hCD4) cassette, the long terminal repeats (LTRs), and the retroviral packaging sequence (ψ). The 
relative position of the pC and pB oligonucleotides (arrows) used for PCR analysis of coding joint 
(CJ) formation and the pD oligonucleotide (bar) used to probe the PCR products are also shown. 
(c) Rag2-/-:NRE and Rag2-/-:NRE:R2 abl pre-B cells were un-treated (-) or treated with STI571 for 48 
hours (+) and GFP+ and GFP- Rag2-/-:NRE:R2 abl pre-B cells isolated by flow cytometric cell 
sorting.  Serial 4-fold dilutions of genomic DNA from all cells was assayed for pMX-DELCJ 
rearrangement by PCR.     
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Figure 34.  Transient breaks in vivo activate a broad genetic program.  Flow cytometric 
analyses of CD40, CD69 and CD62L expression by B220+:IgM- bone marrow B cells (gated 
cells in dot plot) from WT and Atm-/- mice.  Histograms for the specific antibodies (red) and 
isotype control (blue) are shown.  
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The generation of a functional antigen receptor gene in developing lymphocytes requires 
that the second exon be assembled through a process known as V(D)J recombination, which 
necessarily involves the generation and repair of DNA double-strand breaks made by the RAG 
endonuclease(1-3).  Double strand breaks incurred during G1 of the cell cycle activate ATM, a 
PI3-kinase-like-kinase (PIKK) that, in response to genotoxic DNA damage, is known to 
phosphorylate hundreds of proteins with unique and diverse functions that coordinate the DNA 
damage response(71-73).  Notably, deficiencies in ATM lead to ataxia-telangiectasia, a syndrome 
characterized by lymphopenia, genomic instability and a predisposition to tumors involving 
antigen receptor loci(99).  These findings indicate that ATM plays a critical role downstream of 
RAG-mediated DNA DSBs during V(D)J recombination.  The work presented here defines novel 
pathways activated by ATM in response to RAG DNA DSBs.  Taken together with previous 
findings, the major ATM-dependent effector functions of the DNA damage response activated by 
RAG DNA DSBs include the following: 
1—ATM promotes the efficient, proper repair of RAG DNA DSBs by maintaining coding ends in a 
stable post-cleavage complex through the MRN complex. 
2—ATM promotes the activation of a broad genetic program that promotes the survival of cells 
actively undergoing V(D)J recombination but that also has potential diverse implications for 
lymphocyte development and function. 
3—ATM activates p53-dependent apoptotic pathways in response to persistent unrepaired RAG 
DNA DSBs. 
4—ATM phosphorylates H2AX to prevent resection of unrepaired coding ends and their aberrant 
resolution by homology-mediated pathways in G1 of the cell cycle. 
Below I discuss how defects in each of these functions likely underlie the phenotypic 
manifestations of ATM-deficiency, namely lymphopenia and a predisposition to lymphoid tumors 
involving antigen receptor loci.   
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Lymphopenia of ATM-Deficiency 
Lymphopenia caused by a defect in the repair of RAG DNA DSBs. 
V(D)J recombination is the process by which the antigen receptors that are absolutely 
required for lymphocyte development are assembled.  As such, defects in the generation or repair 
of RAG-induced DNA DSBs during V(D)J recombination can result in severe lymphopenia.  As 
discussed above, SCID and RS-SCID patients harbor mutations in the RAG components that 
prevent DSB generation or in NHEJ factors that prevent the repair of the RAG-induced DSBs, 
respectively(65). Interestingly, A-T patients and ATM-deficient mice exhibit a phenotype that 
might be described as mild RS SCID.  The patients and mice have a mild lymphopenia with 
reduced numbers of T cells primarily(111, 112).  Furthermore, ATM-deficient mice are sensitive to 
ionizing irradiation, and AT patients have sensitivities to DSB-generating chemotherapeutic 
agents further suggesting that there may be a general defect in repair of DNA DSBs in the 
absence of ATM(122).  Unlike the known core NHEJ-factors, however, we show that ATM is not 
absolutely required for V(D)J recombination and a majority of IR-induced breaks are repaired in 
the absence of ATM activity (122, 140).  However, we reasoned that a non-absolute defect in the 
repair of RAG DNA DSBs could also impart radiosensitivity and cripple V(D)J recombination 
which would impact total lymphocyte numbers.   
We demonstrate that ATM-deficient lymphocytes do, in fact, have a defect in the repair of 
RAG DNA DSBs characterized by an accumulation of unrepaired coding ends and an overall 
decrease in normal coding joint formation during rearrangement by both deletion and 
inversion(107, 108).  Additionally, during rearrangement by inversion, ATM-deficient cells form 
aberrant hybrid joints with near equal kinetics as normal CJs(107). 
How do we explain the decrease in normal CJ formation during rearrangement by 
deletion and inversion and the increase in HJ formation during rearrangement by inversion only? 
This defect is currently most aptly explained by a requirement for ATM in promoting the stability of 
the post-cleavage complex(107).  One would predict that the loss of coding ends from this 
complex would lead to a decrease in CJ formation as ends that drift apart cannot be efficiently 
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joined.  In fact, there is much redundancy amongst DNA repair factors that tether the broken DNA 
ends in many DNA repair pathways suggesting that keeping these broken ends in close physical 
proximity is absolutely required for efficient joining.  Indeed, in our ATM-deficient cells, FISH 
analysis supported this hypothesis; unrepaired coding ends are more frequently separated from 
one another in Atm
-/-
 cells as compared to WT cells(107).  This defect would affect rearrangement 
by deletion and by inversion.  Furthermore, instability of the post-cleavage complex might also 
explain the aberrant formation of hybrid joints only during rearrangement by inversion.  During 
rearrangement by inversion, a decrease in the stability of the post-cleavage complex would allow 
the intervening sequence to escape from the complex.   A resulting joint between the remaining 
coding end and signal end to form a HJ may reflect an act of desperation on the cell’s behalf to 
maintain genomic integrity.  During rearrangement by deletion, the intervening sequence is 
normally lost.  Instability of the post-cleavage complex would not worsen this situation.  In fact, 
hybrid joint formation during rearrangement by deletion would require that the intervening 
segment of DNA that is normally excised be inverted and maintained within the complex.  Thus, 
we believe that the aberrant HJ formation during inversional rearrangement and the decrease in 
CJ formation during both deletional and inversional rearrangment can both be attributed to a 
decrease in the stability of the post-cleavage complex(107).   
This activity of ATM during the repair of RAG induced DNA DSBs requires its kinase 
activity as treating wild-type cells with an ATM-specific kinase inhibitor leads to a phenotype 
similar to that of ATM deficiency(107).  Presumably, then, ATM does not have a direct structural 
role in promoting post-cleavage complex stability.  Rather, it may rely on the phosphorylation-
dependent end stabilizing activities of an ATM substrate(s) at the break site.  In this regard, the 
MRN complex is a potential candidate substrate.  As discussed above, Mre11 can align two 
broken DNA ends and Rad50 can tether two broken DNA ends(75, 76, 78, 81, 83, 86).  All three 
components of the MRN complex (Mre11, Rad50, and Nbs1) are phosphorylated by ATM(71, 
300-302).  Indeed, we demonstrate here that MRN-deficient cells have a similar, though milder, 
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repair defect as that characterized in the ATM-deficient cells.  We note an increase in the number 
of HJs and a decrease in CJ efficiency. 
Mice and patients deficient in any MRN component exhibit phenotypes that mimic ATM-
deficiency(117, 291-298).  Many have reasoned that the similarities in these phenotypes could 
simply reflect the role of the MRN complex as sensor in the DNA damage response in recruiting 
ATM and promoting ATM activity(70, 77, 90, 91, 104, 291, 299).  Thus, the repair defect we see 
in the MRN-deficient cells may simply reflect an inability to fully activate ATM and the DNA 
damage response.  That is, MRN may be acting upstream of ATM to promote the proper repair of 
RAG DNA DSBs.  However, we do not see a global decrease in the phosphorylation of ATM 
substrates such as H2AX or the activation of ATM dependent DNA damage response pathways 
such as NF!B activation.   These data suggest that MRN has important roles downstream of ATM 
in promoting the stability of the post-cleavage complex during the repair of RAG-mediated DSBs.    
Does this repair defect observed in the ATM and MRN-deficient cells explain the 
lymphopenia observed in patients and mice with deficiencies in these factors?  In both situations, 
T cell numbers are depleted moreso than B cell numbers(108, 292).  In both ATM- and Nbs-
deficient mice, we note a block in thymocyte development that results in decreased numbers of 
TCR-" intermediate DP thymocytes and partially explains the paucity of fully developed T 
cells(108).  To reach this stage of development the thymocytes must rearrange the TCR# allele 
and the resulting TCR must be capable of positive selection(108).  Often, a single round of V(D)J 
recombination does not produce a receptor that fulfill this requirements and successive 
rearrangements must take place.   Failed repair at any juncture could result in thymocyte 
death(108).  Thus, slightly attenuated efficiency of CJ formation during TCR# rearrangement 
could explain this block in thymocyte development(108).  The repair defect of ATM- and MRN-
deficiency may at least partially explain the T cell lymphopenia.  However, we would note that the 
joining is likely similarly impaired in thymocytes at other stages of development and B cells 
undergoing V(D)J recombination but not manifested as a decrease in these populations as the 
antigen receptor loci rearranged in these cells at other developmental stages do not undergo 
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successive rearrangements to the same extent that T cells undergoing alpha 
rearrangement(108).  Analysis of rearrangement of the TCR# locus and numbers of DP 
intermediates may simply be a more sensitive assay for defects in CJ formation in the 
endogenous loci. 
We conclude that the described defect in the repair of RAG DNA DSBs contributes to the 
lymphopenia of ATM-deficient mice and humans as well as those deficient in MRN complex.  We 
would note, however, that the described repair defect only leads to an ~50% reduction in CJ 
formation and is not likely to completely account for this aspect of the ATM-deficient 
phenotype(107, 108).  Thus, we sought to identify other ways in which ATM might affect 
lymphocyte development.   
Lymphopenia caused by defects in the RAG-dependent genetic program. 
The canonical DNA damage response is largely concerned with promoting survival and 
cell cycle checkpoints during the repair of the break and initiating apoptosis in the event that the 
break cannot be repaired(73).   In this regard, ATM activates p53 in cells with persistent RAG 
DNA DSBs(244).  To this point, however, it was difficult to determine whether every RAG break or 
just those that remained unrepaired initiated the DNA damage response.  Indeed, activating p53 
in response to each RAG DNA DSB would be problematic because all lymphocytes must make 
and repair numerous RAG DNA DSBs during the course of development.   The activation of p53, 
which initiates cell cycle checkpoints as well as apoptotic pathways, in response to each transient 
RAG DNA DSB, would significantly decrease the number of lymphocytes that successfully 
undergo V(D)J recombination.  However, ATM might activate p53 in response to every RAG DNA 
DSB if it could simultaneously activate pro-survival pathways.  The balance of these two 
pathways might determine cell survival.  In this regard, ATM activates both p53 and NF!B in 
response to genotoxic DNA damage(244, 247, 269).  Furthermore, inactivation of NF!B signaling 
leads to increased IR sensitivity, demonstrating that NF!B activation by ATM promotes cell 
survival following DNA damage(247).  Similarly, we detect robust NF!B activation in response to 
persistent RAG DNA DSBs in NHEJ-deficient lymphocytes.  Interestingly, we also detect NF!B 
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activation in response to transient RAG DNA DSBs in WT cells undergoing V(D)J recombination.  
Thus, it is likely that all RAG DNA DSBs activate the DNA damage response and result in 
transcriptional changes within the developing lymphocyte. 
Lymphocytes with RAG DNA DSBs exhibit higher levels of pro-survival genes such as 
Pim-2 and Bcl-3 than observed in cells without RAG DNA DSBs.  These transcriptional changes 
are dependent on both ATM and NF!B.   Pim2 expression promotes the survival of lymphocytes 
following withdrawal of IL-7, a situation that mimics the environment of a lymphocyte undergoing 
V(D)J recombination; pre-B cells undergoing rearrangement of the kappa locus actively move 
away from IL-7 producing stromal cells(313).  Thus, the ATM-dependent up-regulation of Pim-2 in 
response to RAG DNA DSBs might promote the survival of cells actively undergoing V(D)J 
recombination in an IL-7-depleted environment(J. Bednarski, unpublished).  We conclude that the 
activation of NF!B by ATM in response to each RAG DNA DSB may promote the survival of cells 
undergoing V(D)J recombination and may be required to counteract the activation of p53 by the 
same DNA DSB.  Defects in the activation and regulation of these pathways might lead to a 
disruption of the pro-life and pro-death balance in these developing lymphocytes and might also 
contribute to the lymphopenia observed in the setting of ATM-deficiency. 
Lymphopenia caused by defects in the RAG-dependent genetic program. 
We often think of the cellular response to DNA DSBs as a “damage” response.  As 
discussed above, the canonical DNA damage response is known primarily to promote survival 
and cell cycle checkpoints during the repair of the break and initiating apoptosis in the event that 
the break cannot be repaired(244).  In lymphocytes, however, RAG DNA DSBs are requisite 
intermediates in a process that is absolutely required for their proper development(1-3).  Even 
transient RAG DNA DSBs can activate these DNA damage response pathways.  As such, this 
“damage” response is likewise a part of normal development and the signaling pathways initiated 
in response to RAG-mediated DNA DSBs could affect lymphocyte development and/or function.  
With these thoughts in mind, we decided to more fully characterize the transcriptional 
pathways activated by ATM in response to RAG DNA DSBs.  Comparing the microarray analysis 
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data of lymphocytes with RAG DNA DSBs and those without DNA DSBs enabled us to globally 
determine the transcriptional changes afforded by the RAG DNA DSB.  Analysis of this 
microarray data revealed that the transcriptional pathways activated by ATM in response to DNA 
DSBs are more numerous and diverse than previously thought; ATM activates a broad genetic 
program in response to RAG DNA DSBs.  Only half of the ATM-dependent transcriptional 
changes caused by RAG DNA DSBs are mediated by NF!B.  The others, we reason, are caused 
by transcription factors similarly directly or indirectly activated by ATM.  It is notable that other 
transcription factors such as Stat3 and Foxo1 have SQ/TQ motifs that could be potentially 
modified by ATM(71).  
A large fraction of this broad genetic program initiated by RAG DNA DSBs includes 
genes with no known function in the canonical DNA damage response.  Rather, these are genes 
whose known functions implicate them in lymphocyte development and/or function.  For example, 
a subset of these genes (L-selectin, Swap70, and CD69) have known roles in lymphocyte homing 
and migration(309-312).  This suggests that RAG DNA DSBs might cause changes in the cell that 
somehow affect the localization of lymphocytes undergoing V(D)J recombination, perhaps 
through alterations in the expression levels of cell surface receptors.  In support of this possibility, 
we find that lymphocytes harboring RAG dependent DNA DSBs partition differently between the 
peripheral blood and bone marrow than lymphocytes without breaks.  The transcriptional 
changes, then, initiated by RAG DNA DSBs can have physiological consequences for the 
developing lymphocyte.  While this is just one example, we believe that future work will elucidate 
additional developmental or functional consequences of the broad transcriptional program 
activated by ATM in response to RAG DNA DSBs.  ATM influences lymphocyte development in 
ways not directly related to DNA repair or the survival of lymphocytes with breaks.   Defects in 
this program might additionally contribute to the lymphopenia and immunodeficiency of ATM-
deficient mice and humans.   
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Lymphopenia—A Combination of Two Distinct Defects 
Based on the collected evidence, we propose that the lymphopenia observed in the 
setting of ATM-deficiency is caused by two primary factors.  First, defects in the repair of RAG 
DNA DSBs lead to a smaller number of developing lymphocytes that successfully undergo V(D)J 
recombination to produce a functional antigen receptor gene.  Second, ATM is required to 
activate a broad transcriptional program in response to RAG DNA DSBs.  This program promotes 
the survival of cells actively undergoing V(D)J through the activation of NF!B.  However, ATM 
also activates the transcription of genes that may affect lymphocyte development and/or function 
in additional and diverse ways. 
A Predisposition to Lymphoid Tumors Involving Antigen Receptor Loci 
In addition to lymphopenia, ATM-deficient mice and humans have a predisposition to 
lymphoid malignancies with translocations involving antigen receptor genes.  The development of 
lymphoid malignancy requires a failure of the DNA damage response at multiple levels.  Thus, 
just as defects in multiple ATM-dependent pathways can contribute to lymphopenia, the same is 
likely true for the development of lymphoid malignancies. 
ATM deficiency causes a combined repair and checkpoint defect. 
We have described a repair defect in ATM-deficient cells and mice that leads to an 
accumulation of unrepaired coding ends(107, 108).  Notably, ATM is also required to promote 
p53 activation in response to DNA damage(244).  Thus, in the absence of ATM, a single protein, 
we have essentially recapitulated the phenotype of mice deficient in both NHEJ and p53-
dependent pathways that develop lymphoid malignancies at a young age(150).  
It is thought that broken DNA ends form translocations primarily by joining with other 
broken DNA ends present in that particular cell(314).  Cells arrested in G1-phase of the cell cycle 
generally have very few DNA DSBs besides RAG DNA DSBs.  This is evidenced by the fact that 
we rarely see $-H2AX foci in G1-arrested Rag
-/-
 Abl pre-B cells(211, 276).  While RAG DNA DSBs 
can occur outside the confines of the antigen receptor genetic loci, this is rare.  Thus, unrepaired 
coding ends would not have ample opportunity to form translocations in G1.  However, the 
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combined defect in repair and cell cycle checkpoint allows these ends to persist through multiple 
rounds of cell division(202, 272).  During cell division, many DSBs are produced during DNA 
replication and other cellular processes.  Thus, the persistence of these ends throughout the cell 
cycle would greatly increase the chance that they would form translocations(202, 272).  The 
combined repair and checkpoint defect in ATM-deficient mice and humans likely contributes to 
the predisposition to lymphoid tumors with translocations involving antigen-receptor loci.  
ATM actively prevents the aberrant resolution of persistent DNA ends. 
However, we reasoned that ATM might play an additional active role in preventing 
unrepaired coding ends from accessing aberrant repair pathways, effectively shuttling cells that 
harbor these persistent breaks towards p53-mediated pathways.  As discussed in the 
introduction, DNA repair pathway choice is determined at the level of end-resection(139).  Even 
small amounts of end resection prevent NHEJ and commit the cell to repair through alternative 
homology-mediated pathways(140-142, 176).  Cells undergoing V(D)J recombination are 
arrested in G1, where no sister chromatid is present; thus, repair by homology-mediated 
pathways would be particularly deleterious as it would lead to deletions and/or translocations.  
During HR, end resection is initiated through the cooperative action of Mre11 and CtIP(76, 129-
136).  Importantly, we have shown that Mre11 functions during V(D)J recombination as a 
component of the MRN complex and is present at RAG DNA DSB sites.  Mre11 possesses both 
endo- and exo-nucleolytic activities but is not able to efficiently open the hairpin-sealed coding 
ends in Artemis
-/-
 cells(77, 81).  Thus, we know that end resection is tightly regulated during V(D)J 
recombination.  We hypothesized that another ATM-dependent effector function of the DDR might 
be to ensure that persistent unrepaired DNA ends are not resected in a manner inappropriate to 
the stage of the cell cycle.  Specifically, we predicted that unrepaired coding ends in the G1-
phase of the cell cycle during V(D)J recombination are not resected. 
We further reasoned that ATM would modulate end-processing pathways through the 
break-induced phosphorylation of one or more of substrates.  In this regard, histone H2AX is 
phosphorylated in chromatin flanking DNA DSBs, including those generated by the RAG-
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endonuclease forming $-H2AX(206, 211).  $-H2AX is required for the maintenance of a host of 
repair and signaling proteins at the site of a DNA DSB(233).  H2AX-deficient cells have a 
predisposition to genomic instability but no overt defect in the repair of RAG DNA DSBs, which is 
what we might expect if H2AX functions mainly in dealing with rare persistent RAG DNA 
DSB(233, 235, 243).   Furthermore, while hairpin-sealed coding ends in Artemis
-/-
 cells are rarely 
resolved as translocations, those in Artemis
-/-
:H2AX
-/- 
cells are more frequently resolved as 
translocations(243).  The resolution of a hairpin-sealed coding end, at a minimum, would require 
end opening.  Thus, we hypothesized that H2AX might regulate the processing of unrepaired 
coding ends and furthermore, that the phosphorylation of H2AX by ATM at the site of these RAG 
DNA DSBs might be required to facilitate end processing.  Accordingly, we designed experiments 
to assess the integrity of unrepaired coding ends that accumulate in NHEJ-deficient cells in the 
presence and absence of H2AX. 
We find that, in the absence of H2AX, unrepaired coding ends are robustly resected.  We 
further demonstrate that the ATM-dependent phosphorylation of H2AX(forming $-H2AX) and 
Mdc1, a factor that directly binds $-H2AX, are both required to prevent this resection.  Finally, we 
demonstrate that the end resection we see is mediated by CtIP, the mammalian homologue of 
yeast endonclease Sae2.  The coding ends that have undergone aberrant CtIP-dependent 
processing are not efficiently joined by NHEJ.  Furthermore, the joints that do form exhibit large 
deletions and usage of homology-mediated repair.  The numerous implications of this novel role 
for $-H2AX during DNA repair as well as additional thoughts regarding the resection and joining of 
these aberrantly processed ends are addressed below. 
Regarding the End Resection 
As discussed in the introduction, during HR, Mre11 and CtIP cooperate to initiate the 
resection of broken DNA ends that allows for the formation of a long 3’ ssDNA overhang that 
permits strand invasion(76, 129-136).   However, the activity of CtIP and Mre11 is normally 
restricted to post-replicative stages of the cell cycle.  How, is it then, that H2AX prevents the CtIP-
mediated opening and resection of persistent coding ends in Artemis
-/-
:H2AX
-/- 
and Ligase IV
-/-
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:H2AX
-/-
 cells that are arrested in G1 of the cell cycle?  We hypothesize, based on known protein-
protein interactions and crystallographic data, that the phosphorylation of H2AX may be required 
to exclude CtIP from the site of a persistent RAG DNA DSB in G1-phase cells.  As demonstrated 
above, MRN functions during V(D)J recombination and Nbs1 has been demonstrated to localize 
at RAG DNA DSBs(105).  We also know that MRN and CtIP directly interact in mammalian 
cells(89, 229, 230, 315).  In fission yeast, Ctp1 (the homologue of CtIP) associates with the FHA 
domain of Nbs(88, 89, 229-231, 315).  Interestingly, MDC-1 binds to that same FHA domain of 
mammalian Nbs1(89).  In response to a DNA DSB, H2AX is rapidly phosphorylated and this 
phosphorylated H2AX is subsequently bound by Mdc1(206, 214, 228).  Mdc1 then interacts with 
Nbs1 in a manner that is thought to potentiate ATM signaling(228, 316).  However, in doing so, 
we hypothesize that it may competitively displace CtIP associated with the MRN complex at the 
break site.  Such a model would be completely congruent with our findings as $-H2AX and Mdc1 
are both required to prevent end resection, and furthermore, we now know that the MRN complex 
functions during V(D)J recombination.  We plan to test this hypothesis using ChIP assays to 
determine whether CtIP is associated with RAG DNA DSBs and whether that association is 
increased or altered in some manner in the absence of H2AX or Mdc1, perhaps explaining the 
aberrant end resection observed in H2AX-deficient cells. 
ATM is required to generate $-H2AX in chromatin flanking RAG DSBs(209-211).  In turn, 
MDC-1 amplifies DNA damage response signals, in part, by recruiting ATM to the site of a 
DSB(228, 316).  As such, we reasoned that ATM would be required to prevent the nucleolytic 
resection of coding ends in G1-phase cells.  However, we do not detect degradation of coding 
ends in Artemis
-/-
:Atm
-/-
 Abl pre-B cells though $-H2AX formation is largely disrupted in these 
cells.  This seemed at odds with our data demonstrating that ATM-mediated phosphorylation of 
H2AX is required to prevent end resection.  However, we subsequently show that ATM kinase 
activity is required to promote CtIP-mediated resection of persistent coding ends in the absence 
of H2AX.  Inhibition of ATM kinase activity in Artemis
-/-
:H2AX
-/-
 cells completely abrogates the 
opening and resection of hairpin-sealed ends.  Thus, ATM activates opposing pathways that 
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regulate resection of persistent coding ends.  How ATM promotes CtIP activity, however, is still 
largely unknown.  In Xenopus extracts that have characteristics of G1-phase cells, ATM activity is 
also required for CtIP activity, possibly through affecting its recruitment to a DNA DSB.  In this 
system, CtIP is recruited to a DNA DSB after ATM and Nbs in a manner that requires MRN and 
ATM kinase activity(135).   We know that CtIP is phosphorylated by ATM in response to DNA 
damage(71, 135, 317).  However, in Xenopus extracts, mutation of all possible SQ/TQ sites in 
CtIP does not alter the localization of CtIP to a DNA DSB suggesting that ATM might affect the 
localization of CtIP indirectly(135).  One possibility is that the ATM-dependent phosphorylation of 
another substrate might recruit CtIP to the site of a DNA DSB.  We would like to test whether 
ATM kinase activity similarly alters the localization of CtIP in lymphocytes and whether the 
phosphorylation of CtIP in response to DNA damage alters its localization.  It is also notable that 
CtIP has known functions as a transcriptional regulator, and the ATM-dependent phosphorylation 
of CtIP can lead to alterations in gene expression(317).   CtIP associates with CtBP and they 
function together as a transcriptional co-repressor; interaction of CtIP and CtBP with BRCA1, for 
example, leads to decreased expression of BRCA1 target genes p21 and GADD45(317).   
Phosphorylation of CtIP by ATM causes its dissociation from BRCA1.  This releases the 
repression and the cellular levels of both p21 and GADD45 transcripts increase(317).  Thus, the 
ATM-dependent end resection of the persistent coding ends in Artemis
-/-
:H2AX
-/-
 and Ligase IV
-/-
:H2AX
-/-
 cells could also be a consequence of indirect effects of CtIP on gene transcription.  For 
example, phosphorylation of CtIP may activate (de-repress) the transcription of a nuclease that 
can promote the degradation of persistent coding ends.   
While it is likely that Mre11 and CtIP cooperate to cause the resection of persistent 
coding ends in the Artemis
-/-
:H2AX
-/-
 and Lig4
-/-
:H2AX
-/-
 cells, it is possible that CtIP is directly 
modulating the activity of another nuclease.  Though no nuclease activity of CtIP has been 
formally demonstrated, CtIP contains a domain structurally similar to the catalytic domain of the 
budding yeast endonuclease Sae2(135, 137).  In vitro, CtIP can alter the nuclease activity of 
Mre11(318).  It is also notable that while Mre11 and CtIP are required to initiate resection during 
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HR, other nucleases (Dna2/Sgs1 and Exo1 for example) are thought to cause the formation of 
the ssDNA strand(137, 139).  Thus, the degradation that we see may actually be a result of the 
nuclease activity of Mre11 or potentially other cellular nucleases.  Additional evidence from our 
laboratory suggests that other nucleases play a role in the resection of unrepaired coding ends 
during V(D)J recombination.  Consistent with this possibility, the coding ends that escape from 
the post-cleavage complex in Atm
-/-
 cells are degraded at late time-points as are unrepaired 
coding ends in Lig IV
-/-
:Atm
-/- 
cells; this end resection is not CtIP-mediated as we now know that 
ATM is required to promote robust CtIP activity.  However, this resection could also be regulated 
by H2AX as H2AX phosphorylation is largely abrogated in the absence of ATM.  In addition to the 
CtIP- and ATM-dependent resection of open coding ends in Ligase IV
-/-
:H2AX
-/-
 Abl pre-B cells, 
we note a delayed ATM-independent resection of these ends.  Finally, we observe residual end 
resection upon knockdown of CtIP in both the Artemis
-/-
:H2AX
-/-
 and Ligase IV
-/-
:H2AX
-/-
 cells.  
While the latter could be due to residual CtIP in these cells, it could also indicate that other 
nucleases act on persistent RAG DNA DSBs.  Together, these data suggest that the activity of 
other nucleases must also be regulated during V(D)J recombination.  By knockdown of candidate 
nucleases, specifically those known to function during HR with CtIP and Mre11, we may be able 
to further dissect components of the end processing pathways that collectively regulate the 
outcome of unrepaired ends.  These future experiments may also provide insight into whether 
CtIP itself promotes end resection or does so by regulating the activity of other cellular nucleases. 
Given the near normal repair of RAG DNA DSBs during V(D)J recombination in H2AX-
deficient cells but the profound effect of H2AX-deficiency on persistent coding ends, we propose 
that the phosphorylation of H2AX might be especially important to protect coding ends when they 
are not joined efficiently.  We predict that H2AX deficiency, when combined with defects that 
decrease the efficiency of RAG DNA DSB repair would lead to dramatic defects in V(D)J 
recombination.  XLF or Cernunnos is a recently discovered NHEJ-component with an 
undetermined role in V(D)J recombination(152, 319, 320).  In other settings, however, XLF 
associates with XRCC4 and Lig4 to alter the activity of this complex, increasing the efficiency of 
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joining and also enhancing the diversity of DNA ends that can be ligated by this complex(152, 
155, 157).  Intriguingly, while H2AX and XLF alone have no demonstrable defect in the repair of 
chromosomal RAG DNA DSBs in developing lymphocytes, a combined deficiency causes a 
profound defect in coding joint formation, with unrepaired coding ends exhibiting robust resection 
(unpublished data, Fred Alt lab).  These findings support our hypothesis that H2AX is especially 
important for cells in which breaks are not efficiently repaired; that is, XLF may cause a decrease 
in joining efficiency that necessitates end protection by H2AX.  Furthermore, XLF and H2AX may 
serve a redundant function in preventing the resection of unrepaired ends since end degradation 
in double mutants is greater than seen in the Artemis
-/-
:H2AX
-/- 
or Ligase IV
-/-
:H2AX
-/- 
Abl pre B 
cells alone.  Furthermore, combined deficiency of H2AX and NHEJ-component XLF leads to 
embryonic lethality ((278, 321) and unpublished communication), suggesting that their 
cooperative action has additional roles for other types of DNA DSB repair.  Determining how 
H2AX and XLF cooperate to promote repair and prevent end resection is, thus, a high priority. 
Finally, it remains puzzling that H2AX
-/- 
mice exhibit such profound genomic instability 
that is increased even further with genotoxic DNA damage but still lack an overt defect in the 
repair of RAG DNA DSBs(233, 235, 243).  This may indicate that H2AX-deficiency impacts the 
resolution of DNA DSBs generated by genotoxic agents moreso than those generated by the 
RAG endonuclease.  Importantly, RAG DNA DSBs are initiated by an enzymatic reaction that 
includes a hairpin-sealed intermediate(1).  RAG-generated DNA ends are maintained in a post-
cleavage complex that would presumably insulate them from the effects of cellular 
nucleases(198).  In contrast, broken DNA ends resulting from irradiation or other genotoxic 
agents are diverse; many of these ends incorporate modified bases that must be processed prior 
to joining, thus increasing the amount of time they persist(322).  Furthermore, these ends are not 
maintained in a post-synaptic complex.  Thus, the ATM-dependent phosphorylation of H2AX at 
such damage sites may be especially important in preventing end resection.  We propose that the 
lack of a significant defect in V(D)J recombination in H2AX
-/-
 mice may reflect these unique 
features of physiologic RAG DNA DSBs.   
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Regarding the joints formed in Artemis
-/-
:H2AX
-/-
:DEL
CJ
 Abl pre-B cells. 
Our observation that open resected ends in Artemis
-/-
:H2AX
-/-
 cells are not efficiently 
joined by NHEJ was especially surprising given that all requisite NHEJ components are present.  
This finding suggests that the nature of resected end prevents joining in G1 of the cell cycle, 
perhaps due to specific DNA end modifications or the generation of a significant ssDNA 
overhang.  Even small ssDNA overhangs can prevent Ku-binding to a DNA end, thereby inhibiting 
NHEJ(140-142, 176).  During HR, the combined activity of Mre11 and CtIP initiates a process that 
results in a long ssDNA structure(76, 129-136).  Therefore, we hypothesize that the combined 
activities of Mre11 and CtIP might similarly generate a ssDNA fragment during the processing of 
unrepaired coding ends in the absence of H2AX.  This would preclude joining by NHEJ during G1 
where these cells are arrested and may explain the persistent open coding ends we observe in 
the Artemis
-/-
:H2AX
-/-
 Abl pre-B cells.   Elucidating the structure of DNA ends generated in 
Artemis-deficient cells that also lack H2AX will be an important goal of future studies.   
It is notable that a low level of coding joints are formed successfully in our G1-arrested 
Artemis
-/-
:H2AX
-/-
 Abl pre-B cells.  However, PCR and sequence analyses of these joints reveal 
significant deletions (>1 kB).  During V(D)J recombination, deletions such as these would 
preclude the formation of a functional antigen receptor gene.   It is also possible this observation 
may have uncovered a potential source of the general genomic instability observed in H2AX
-/- 
mice.  Similar deletions at joints formed throughout the genome following genotoxic DNA damage 
could cause genomic instability and possibly lead to malignant transformation.  While 
chromosomal instability is often thought of in terms of whole chromosome loss or translocation, 
small deletions are frequent contributors to oncogenic transformation.  In this regard, small 
deletions in Brca-1 genes have been associated with breast and ovarian cancer; likewise, 
deletions in p53 are observed in a wide variety of tumors(323-325).  Thus, maintaining the 
integrity of broken DNA prior to joining is crucial.  Interestingly, H2AX may protect the genome 
from small cancer-causing deletions during DNA DSB repair.  It has been described that small 
deletions in p53 led to a reduced latency of disease, specifically thymic lymphomas, in H2AX
-/-
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:p53
+/-
:RAG-2
-/-
 mice as compared to p53
+/-
:RAG-2
-/-
 mice(326).  This noted predisposition to 
small deletions during other types of DNA DSB repair may be due to the role of $-H2AX in 
preventing the resection of broken DNA ends as demonstrated herein.  
 
Coding joints that form in Artemis
-/-
:H2AX
-/-
 may derive from a subset of ends whose 
processing does not generate a significant ssDNA overhang.  As such, these ends could be 
joined by classical NHEJ.  Alternatively, these ends may be processed in ways that produce 
structures incompatible with NHEJ.  In this case, the low level of joints we observe may form via 
an alternative homology-mediated pathway which is active but not efficient during G1.  In support 
of this notion, we demonstrate that the ends that are joined in the Artemis
-/-
:H2AX
-/- 
 Abl pre-B 
cells more frequently use microhomologies (up to 50% of joins in Artemis
-/-
:H2AX
-/- 
as compared 
to less than 5% in WT cells) and the tracts of homology are generally longer.  Importantly, the 
number of joints with microhomology that we detect are likely an underestimate of the true 
numbers since TdT is present and active in these cells.  TdT adds nucleotides to DNA ends in a 
non-templated fashion, and, in doing so, could create microhomologies that facilitate joining.  
However, these joints would not be classified as microhomology-mediated as these sequences 
would not be present in the germ-line.  Thus, the addition of non-templated nucleotides by TdT 
would obscure joining that does actually occur by homology.  We are currently generating 
Artemis
-/-
:H2AX
-/-
:TdT
-/-
 mice and cell lines that will enable us to more accurately assess whether 
joins made in the Artemis
-/-
:H2AX
-/-
 cells preferentially engage homology mediate repair pathways 
to resolve unrepaired coding ends during G1.  Importantly, the joining of unrepaired ends in a 
homology-mediated manner during G1 is particularly dangerous as there is no sister chromatid 
available to be used as a template for repair.  These ends might use regions of homologous DNA 
sequence on the same or other chromosomes to mediate joining, leading to larger chromosomal 
deletions and/or translocations that could likewise cause genomic instability.  We conclude that 
this aberrant resection and joining, could, in addition to the described combined repair and 
checkpoint defect, predispose ATM-deficient mice and humans to lymphoid tumors with 
translocations involving the antigen receptor loci. 
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Summary (see model in Figure 35) 
 Based on the work described here, we propose the following model for the functions of 
ATM during normal lymphocyte development.  ATM contributes to V(D)J recombination in two 
main ways to generate normal numbers of functional lymphocytes.  First, ATM maintains coding 
ends within a stable post-cleavage complex to promote efficient and proper repair of RAG DNA 
DSBs and enable developing lymphocytes to produce a functional antigen receptor gene.  
Second, ATM, through the activation of NF!B and other transcription factors, induces the 
activation of a broad genetic program that promotes the survival of lymphocytes while they 
rearrange their antigen receptor loci.  Moreover, this program includes gene products that are 
required for proper lymphocyte development and/or function.  In the event that RAG DNA DSBs 
persist unrepaired, ATM activates p53 to ensure that cells harboring these breaks undergo 
apoptosis.  Additionally, ATM, through the phosphorylation of H2AX, actively prevents unrepaired 
ends from being processed in ways that enable their aberrant resolution and effectively shuttles 
the cells harboring these breaks towards apoptotic pathways.  Together, these functions of ATM 
downstream of RAG DNA DSBs explain the lymphopenia and predisposition to lymphoid tumors 
observed in the absence of ATM. 
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Figure 35.  Functions of ATM during V(D)J recombination.
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